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ABSTRACT 
SCHWANN CELL PRECURSORS AND SCHWANN CELLS: 
SURVIVAL, PROLIFERATION, MATURATION, 
AND INTERACTION WITH NEURONS 
The first part of the studies presented in this thesis shows that NDFP (but not NDFOC), 
a member of a novel family of growth factors, acts as a long-term survival factor for 
Schwann cell precursors. The potential of NDFP to rescue precursors from apoptotic 
cell death is independent of activation of either IGF receptors or insulin receptors. In 
contrast, FGF in the presence of IGF only supports precursor survival for 20 hr. The 
loss of survival activity of this factor in long-term precursor cultures may be due to 
the fact that precursors lose their responsiveness to FGF. NDFP not only rescues 
precursors from apoptotic cell death but also stimulates DNA synthesis in these cells. 
The mitogenic potential generated by this factor is also independent of both activation 
of IGF receptors and elevation of cANW levels. FGF in combination with forskolin, a 
well known Schwann cell mitogen combination, fails to promote DNA synthesis in 
Schwann cell precursors. Interestingly, TGFP acts as a mitogen but not survival factor 
for these cells. Schwann cell precursors cultured in NDFP containing medium not 
only survive, but also develop into Schwann cells as judged by their ability to survive 
in defined medium and expression of S 100. Furthermore, this study also demonstrates 
that Schwann cell precursors express the NDF receptors: ErbB2 and ErbB4. 
The ability of NDF to regulate survival and DNA synthesis in Schwarin cell 
precursors suggests that this molecule may play an important role in the interaction 
between neurons and precursors. The second part of the thesis shows that both pure 
neuron conditioned medium and neuronal surface molecules support Schwann cell 
precursor survival, and neurons, but not Schwann cell precursors, express NDF 
protein. A soluble ErbB4 protein blocks the survival activity in neuron conditioned 
medium and that associated with neuronal surfaces, indicating that NDF acts as 
neuro-glia signalling molecule, mediating precursor survival. Furthermore, the 
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neuronal signals also induce DNA synthesis in Schwann cell precursors and drive the 
maturation and differentiation of these cells in the neuron-precursor co-cultures. 
The third part of the thesis demonstrates that two different mitogenic assays may give 
information that can be related to two different proliferation events, i. e. during nerve 
development and during Wallerian degeneration. In the first assay, using cells which 
are assayed immediately after dissociation from nerves, FGF, NDF, TGFP and PDGF 
have differing mitogenic activities which may reflect the mitogenic activity of these 
factors in normal nerve. In the second assay, using Schwann cells pre-cultured in 
serum-containing medium for 5 days, all the factors mentioned above are mitogenic, 
and the DNA synthesis stimulated by these factors is higher in adult Schwann cells 
than younger cells, which is in line with the massive proliferation of adult Schwann 
cells seen in Wallerian degeneration. 
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CHAPTERI 
GENERAL INTRODUCTION 
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SCHWANN CELL PRECURSORS AND SCHWANN CELLS: 
SURVIVAL, PROLIFERATION, MATURATION, 
AND INTERACTION WITH NEURONS 
It has been widely accepted that Schwann cells play an important role in the 
development and regeneration of the peripheral nervous system (PNS). During early 
development, neural crest cells give rise to several cell types: these include neuronal 
precursors , melanoblasts and Schwann cell precursors. The Schwann cell precursor, 
a intermediate cell in the Schwann cell lineage, undergoes programmed cell death 
when cultured without neurons in routine medium. In order to support its survival 
molecules from neurons are necessary. Neuronally derived molecules not only 
support Schwann cell precursor survival, but also allow them to generate Schwann 
cells in vitro. In vivo Schwann cells undergo massive proliferation during maturation. 
After birth, Schwann cells stop dividing and differentiate into two different cell types, 
myelin-forming and non-myelin-forming Schwann cells (Mirsky and Jessen, 1990; 
Jessen and Mirsky 1991; Jessen and Mirsky, 1992). Many efforts have been made to 
explore the molecular basis of the interactions between Schwann cells and neurons 
that regulate proliferation and differentiation. So far, the molecules derived from 
neurons that are important for Schwann cell precursor survival, proliferation and 
maturation have not been identified although FGFs were found to act as survival 
factor for precursors in short-term culture. Meanwhile, much remains to be learned 
about the growth factor regulation of Schwann cell proliferation at different 
developmental stages and under different culture conditions. This study focuses on 
Schwann cell precursor and Schwann cell survival, proliferation and maturation 
during development. The interaction between Schwann cells and neurons is explored 
and molecules from neurons involved in Schwann cell precursors survival are 
identified 
Thesis aims and objectives 
1. To explore molecules which cause the survival and proliferation of Schwann cell 
precursors at early stages of development. 
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2. To investigate survival, proliferation and maturation of Schwann cell precursors in 
contact with neurons and also to identify the possible neuronal molecules involved in 
Schwann cell precursor survival. 
3. To study the mitogenic response of Schwann cells derived from rats of different 
developmental stages in different growth factors and also under different culture 
conditions. 
DEVELOPMENT OF SCHWANN CELLS 
At an early embryonic stage, the ectoderm of the embryo thickens in the middle 
region and forms a neural plate. Soon after this, the lateral edges of this plate are 
elevated (neural folds) and fuse, finally leading to the formation of the neural tube. 
Using a fluorescent marker in chicken embryos it has been shown that neural crest 
cells arise mainly from the dorsal portion of the neural tube (Serbedzija et al., 1989). 
Trunk neural crest cells undergo widespread migration along characteristic pathways 
during embyrogenesis, giving rise to neurons, peripheral glia, melanocytes and 
adrenomedullary cells (Selleck et al., 1993; Stemple and Anderson, 1993; Anderson, 
1989; 1993; 1994; Bronner-Fraser, 1994). In the glial lineage, neural crest cells at 
trunk level meet up with outgrowing axons in the anterior part of each somite, and 
join with them to form embryonic peripheral nerves and eventually differentiate to 
form myelin-forming and nonmyelin-forming Schwann cells (Rickman et al., 1985; 
Loring and Erickson 1987; Le Douarin et al., 1991; 1993; Jessen and Mirsky 1992; 
Jessen et al., 1994). 
Neural crest cells 
As mentioned above, neural crest cells are a population of cells that emerge from the 
dorsal part of the neural tube to migrate to various locations where they finally 
differentiate into different cell types. It is clear that before they emerge, the neural 
tube is a single cell layer and contains morphologically similar cells (Selleck et al., 
1993; Bronner-Fraser, 1994). By using microinjection of lineage tracers into 
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individual trunk neural tube cells in birds and mouse, Bronner-Fraser and her 
colleagues demonstrated that cells arising from the dorsal neural tube were able to 
form multiple types of neural crest derivatives. Labeled cells were found in the neural 
tube, dorsal root ganglia (DRG), sympathoadrenal derivatives, Schwann cells and 
pigment cells (Bronner-Fraser and Fraser, 1988; 1988; Serbedzija et al., 1994). It is 
unclear why cells in the dorsal region of the neural tube depart from the tube and 
undergo migration. It has been suggested that disruption of the basement membrane 
surrounding the neural tube and the loss of high affinity of cell-cell adhesion 
molecules might allow the escape of the neural crest cells (Akitaya and Bronner- 
Fraser, 1992; Dupin et al., 1990) In the trunk, neural crest cells migrate along two 
ma . or pathways: a dorsal migration pathway which gives rise to melanocytes, and a 
ventral pathway through the somites, involving progenitors which form neurons, 
adrenomedullary cells and Schwann cells. (Le Douarin, 1982; Le Douarin et al., 
1991; Bronner-Fraser, 1993; Bhattacharyya et al., 1994). 
It is likely that the final determination of neural crest cell fate occurs Progressively 
during migration and in association with environmental influences. At one time, it 
was thought that committed precursors of peripheral neurons were present in the 
neural crest before the migration had started (Ziller et al., 1983). More recently, 
some chick neural crest cells have been found to express Po protein, a specific 
marker for the Schwann cell lineage, before they start to migrate along the axons, 
suggesting, again, early lineage commitment (Bhattacharyya et al., 1991; 1994). On 
the other hand, evidence for the existence of multipotent stem cells comes from both 
in vivo and in vitro experiments. In vivo microinjection of dye into a single crest cell 
shows that in many cases individual cells give rise to several cell types (Bronner- 
Fraser and Fraser, 1988; 1989; Serbedzija et al., 1994). In vitro, Sieber-Blum and 
Cohen (1980) first showed that certain clones derived from single neural crest cells in 
culture contained both catecholaminergic neurons and pigmented cells. Furthermore, 
clonal culture studies using rat cells show that firstly, single neural crest cells are able 
to generate homogenous clones containing only neurons or glia and clones that 
contain both cell types, secondly, multipotent neural crest cells also generate 
multipotent progeny indicating that neural crest cells are self-renewing multipotent 
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stem cells (Stemple and Anderson, 1992; Shah et al., 1994; Davis and Temple, 1994). 
Together, this evidence indicated that variation in at least some molecular signals in 
the environment may play a role in lineage fate decisions (Bronner-Fraser and Fraser, 
1988; Anderson, 1993; 1994; Bronner-Fraser, 1994). Perhaps the clearest evidence of 
this is a demonstration in which glial growth factor (GGF, also referred to as Neu 
differentiation factor [NDF], heregulin and ARIA see below) strongly suppresses 
neuronal differentiation of rat neural crest cells while promoting or allowing glial 
differentiation (Shah et al., 1994). In the sensory neuron lineage, BDNF may act 
instructively to direct neural crest cells along the sensory neuron pathway in clonal 
cultures (Sieber-Blum, 1991), and leukemia inhibitory factor (LIF) has also been 
shown to promote 50% of cultured neural crest cells to differentiate into neurons 
(Murphy et al., 1991b; 1992; 1994). In mammals, FGF-I or FGF-2 was able to 
stimulate neural crest cells proliferation in both serum, and serum free medium 
containing neural tube (Bannerman and Pleasure, 1993; Murphy et al., 1994). 
Furthermore FGF has been shown to promote both avian and rat neural crest cell 
survival (Heuer et al., 1990; Kalcheirn and Neufeld, 1990; Bannerman and Pleasure, 
1993). In addition to FGF, NT-3 has also been reported to stimulate proliferation of 
quail neural crest cells (Kalcheim et al., 1992). A analysis of melanocyte lineage 
demonstrates that the Steel factor and PDGF may positively affect melanogenesis in 
the mouse (Nishikawa et al., 199 1), and FGF-2 and TGFP influence neural crest cells 
commitment to melanogenesis in chick and quail (Stocker et al., 1991; Rogers et al., 
1992). Interestingly, FGF-2 and 12-0-tetradecanoyl phorbol- 13 -acetate (TPA) have 
been reported to cause Schwann cell precursor transdifferentiation into melanocytes 
in culture (Hess et al., 1988; Sherman et al 1993). This accumulating evidence further 
supports the idea that local extracellular signals may play a key role in determining 
neural crest cell fate. 
Schwann Cell Precursors 
The Schwann cell precursor has been described as a distinct intennediate cell lying 
between neural crest cells and Schwann cells (Jessen et al 1991; 1992). A Schwann 
cell precursor has been isolated from early embryonic peripheral nerve and shows 
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significant differences in its morphology, antigenic phenotype, survival ability and 
proliferation from either neural crest cells or Schwann cells. In embryo day (E) 14 rat 
sciatic nerve, many tight bundles of axons are accompanied by relatively few 
dividing precursors. These cells contain a small amount of cytoplasm and form 
relatively long processes to separate the packed axons into several domains (Jessen et 
al 1994). In vitro, these cells appear more flattened and group-forming in morphology 
than Schwann cells. They express low affinity nerve growth factor receptor 
(p75NGF-R) and growth associated protein (GAP-43), but do not express SlOO 
which is frequently used to distinguish Schwann cells from non-glial cells (Jessen et 
al 1991, Curtis et al., 1992; Stewart et al., 1992). This is in line with early work by 
Holton and Weston (1982) that indicated that glial cells in early embryonic quail 
nerves were SlOO negative. It has also been shown that early glial cells in human 
embryonic nerves lack S 100 immunoreaction although human Schwann cells express 
this protein (Kim et al., 1989). In vitro Schwann cell precursors have also been shown 
to express the cell adhesion molecules N-CAM ,LI and other molecules including the 
surface antigens A5E3, rat neural antigen-2 (RAN-2) and the intermediate filament 
protein vimentin. The GAP-43 protein, which is not expressed by neural crest cells, 
has also been detected in Schwann cell precursors. Interestingly, all these molecules 
are also expressed by non-myelin-forming Schwann cells in adult. Molecules such as 
Po protein and 04 lipid antigen are absent in rat Schwann cell precursors cultured for 
20 hr (Jessen et al 1994), although recent evidence shows that Po mRNA is detectable 
in E14 rat peripheral nerve and Schwann cell Precursors (Lee M, 1995 personal 
communication; Zhang et al., 1995). Furthermore, in chicken, Schwann cell 
precursors and even neural crest cells have been shown to express Po protein 
(Bhattacharyya A 1991; 1994). Nevertheless, in terms of phenotypic expression, 
Schwann cell precursors are more like non-myelin-forming Schwann cells than 
myelin-forming Schwann cells. 
In addition to differences in antigenic phenotype and morphology, Schwann cell 
precursors undergo programmed cell death when deprived of axonal contact and 
placed in routine serum-containing or serum free media. The death of E14 and E15 
Schwann cell precursors in vitro occurs rapidly: although the cells plate readily on the 
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coverslip and are visible for the first 4-6 hr, nearly all the cells die during the next 10- 
15 hr (Jessen et al 1994). Under the electron microscope, the death of Schwann cell 
precursors is accompanied by a typical apoptotic feature, namely a shrunken cell 
body, condensed chromatin and intact mitochondria (Wyllie et al., 1980). It was 
found that neuron-conditioned medium had the potential to rescue Schwann cell 
precursors from apoptosis, whereas glial conditioned medium was ineffective (Jessen 
et al., 1994). This experiment implies that Schwann cell precursors require neuron- 
derived molecules for their survival. This raised the question of what was the 
molecular nature of the neuronal factors which promote Schwann cell precursor 
survival. A molecule, basic fibroblast growth factor (FGF-2), expressed both in vivo 
and vitro by neurons and axons (Neuberger and DeVries, 1993; 1993; Weise et al., 
1993), was found to support Schwann cell precursor survival in a 20 hr survival assay 
in the presence of IGF I or II (Jessen et al., 1994; Gavrilovic et al 1995). Other FGF 
family members including FGF-I and FGF-4 are all potent survival factors for 
precursors in combination with IGF using a 20 hr assay. IGF does not rescue 
precursors in vitro by itself (Gavrilovic et al., 1995). For long term survival, only 
neuron conditioned medium and FGF-2 in the presence of serum has been shown to 
enhance precursors survival for at least 4 days (Jessen et al., 1994). 
In vivo Schwann cell precursors not only survive but also proliferate (Friede and 
Samorajski, 1968; Stewart et al., 1993). FGF-2 and FGF-I have been shown to 
promote rat and avian neural crest cell proliferation in the presence of serum, neural 
tube and embryo extract (Bannerman and Pleasure, 1993; Murphy et al 1994). But in 
serum-free defined medium the combination of FGFs, IGFs and forskolin, a routine 
mitogen for Schwann cells, fails to induce DNA synthesis of Schwann cell precursors 
(Gavrilovic et al., 1995). In vivo, it has been shown that following injection of short 
pulses of brododeoxyuridine (BrdU) into pregnant rats, 16-18% of Schwann cell 
precursors in E14 embryo have BrdU positive nuclei, indicative of DNA synthesis 
(Stewart et al., 1993). Therefore, it seems likely that some unidentified neuronal 
molecules do exist that stimulate Schwann cell precursor proliferation. There are only 
a few reports that consider Schwann cell precursor maturation. Neuron conditioned 
medium again has been shown to cc"ývert precursors to Schwann cells during a5 day 
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culturing period as judged by expression of S-100 and a dramatically increased ability 
to survive in routine medium (Jessen et al., 1994). The generation of Schwann cells 
from neural crest cells during relatively long culture periods has been shown by 
Smith-Thomas and Fawcett in serum and embryo extract media and by Shah et al in 
GGF plus growth factor cocktail media (Smith-Thomas and Fawcett., 1989; 1990; 
Shah et al., 1994). 
It is well known that neural crest cells are multipotent stem cells which can give rise 
to several cell types. It is of interest to know whether Schwann cell precursors are 
committed to the Schwann cell lineage or whether other options are still open for 
them. Schwann cell precursors from avian embryonic nerves can transdifferentiate 
into melanocytes by applying FGF-2 or TPA into the culture medium (Ciment et al., 
1986; 1990; Kanno et al., 1987; Stocker et al., 1991). Further study shows that TPA 
can enhance FGF-2 synthesis in Schwann cell precursors and it has been suggested 
that this endogenous FGF-2 induces transdifferentiation of Schwann cell precursors 
into melanocytes via an intracrine mechanism (Sherman et al., 1993). TPA has also 
been shown to decrease protein kinase C (PKC) activities in quail, suggesting that 
regulation of endogenous levels of PKC plays a role in transformation of Schwann 
cell precursors of avian into melanocytes (Hess et al., 1988). These studies indicate 
that rat Schwann cell precursors may still face fate decisions. 
Schwann Cells 
In vivo Schwann cell precursors will eventually develop into Schwann cells. It has 
been shown that some cells from E16 nerves start to express calcium binding 'protein 
SlOO, and that the death rate of these cells is lower than that of E14 precursors when 
these cells are cultured in defined medium for 20 hr. By E17 almost all cells in 
peripheral nerves express SlOO, and the survival percentage of cells at this age has 
reached about 85% (Jessen et al., 1994). Therefore, it is most probable that the 
conversion of Schwann cell precursors to Schwann cells occurs between E14/F-15 and 
El7/El8 in rat. EM studies of E14 and E17 nerves have, so far, failed to find a great 
difference in morphology between E14 Schwann cell precursors and E17 Schwann 
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cells. At E17 cytoplasmic processes of Schwann cells also enclose many axons, but 
the number of axons enclosed by each Schwann cell appears to be much lower than at 
E14 although this has not been quantified. The presumptive perineurial cells start to 
surround nerves around E16 and E17, and Schwann cells at the edge of the nerve 
appear to be associated with some collagen fibrils. At E18 the first blood vessels can 
been seen within the nerve. At E 20, isolated Schwann cells surrounding multiple 
axons can been observed, and the significantly increasing extracellular space and 
collagen fibrils become predominant in nerve (Hashimoto, Jessen and Mirsky, 
unpublished data). By birth, the 1: 1 relationship between Schwann cells and axons is 
seen and myelin wraps are detectable in the first 24 hr after birth. The complete 
maturation of myelin-forming and non-myelin-forming Schwann cells is largely 
complete 3 weeks later (Ziskind-Conhaim, 1988). 
The molecular phenotype of Schwann cells differ from Schwann cell precursors by 
first expressing SlOO at E16. At E17 immature SlOO positive Schwann cells start to 
express the surface lipid protein 04; its function is still unknown. By E18 more than 
95% of cells isolated from peripheral nerves are SlOO positive and about E18-EI9 
these cells start to express another molecule, Galactocereboside (Gal-C), and at E20, 
all SlOO Schwann cells express 04, while expression of Gal-C in all Schwann cells 
only occurs in the 5th postnatal week (Figure 1.1) (Mirsky and Jessen 1990; Mirsky et 
al 1990: Jessen and Mirsky, 1991). Jessen et al (1985,1987) suggested that those 
Schwann cells which expressed Gal-C during the first two-three postnatal weeks 
would develop into myelin-forming Schwann cells and the Gal-C expression by non- 
myelin-forming Schwann cells only appeared after that time. Myelin-forming 
Schwann cells and non-myelin-forming Schwann cells have radically different 
molecular phenotypes (Table 1.1). Myelin-forming Schwann cells express myelin 
proteins including Po (which is the major protein of Schwann cell myelin), myelin 
basic protein (MBP), myelin associated glycoprotein (MAG) and P2 (Mirsky et al., 
1980; Trapp et al., 1981; Hahn et al., 1987; Martini and Schachner, 1986). More 
recently, PNW-22\gas3 has also been shown to be expressed by these cells. Its 
function may relate to cell growth (SR13) and myelination (CD 25) (Snipes et al., 
1992; Bosse et al., 1994; Zoidl et al., 1995). In contrast, the non-myelin-forming 
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Schwann cells express glial fibrillary acidic protein (GFAP), p75NGF-R, A5E3, 
Ran-2 (Jessen and Mirsky, 1984; Jessen et al., 1985; 1985; 1987a; 1990), and also the 
cell surface adhesion molecules N-CAM and Ll (Mirsky et al., 1986; Seiheimer et al., 
1989). Both myelin-forming and non-myelin-forming Schwann cells also express 
some molecules in common. These include S 100, Gal-C and 04 as already mentioned 
(Jessen et al 1985; 1985; Mirsky et al., 1990). More recently, the growth associated 
protein GAP-43 has also been shown to be expressed selectively by non-myelin- 
forming Schwann cells (Stewart et al., 1992). 
SCHWANN CELL PROLIFERATION 
The proliferation of Schwann cells is an important aspect of the development of the 
PNS (Ratner et al., 1985 ; Mirsky and Jessen, 1990; Eccleston, 1992). During the 
early developmental stage, Schwann cell precursors at E14 and EIS undergo rapid 
DNA synthesis. This DNA synthesis increases still further at E16 and peaks at E19. 
Then with the onset of myelination, Schwann cell proliferation decreases and finally 
ends after the third postnatal week (Figure 1.2) (Asbury, 1967; Brown and Asbury 
1981; Stewart et al., 1993). Thus, Schwann cells or their precursors in vivo undergo a 
significant proliferation when in contact with axons. While Schwann cells are 
deprived from axons in neonatal rat the division rate of these cells decreases 
(Komiyama and Suzuki, 1992). These observations indicate that the proliferation of 
Schwann cell in vivo may be driven by axon-associated mitogens. 
The Schwann cells and neurons co-culture system which is based on culturing DRG 
explants, has been established for studying the interaction between Schwann cells and 
neurons (Wood and Bunge 1975). In this co-culture system Schwann cells have been 
found to proliferate rapidly in contact with neurites, and excision of the neurons 
results in rapid decrease in the number of dividing cells (Salzer and Bunge, 1980 1 ). 
Furthermore, the neurite membrane fraction and axolemma made from brain have 
also been shown to stimulate Schwann cell proliferation in culture (Salzer et al., 1980 
II, Sobue et al., 1984). The neuronal membrane mitogen was later detected on the 
neurite surface since preventing Schwann cells from direct contact with neurites in 
21 
co-culture by using a permeable collagen diaphragm resulted in no proliferation of 
Schwann cells. (Salzer et al., 1980 111). These experiments indicated that the axon- 
associated mitogenic effect derived from direct contact with axons although the living 
axon was not required. In a series of experiments Ratner et al., (1984,1985,1988) 
showed that the neuronal cell surface mitogen for Schwann cells is a heparin-binding 
protein, that the surface molecule is able to elevate intracellular cANW levels of 
Schwann cells, and the mitogenic response to this molecule can be reduced by adding 
low concentrations of heparin. Furthermore, an anti FGF neutralizing antibody failed 
to reduce the motigenic function of this molecule which suggests that the mitogenic 
molecule of the neuronal membrane is not an FGF like heparin-binding protein. The 
molecular basis of the axonal mitogen was not identified until Morrissey et al., (1995) 
reported that the rat neuronal surface molecules which stimulated human Schwann 
cell proliferation could be blocked by anti human Heregulin PI (HRGPI) and anti 
human ErbB2 antibody in the co-culture system. Heregulin is the human homologue 
of GGF/NDF and ErbB2 is one of the receptors used by these growth factors (these 
issues are discussed in more detail later). This results imply that HRG/GGF/NDF is 
likely to act as a component of the axonal mitogen for Schwarin cells. 
Before the identification of HRG/GGF/NDF as an axon-associated Schwann cell 
mitogen many growth factors and agents had been shown to stimulate cultured 
Schwann cells to proliferate, and the possible mechanisms of proliferation triggered 
by these factors have also been widely studied. Raff et al (1978) first demonstrated 
that in purified Schwann cell cultures, cAW analogues or agents which could elevate 
intracellular cAW levels were mitogens for Schwann cells in serum containing 
medium. A unpurified GGF extracted from bovine pituitary was the first protein 
found to stimulate the DNA synthesis of Schwann cells (Raff et al 1978; Brockes, 
1980). Afterwards, many growth factors have been found to promote Schwann cell 
proliferation in serum-containing medium, including impure FGF-2, GGF, PDGF and 
TGFO (Eccleston et al., 1989; Ridley et al., 1989; Davis and Stroobant, 1990; Hardy 
et al., 1992). In serum free medium, however, none of these growth factors are 
mitogens by themselves, except impure GGF (Stewart et al., 1991). Only when these 
factors were combined with cAMEP analogues or agents which elevate intracellular 
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cANT level could they act as mitogens in defined serum-free medium (Schubert et 
al., 1991; Stewart et al., 1991; Rogister et al., 1993). It was found that forskolin, 
which elevates intracellular cANT, could significantly increase PDGF receptor 
mRNA expression in serum-containing medium (Weinmaster and Lemke, 1990). 
Furthermore IGF receptors, estradiol receptor and ErbB2 mRNA have also been 
shown to be uPregulated by exposure to cANT analogues or forskolin (Cohen et al., 
1992; Schumacher et al., 1993). This evidence suggests that the cooperation of 
cANT and growth factors in mitogenesis is likely to result in part from cAMT 
induction of the corresponding growth factor receptor. In addition to cANT, other 
growth factors like IGFs have also been demonstrated to play an important role in 
Schwann cell proliferation. IGFs act as a mitogen for Schwann cells when 
synergizing with forskolin in serum-containing medium (Schumacher et al., 1993). In 
serum free medium, however, addition of FGF-2 or PDGF or TGFO is necessary for 
IGF combined with forskolin to promote Schwann cell proliferation (Stewart et al., 
1995). This indicates that activating IGF receptors and elevating intracellular cANT 
levels are two basic conditions for many growth factors to stimulate Schwann cell 
proliferation (Schumacher et al., 1993; Stewart et al., 1995). Two exceptions to this 
general finding exist. The first is GGF/NDF, the other is hepatocyte growth factor 
(HGF). GGF/NDF alone in defined serum-free medium promotes Schwann cells 
DNA synthesis although both forskolin and IGFs enhance this effect (Yoshimura et 
al., 1993; Levi et al., 1995; Stewart et al., 1995). Interestingly, GGF/NDF does not 
elevate intracellular cAW levels in a 10 minute assay, but it does upregulate 
intracellular PKC levels (Yoshimura et al., 1993). GGF/NDF is also able to 
upregulate its own receptor such as ErbB2 in Schwann cells (Cohen et al., 1992). 
HGF is a potent mitogen for purified Schwann cells on its own and in this case, 
simultaneous elevation of cAW by forskolin suppresses DNA synthesis. Anti-HGF 
neutralizing antibodies fail to block neuron-stimulated Schwann cell proliferation. 
Therefore this factor is not the axonal mitogen for Schwann cells (Krasnoselsky et al., 
1994). 
In addition to above studies more and more proteins continue to be identified as a 
mitogens for Schwann cells. A novel macrophage inflammatory protein (MIP)I-a has 
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been shown to stimulate Schwann cell proliferation (Khan and Wigley, 1994). 
Antibody against the tetraspan protein CD9 also promotes Schwann cell proliferation 
(Hadjiargyrou and Patterson, 1995). In this study it is unclear whether the antibody is 
mimicking the action of a putative ligand for CD9 or, alternatively, blocking CD 9 
function. These newly discovered Schwann cell mitogens will help us to further 
understand the molecular interaction between Schwann cells and their environment in 
vivo. In addition to growth factors and agents that elevate cANT, extracellular matrix 
molecules such as laminin, fibronectin and type IV collagen do also, in certain 
circumstances, stimulate Schwann cell division, and can, therefore, be thought of a 
third class of Schwann cell mitogens (Eccleston et al., 1987,1989; Evercooren et al., 
1986; McGarvey et al., 1984; Bunge, 1989). Myelin basic protein (MEBP) is believed 
to Play an important role in stimulating Schwann cell proliferation during Wallerian 
degeneration (see below) (Baichwal and DeVries, 1989; Yoshino et al 1987). 
Consideration of Schwann cell proliferation leads to a related question which is how 
Schwann cell withdraws from proliferation to undergo differentiation. In vivo, 
myelination and proliferation by individual Schwann cells appear to be incompatible. 
It is still not clear what causes the reduction in Schwann cell proliferation. One 
possibility is that the proliferation of Schwann cells is suppressed by growth 
inhibitory factors. It was found that enteric neurons reduced Schwann cell DNA 
synthesis when Schwann cells were co-cultured with these neurons, and also that 
short-term cultured Schwann cells secreted some unknown factors which inhibit DNA 
synthesis in long-term immortalized Schwann cells (Eccleston et al., 1989; 1991). A 
55-kDa protein showing strong antiproliferative activity has been isolated from both 
Schwann cells and Schwannoma conditioned media. (Muir et al., 1990). Furthermore 
TGFP-I and TGFO-2 have recently been reported to slightly inhibit Schwann cells 
proliferation in Schwann cells and DRG neurons co-cultures (Guenard et al., 1993; 
1995). Alternative possibilities include down-regulation in expression of mitogen 
receptors or reduction of amount of mitogens in the Schwann cell environment. 
Nevertheless, withdrawal from proliferation in Schwann cells during nerve 
development is accompanied by Schwann cell differentiation. 
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SCIIWANN CELL DIFFERENTIATION 
The differentiation of Schwann cells into myelin-forming and non-myelin-forming 
Schwann cells is believed to rely on signals from neurons. Therefore, the identity of 
neuronal molecules which drive Schwann cell differentiation or instruct Schwann 
cells to differentiate into two different cell types is of general interest for all 
neurobiologists. 
Many observations support the idea that axonal signals drive Schwann cell 
differentiation and, in particular, myelination. Thus neither in vivo nor in vitro do 
Schwann cells form myelin, or express high levels of the myelin components, except 
when they are in contact with axons or neurites (Bunge et al., 1986; LeBlanc et al., 
1987; Trapp et al., 1988). Schwann cells in newborn rat nerves, many of which have 
just started the myelination program, will abandon myelin synthesis if they are 
removed from axonal contact. Even myelinated Schwann cells will stop making 
myelin if they lose contact with axons due to nerve transection in a process called 
Wallerian degeneration (see below). Myelination can be induced by culturing these 
cells with neurons in a way which allows close association between neurites and 
Schwann cells. Such a co-culture system of Schwann cells and neurons has been 
widely used to study the interaction between Schwann cells and axons. Bunge et al., 
(1986) demonstrated that myelination occurred in medium containing serum and 
embryo extract, while in serum-free and extract-free defined medium neurons failed 
to induce Schwann cells to myelinate. It is probable that under these conditions, they 
failed to make basement membrane. It was found later that the ascorbic acid in chick 
embryo extract was necessary for the formation of the basement membrane (Carey 
and Todd, 1987; Eldridge et al 1987). However, Schwann cells in serum-free medium 
can be induced to express both elevated levels of Po mRNA and some Po protein 
when they are co-cultured with neurons although they do not assemble myelin in this 
system (Morrison et al., 1991; Brunden et al 1990). This suggests that only 
myelination or myelin assembly by Schwann cells requires basement membrane 
formation, but not Po induction. In addition to Po, PNT22 another myelin related 
gene, is also upregulated by contact with axons (Spreyer et al., 1991). But a 
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somewhat controversial result also indicates that neurons both from chicken and rat 
are unable to induce Po expression in Schwann cells from chicken in serum free 
medium (Bhattacharyya et al., 1993). So far the axon-Schwann cell signalling 
mechanisms which drive Schwann cell differentiation are still unknown in terms of 
the identity of the neuron associated molecules and Schwann cell receptors. On the 
other hand , 
it has been found that an axolemmal membrane preparation can elevate 
intracellular cAW levels in cultured Schwann cells (Ratner et al., 1985). This, 
together with other observations (see below) indicates that elevation of intracellular 
cAW levels in Schwann cells may mimic the axonal signals that trigger Schwann 
cell differentiation. 
Sobue and Pleasure (1984) first reported that Gal-C could be re-expressed when 
cultured neonatal Schwann cells were exposed to cAMP analogues. But no Po 
induction was seen when short term cultured Schwann cells were treated with cAMP 
analogues in serum containing medium (Shuman et al., 1988). In contrast, it triggers 
proliferation of Schwann cells (Sobue et al., 1986). Po and MBP mRNA and also Po 
protein can only be induced when intracellular cAMP is elevated in long term 
cultured Schwann cells (Lemke and Chao, 1988). It was unclear why elevation of 
cAMP levels induced Po in long term cultured Schwann cells but not in short term 
cultured cells in the presence of serum until Morgan et al, (1991) first demonstrated 
that myelin-related phenotypes were induced when Schwann cells were exposed to 
cAMP analogues in absence of serum, indicating that only the cells which do not 
divide were induced to express high levels of Po. Meanwhile, the cells showing 
highest levels of Po protein expression also down-regulated GFAP, N-CAM and 
p75NGF-R in response to cAMP analogues (Morgan et al., 1991; Mews and Meyer, 
1993). Further studies indicated that serum, FGF-2 or FGF-I can negatively regulate 
the Po gene expression upregulated by cAMP, at least in part by driving cell 
proliferation (Morgan et al., 1994) which in turn is incompatible with myelin 
differentiation as discussed above. Thus, only when Schwann cells are withdrawn 
from serum or FGF or other growth factors which are mitogens for these cells, can 
Schwann cells be. ý induced to express high levels of Po. TGFO also suppresses 
cAMP-induced Po mRNA and protein in Schwann cells and this suppression is not 
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accompanied by stimulation of DNA synthesis (Mews and Meyer, 1993; Morgan et 
al, 1994). Together, this evidence suggests that myelin-formation may be driven by a 
complex mixture of positive and negative regulatory signals during development. 
In vivo myelin-forming Schwann cells are always in contact with large axons, 
whereas non-myelin-forming Schwann cells relate to several small diameter axons. 
Therefore, two possibilities exist: first the differentiation of Schwann cells may 
depend directly on axon caliber (Friede et al., 1972); second, differentiation may rely 
on molecules expressed by different axons (Spencer et al., 1973). Based on an 
electron microscope study of different cranial nerves in the rat, it was found that onset 
of myelination by Schwann cells had no direct relationship with axon diameter. This 
makes it more likely that molecules associated with axons influence Schwann cell 
myelination (Hahn et al ., 1987). This idea has been 
further supported by the 
observation that the expression of Po mRNA and of the myelin-associated 
transcription factor SCIP (suppressed cAND inducible POU, also known as Oct 6, 
Tst-1) in Schwann cells can be up-regulated in a co-culture system in which 
Schwann cells and neurons have been separated by microporous membrane. This 
suggests that neurons regulate Schwann cell Po and SCIP genes by diffusible 
molecules (Bolin and Shooter 1993). 
In order to know how these neuronal molecules might influence differentiation paths, 
it is essential to know that all Schwann cells can be induced into two alternative paths. 
Aguayo et at (1976) showed that following transplantation of a segment of 
sympathetic trunk into a transected mouse sciatic nerve, the regenerating axons of the 
sciatic nerve were able to induce non-myelin-forming Schwann cells derived from the 
sympathetic trunk to myelinate (Aguayoj, 1976). Furthermore, when Schwann cells 
from sympathetic trunk are co-cultured with DRG neurons, both Po mRNA and Po 
protein are induced (Brunden et at 1990; and Morrison et at 1991), These experiments 
indicate that non-myelin-forming Schwann cells have not been naturally committed to 
be a non-myelin-forming Schwann cell, they can be induced to myelinate if 
appropriate axon-associated signals are provided. This hypothesis has been further 
supported by co-culturing non-myelin-forming Schwann cells with superior cervical 
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ganglia (SCG) neurons in defined serum-free medium. It is known that only a few of 
the axons originating in SCG neurons are normally myelinated, and it was found that 
the myelin protein Po and its mRNA induction was negligible in this co-culture 
system (Brunden et al., 1992). The most likely explanation is that the molecular 
expression by DRG neurons and SCG neurons are different. More recently TGFP has 
been shown to block both Schwann cell myelination and the expression of the myelin- 
related proteins, including Po, N1BP and MAG in co-cultures of Schwann cells and 
DRG neurons (Guenard et al 1995; Einheber et al 1995). It is also found that 
molecules of non-myelin-forming cells such as p75NGF-R, N-CAM and Ll are 
expressed in the presence of TGFP. The expression of GFAP, a molecule only seen 
on mature non-myelin-forming Schwann cells in vivo, is strikingly increased by 10- 
fold in the presence of TGFO in vitro (Mews and Meyer, 1993; Chandross et al., 
1995). Furthermore, TGFP inhibits Schwann cell proliferation by 75% in the co- 
culture system (Einheber et al., 1995; Guenard et al., 1995). All these observations 
suggest that TGFO may serve as an inhibitor of Schwann cell proliferation and 
myelination and thus, perhaps drive Schwann cells into the non-myelinating 
pathway. However, other evidence shows that TGFP not only suppresses Po 
expression but also represses the expression of Gal-C , 04 and 
GAP-43 molecules 
which have been previously reported to be strongly expressed in mature non-myelin- 
forming Schwann cells (Stewart et al., 1995). Clearly, the picture of TGFP action on 
Schwann cells is not simple at present and the neuronal molecules which drive 
Schwann cells to differentiate into two cell types are still not identified. But the 
TGFPs will be some of the most interesting molecules to study further in this context. 
It is also interesting to notice that both Schwann cells and neurons synthesize TGFP 
(Einheber et al., 1995; Rogister et al., 1993; Stewart et al., 1995). Interestingly, the 
interaction of DRG neurons and Schwann cells in vitro results in a reduction of 
TGFP synthesis (Scherer et al., 1993; Einheber et al., 1995). In vivo, regenerating 
axons in sciatic nerve also downregulated the levels of TGFP mRNA in Schwann 
cells (Scherer et al., 1993). Therefore, it is possible that downregulation of TGFP in 
some axons may result in myelination of these Schwann cells. It would be very 
interesting to know whether these phenomena are different in the interaction between 
SCG neurons and Schwann cells. 
28 
Although the molecular mechanisms controlling the process of myelination in 
Schwann cells still remain elusive, some progress has been made in identifying genes 
related to myelin formation. SCIP, a cANT-inducible protein, is a member of the Oct 
transcription factor family. These factors contain a homeobox domain and a DNA 
binding domain (POU domain). One of the properties shared by this family is their 
apparent ability to participate in the determination of cell fate. SCIP, as a member of 
this family, seems to be in some way involved Schwann cell myelination (Monuki et 
al., 1989; 1993). It was found that SCIP is expressed by myelinating glia of both the 
CNS and the PNS (Monuki et al., 1989; Suzuki et al., 1990; He et al., 1991). The 
SCIP expression in Schwann cells were closely associated with axons in developing 
and regenerating nerves, and neurons in the co-culture system (Scherer et al., 1993; 
Bolin et al., 1993). The level of SCIP mRNA peaks prior to the peak in myelin gene 
expression and elevation of intracellular cAMP levels in Schwann cells significantly 
induces SCEP mRNA expression indicating SCIP might promote myelin gene 
expression (Monuki et al 1989). But further studies found that SCIP represses the Po 
promoter in Schwann cells and multiple SCIP binding sites were identified in Po 
promoter (Monuki et al., 1993). Transgenic mice that express a dominant-negative 
form of SCIP (ASCIP) exhibit overexPression of myelin-specific gene products and 
hypermyelination, indicating that SCIP might mediate repression of myelination gene 
(Weinstein et al., 1995). Moreover, expression of SCIP has also been correlated with 
Schwann cell proliferation (Monuki et al., 1990). Therefore the function of SCIP in 
Schwann cell differentiation is still controversial. Krox-20, a zinc-finger transcription 
factor is expressed by neural crest cells, has been reported to be important for 
Schwann cell myelination (Wilkinson et al., 1989; Topilko et al., 1994). In mouse, 
Krox-20 is expressed in spinal roots at E12 and more distal peripheral nerves at E15 
(Herdegen et al., 1994). In Krox-20 knock out mice myelin proteins such as Po and 
MBP are absent and myelin is not formed, although the Schwann cell forms a 1: 1 
relation with large axons. This implies that Krox-20 is likely to control a set of genes 
required for completion of myelination in the PNS (Topilko et al., 1994). 
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SCHWANN CELLS IN WALLERIAN DEGENERATION 
In the PNS, injury initiates a sequence of characteristic changes in the distal. stump of 
nerves which include: disappearance and fragmentation of axons; myelin sheaths 
break down; macrophages invade and Schwann cells proliferate. These characteristic 
changes are referred to as Wallerian degeneration (Fawcett and Keynes, 1990). 
During Wallerian degeneration Schwann cells undergo de-myelination, change of 
phenotype expression and proliferation. As discussed previously, Schwann cells in 
normal peripheral nerves express two; distinct phenotypes: myelin phenotypes (Po, 
MBP, MAG, P2 and PMP-22) and non-myelin phenotypes (GFAP, p75NGF-R, 
A5113, Ran-2, N-CAM, LI and GAP-43) (Mirsky and Jessen, 1990; Jessen and 
Mirsky, 1991; 1992). In denervated nerve, Schwann cells downregulate myelin 
molecules such as Po and NIBP, and express non-myelin molecules such as N-CAM, 
Ll, p75NGF-R and GAP-43 (Daniloff et al., 1986; Jessen et al., 1987; Martini and 
Schachner, 1988; Taniuchi et al., 1988; Lemke and Chao, 1988; Curtis et al., 1992). 
A similar regulation of these molecular phenotypes is also found when Schwann cells 
are isolated from peripheral nerve and placed in culture although the time course of 
the reversal of phenotype is earlier (Mirsky, 1990). 
Schwann cells in adult peripheral nerve are generally quiescent. When peripheral 
nerves in adult animals were transected Schwann cells in the distal stump underwent 
significant proliferation peaking at between 3 and 5 days post-transection (Oaklander 
and Spencer, 1988; Clemence et al., 1989; Komiyama and Suzuki, 1992). 
Interestingly, Schwann cells in neonatal sciatic nerve which normally divide at a 
distinct rate (Komiyama and Suzuki, 1991; Stewart et al., 1993), show a significant 
decrease of proliferation rate when this nerve is transected (Komiyama and Suzuki, 
1992). It was suggested that myelin debris and also myelin associated proteins might 
contribute to the striking proliferation in adult Schwann cells (Yoshino et al., 1978; 
Baichwal and DeVries, 1989; DeVries and Baichwal, 199 1). 
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PROGRANENIED CELL DEATH 
Programmed cell death is a natural cell death process which is widespread during 
animal development. It has been known for more than 40 years since Glucksmann 
(1950) first reported this phenomenon. It is known that cells undergoing programmed 
cell death die by apoptosis rather than by necrosis (Wyllie et al., 1980; Oppenheim, 
1991; Raff, 1992; Williams et al., 1992; Vaux et al., 1994). Cells dying by apoptosis 
show characteristic morphological changes. In the early stages, the chromatin 
aggregates into large compact granular masses and later apparently discrete nuclear 
fragments appear, meanwhile the cytoplasm becomes condensed and microvilli 
disappear. The whole cell body shrinks but the organelles initially remain intact. Then 
the dead cells or fragments are rapidly phagocytosed by their neighbors or 
macrophages (Wyllie et al., 1980). This model of natural cell death is thought to 
result from activation of a suicide program although the molecular mechanisms are 
not yet clear (Wyllie et al., 1980; Ellis et al., 1991). Many studies have shown that 
cells can be rescued from programmed death by the signals from other cells. Levi- 
Montalcini and her colleagues (1951) first demonstrated that the degree of normal 
neuronal death during development could be dramatically increased by removing a 
target in early development. It is clear now that nerve growth factor (NGF) released 
by their target cells supports the survival of these neurons and rescues them from 
apoptosis (Barde, 1989). Schwann cell precursors, the cells in E14-EI5 peripheral 
nerve, undergo programmed cell death when they are dissociated from axons in vitro 
(Jessen et al., 1994). As mentioned previously, protein(s) in neuron conditioned 
medium or FGFs in combination with IGFs can rescue these cells from the suicide 
pathway (Jessen et al., 1994; Gavrilovic J et al., 1995). 0-2A progenitor cells and 
oligodendrocytes have also been shown to depend on signals from other cells in vitro, 
and PDGF, NT-3, IGF, CNTF and LIF are reported to decrease cell death by up to 
90% (Barres et al., 1992; 1993; 1994). Results so far suggest that cells during 
development or some cells in almost all lineages undergo programmed cell death, and 
the survival chance for each cell may depend on when and how it contacts other cells 
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to obtain survival signals. This competitive survival principle may efficiently 
eliminate unwanted cells. 
One of the most exciting finding in this field is the identification of specific genes 
that regulate cell death. Thus, two novel genes ced-3 and ced4 have been identified 
as suicide genes in the nematode C elegans (Ellis et al ., 1986; Yuan, 1994). It was 
found that during embryonic development, 131 of a total 1090 somatic cells died in 
every organism, and loss-of-function mutations in ced-3 or ced-4 resulted in a 
blockade of all programmed cell death in the organism (Ellis and Horvitz, 1991). 
Another gene named ced-9 has been identified as a negative regulator of cell death. 
Gain-of-function mutations in ced-9 block almost all cell death. Furthermore, loss-of- 
function mutations in ced-9 result in death of the animal during early development 
(Hengartner et at., 1992). Mapping and cloning the ced-3 and ced-4 genes indicated 
that the ced-3 gene encodes a protein of 503 amino acid residues which turns out to 
be homologous to a previously identified protein-interleukin-ID coverting enzyme 
(ICE) (Yuan et al., 1993). ICE has also been shown to activate cell death in several 
cell lines (Miura et al., 1993). More recently another two members of the ICE family 
have been identified, ICH-I and Nedd-2. Further study on ICH-1 indicates that there 
are two isoforms of ICH-1, one is a 435 amino acid protein named ICH-11, which is 
homologous to both ICE and ced-3 protein. The other is a truncated version of the 
ICH-11, protein called ICH-ls which contains 312 amino acids. Overexpression of 
ICH-IL induces apoptosis, whereas overexpression of ICH-Is suppresses cell death 
(Wang et al., 1994). The ced-9 gene encodes a 280 amino acid protein which is 
homologous to the mammalian proto-oncogene Bcl-2. The Bcl-2 gene was first 
cloned from the breakpoint of a chromosomal translocation and has been reported to 
prevent haematopoietic and neuronal cell apoptosis (Garcia et al., 1992; Allsop et al., 
1993). Several other Bcl-2 family members have been identified recently including 
Bcl-Bax, Bax, mcl-I and Al (Nunex and Clarke, 1994). Interestingly, heterodimers of 
Bcl-2/Bax suppress apoptosis while homodimers of Bax promote apoptosis 
(Miyashita et al., 1994). Further interest in this field is likely to focus on the link 
between survival growth factors and the regulation of death-promoting or death- 
suppressing genes. 
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GROWTH FACTORS AND THEIR RECEPTORS 
Since the first discovery of NGF and epidermal growth factor (EGF) in the 1950s 
(Levi-Montalcini and Hamburger, 1951; Cohen, 1962), peptide growth factors have 
been recognized as key molecular elements in the regulation of cell survival, 
proliferation and differentiation both in vivo and vitro. Recently, molecular biology 
techniques have made it possible to isolate and characterize many growth factors such 
as FGF, IGF, NDF, PDGF, TGFP and many others. It is known that many growth 
factors are unable to pass the hydrophobic cell membrane, and they have to bind to 
individual cell surface receptors to transduce their signals (Westermark and Heldin, 
1989; Raivich and Kreutzberg, 1994; Heldin, 1995). Because of the very important 
functions that growth factors are likely to have in mediating developmental cell-cell 
signalling, understanding of the interactions between growth factors, growth factor 
receptors and signal transduction pathways has become of fundamental importance to 
developmental biologists. 
Neu Differentiation Factors MFs) 
The search for soluble factors that interacted with the neu (ErbB-2) receptor led to the 
discovery of a 44 kDa glycoprotein. This protein was able to induce differentiation of 
human breast cancer cells (MDA-MB23 1) into mature milk-secreting cells and was 
therefore named Neu Differentiation Factor (NDF) (Peles et al., 1992). NDF was 
purified from medium conditioned by ras-transformed fibroblasts. This soon led to a 
cDNA clone and nucleotide sequence. A recombinant NDF can be produced in 
transfected COS-7 cells with full biological activity (Wen et al., 1992). Meanwhile 
several other groups also reported the purification and sequence of proteins of the 
same family which they named heregulin (HRG) from human breast carcinoma cells 
(Holmes et al., 1992), glial growth factor (GGF) from bovine pituitary glands 
(Marchionni et al., 1993) and acetylcholine receptor-inducing activity (ARIA) from 
chicken brain (Corfas et al., 1993). The primary structural analysis indicates that 
NDF, HRG, GGF, and ARIA comprise a new family of polypepide factors. All these 
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proteins turn out to be the products of a single gene, generated by alternative splicing 
(Marchionni et al., 1993). This gene has been mapped to the short arm of human 
chromosome 8 (Off-Urtreger et al., 1993). 
Now there are 15 members of the NDF family which have been fully cloned at the 
molecular level from rodent, human, bovine and avian sources. The structural 
analysis has indicated that a total of 10 isoforms exist. They are oc2a, oc2b, cc2c, PIa, 
02a, 03,04a, 01,01-kringle and Pla-ARIA (Table 1.2) (Mudge 1993; Peles and 
Yarden, 1993; Ben-Baruch and Yarden, 1994). Most isoforms contain seven basic 
domains: the N-Terminus, a immunoglobulin domain, a spacer domain, an EGF-like 
domain, a juxtamembrane domain, a transmembrane domain and a cytoplasmic 
domain (Figure 1.3). The N-terminus is a 50 amino acid long hydrophilic sequence 
and undergoes proteolytic cleavage upon maturation of the molecule. Since most of 
the isoforms lack a hydrophobic signal it is thought that the N-terminal sequence 
combined with the transmembrane domain allows secretion of a pro-molecule. Most 
isoforms of NDF family share a similar N-terminus except GGFII and ARIA (Holmes 
et al., 1992; Goodearl et al., 1993; Wen et al., 1994). GGFII has a kringle domain and 
a hydrophobic 22 amino acid long signal peptide which enables the GGFII molecule 
to be secreted (Marchionni et al., 1993). The immunoglobulin domain is present in all 
isoforms. It may promote the dimerization of soluble NDF molecules. The spacer 
domain is the region that connects the immunoglobulin domain with the EGF-like 
domain. This 34 amino acid long sequence contains many sites of N- and O-linked 
glycosylation which may act as attachment sites for heparin sulfate. GGFII and 
ARIA lack this region (Marchionni et al., 1993; Falls et al., 1993). The EGF-like 
domain is defined by six cysteine residues that are characteristically spaced over a 40 
amino acid sequence, it folds into a typical structure with three disulfide-linked loops, 
namely a-loop, b-loop and c-loop. It has been demonstrated that this domain acts as 
the receptor binding site and also as a functional domain of NDF (Nagata et al., 1994; 
Wen et al., 1994). Two types of EGF-like domain, named cc and 0 isoforms, are 
found in the 10 isoforms of NDF. They differ in a 19 amino acid sequence in the 
region of the c-loop (Peles et al., 1993; Wen et al., 1994). The juxtamembrane 
domain is the most variable region in NDF, and four subtypes of NDF exist which 
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differ in the amino acid sequence, namely 1,2,3 and 4. The transmembrane domain 
is composed of 23 amino acids. All isoforms of NDF except 03 isoform contain this 
region. NDF03 is not secreted into the medium from transfected COS-7 cells 
suggesting that this region may also be involved in signalling protein secretion (Wen 
et al., 1994). The cytoplasmic domain exists in all the transmembrane isoforms of 
NDFs. It contains a common sequence of 157 amino acids which is called the c- 
subtype. The a-subtype and b-subtype extend an additional 217 and 39 more amino 
acids respectively (Figure 1.3). 
To gain insight into the biological role of NDFs several groups have examined the 
expression of NDFs in development in rat, mouse and chicken. In mouse, NDF 
mRNA signal is found by in situ hybridization in cells of the spinal cord at E9 and the 
expression of NDF in DRG and ventral homs of the spinal cord is detected at E10. 
Distinct NDF mRNA positive cells were present in the cerebral cortex and the 
superficial marginal zone during early development. NDFs are also detected in 
mesenchymal cells of the lung, intestine, stomach and kidney and in the genital ridge, 
(Off-Urtreger et al., 1993; Meyer and Birchmeier, 1994). It was also shown that non- 
neuronal satellite cells and Schwann cells do not express GGF mRNA (Marchionni 
MA et al., 1993). In rat, NDF mRNA expression is similar to that in mouse, i. e. high 
expression in motor neurons of the spinal cord and DRG. In brain, most cholinergic 
neurons are heavily labelled (Wen et al., 1992; 1994; Corfas et al., 1995). An analysis 
of the distribution of various NDF isoforms indicates that NDFs containing a kringle 
domain are predominant in the nervous system and that the cc isoform is absent in 
adult mouse brain (Meyer and Birchmeier, 1994). Other studies have also shown that 
NDF01 is a neuronal isoform and NDFcc2 is the predominant form in mesenchymal 
and nonneuronal organs (Wen et al., 1994). 
NDFs were originally described as neu ligands but have now been found to bind to a 
family of tyrosine kinase receptors, including neu\ErbB2\Her-2, ErbB3\Her-3 and 
ErbB4\Her-4. The neu gene was first described as a mutationally activated proto- 
oncogene in cell lines derived from neural tumors. It encodes a 185 kDa 
transmembrane glycoprotein with tyrosine kinase activity termed p185'e' (Padhy., et 
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al 1982; Schechter., et al 1984). The similarity of the neu sequence to that of the 
epidermal growth factor receptor (EGF-R), originally led to the idea that it acted as a 
receptor for a unknown growth factor (Bargmamm et al., 1986b). ErbB3\Her-3 was 
cloned and sequenced on the basis of its homology with ErbB2 and EGF-R by two 
separate groups. It was found that ErbB3 is a single 6.2 kb specific mRNA encoding a 
160 kDa protein. It has all the structural features of a tyrosine kinase receptor, with a 
single hydrophobic transmembrane domain consisting of 32 amino acids that 
separates the sequence into a 612-residue extracellular region and a 677-residue 
cytoplasmic domain. The cytoplasmic domain is strongly homologous with other 
members of the tyrosine kinase family, and the total protein of ErbB3 has been shown 
to share 40-50% identity with EGF-R and 40-45% identity with ErbB2 (Kraus et al., 
1989; Plowman et al., 1990). More recently a fourth member of the ErbB family has 
been identified. This is the ErbB4\Her-4 gene which encodes a 180 kDa 
transmembrane tyrosine kinase. Its extracellular domain is most similar to that of 
ErbB3, whereas its cytoplasmic kinase domain is 79% and 77% identical with EGF-R 
and ErbB2 respectively, while it has less identity with ErbB3 (63%) (Plowman et al., 
1993). 
Although NDF was originally identified as a neu ligand which stimulates the tyrosine 
phosphorylation of ErbB2 in some human mammary cancer cells, it is known that in 
certain ovarian cancer cells or in ErbB2 transfected fibroblasts NDF is unable to 
activate ErbB2 (Peles et al., 1993). Furthermore, Plowman et al., (1993) demonstrated 
that NDF was a specific ligand for ErbB4 and it failed to induce phosphorylation of 
ErbB2 in the absence of ErbB4 (Plowman et al., 1993; Culouscou et al., 1993). NDF 
also phosphorylates ErbB3 and ErbB2 only when ErbB2 is co-expressed with ErbB3 
(Carraway et al., 1994), but when cells are transfected with ErbB3 alone no 
stimulation of tyrosine phosphorylation is observed (Sliwkowski et al., 1994; Guy et 
al., 1994). These experiments suggest that extensive heterodimerization of receptors 
and cross-phosphorylation of heterodimers takes place among the ErbB receptor 
family, and the lack of intrinsic tyrosine kinase activity in ErbB3 results in no 
stimulation of phosphorylation in ErbB3 alone (Carraway and Cantley 1994). In a 
binding study, using aP isoform of NDF it was found that NDFP bound to ErbB4 
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with high affinity and to ErbB3 with relatively low affinity; no binding to ErbB2 was 
detected (Tzahar., et al 1994). This suggests that ErbB4 is the only receptor which on 
it own can bind NDF and be triggered to phosphorylate. ErbB3 may have a low 
affinity binding with NDF and carry out no tyrosine phosphorylation by itself, but it 
may heterodimerize with other receptors, such as ErbB I and ErbB2 and, in this case, 
cross-phosphorylate its partner ( Soltoff et al., 1994). The lack of binding of NDF to 
ErbB2 suggests that a unknown ligand may still exist for this receptor (Tzahar et al., 
1994; Carraway and Cantley, 1994). 
The expression and functional analysis of ErbB receptors has been extensively studied 
recently. ErbB2 mRNA is expressed at very high levels in the rat sciatic nerves and at 
lower levels in the brain. During development the levels of ErbB2 mRNA are 
decreased dramatically in both sciatic nerve and brain (Jin et al., 1993). In cultured 
Schwann cells and also sciatic nerves the expression both of ErbB2 mRNA and 
protein is maximal at postnatal days I and 7, with substantially lower expression in 
adulthood (Cohen et al., 1992; Jin et al., 1993). ErbB3 mRNA is detected in neural 
crest cells and Schwann cell precursors in mouse (Meyer and Birchmeier, 1995). An 
other study indicated that ErbB3 protein is- found at very low levels in peripheral 
nerve and brain at early developmental stages and to have a high expression in adult 
nerve and brain (Prigent et al., 1992). In ErbB2 and ErbB4 gene mutated mice, the 
innervation of cranial neural-crest-derived sensory ganglia, motor neurons and hind 
brain are markedly affected suggesting that the important function of these receptors 
in the early development of both PNS and CNS (Lee et al., 1995; Gassmann et al., 
1995). 
The isolation of the NDF family and their receptors has raised general interest in the 
function and expression of NDFs in the nervous system. In cultured rat Schwann 
cells, NDF stimulates DNA synthesis in a dose-dependent manner (Marchionni et al., 
1993; Goodearl et al., 1993; Stewart et al., 1995) and some evidence has showed that 
different isoforms of NDF may differentally affect Schwann cell proliferation and 
differentiation (Neuberger et al., 1993). In human Schwann cells NDF acts as a 
effective mitogen (Levi et al., 1995). As discussed earlier, Anderson and his 
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colleagues recently reported that NDF strongly suppressed neuronal differentiation of 
rat neural crest stem cells and promoted glial differentiation, suggesting that apart 
from its function as a mitogen, NDF may act as a diversionary factor to instruct 
neural crest cells into the Schwann cell lineage or alternatively prevent them from 
adopting a neuronal fate (Shah et al., 1994). In the CNS, NDF can promote 0-2A 
progenitor cell development into oligodendrocytes, but it has no mitogenic role for 
this cell type (Vartanian et al., 1994). NDF was also reported to stimulate neurite 
outgrowth in PC12 cells when the cells were transfected with the ErbB2 gene 
(Gamett and Cerione, 1994). In developing neuromuscular synapses, NDF may be 
involved in regulating acetylcholine receptor synthesis via ErbB2 tyrosine 
phosphorylation (Corfas et al., 1993). In the NDF knock out mouse, Schwann cell 
precursors and cranial ganglia, but not DRG, fail to develop normally, indicating that 
NDF may play a role in the fate decisions or survival of these cells (Meyer and 
Birchmeier, 1995). 
Fibroblast Growth Factor (EGFD 
Fibroblast growth factor (FGF) was originally identified as an activity in pituitary 
extracts that stimulated the proliferation of mouse 3T3 cells (Armelin, 1973; 
Gospodarowicz et al., 1974). The partially purified protein had a 14-16 kDa 
molecular weight with a basic isoelectric point (Gospodarowicz 1975; 1978a). These 
pioneer studies leads to the discovery of a large family of growth factors, the FGFs. 
To date nine members of the FGF family are known. They have been assigned 
numbers in the order of their identification. Acidic FGF\FGF-1, basic FGF\FGF-2, 
FGF-3, Kaposi's FGF\FGF-4, FGF-5, FGF-6, keratinocyte growth factor 
(KGF)\FGF-7, androgen-inducible growth factor\FGF-8 and FGF-9 (Baird, 1994). In 
this big family, FGF-I and FGF-2 have been most extensively studied in the last ten 
years. FGF-2 has four different forms due to variation in the N-terminal (155,196, 
201 and 210 amino acids correspond to 18 kDa, 22 kDa, 22.5 kDa and 24 kDa 
proteins). The remaining part of FGF-2 shows a high homology to other members of 
the family including two receptor binding sites (amino acids 32-76 and 114-123), one 
PKC phosphorylation site (Ser-72) and one protein kinase A phosphorylation site 
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(Thr-120) (Basilico and Moscatelli, 1992). FGF-1 is a 154 amino acid protein and has 
a 55% amino acid sequence identity to 18 kDa FGF-2. Interestingly most members of 
this family have no secretory signal in the N-terminal region except FGF-7 and FGF- 
9 (Rubin et al., 1989). 
FGF genes and proteins have been shown to be expressed in most tissues at a 
relatively high concentration. In particular FGF-2 mRNA is expressed at much higher 
levels in brain than in other tissues (Shimasaki et al., 1988). During development, 
FGF-2 increases significantly from embryonic to postnatal stages in brain (Caday et 
al., 1990). But recent studies indicate that the 18 kDa FGF-2 mRNA is predominant 
in embryonic brain and essentially undetectable 20 days after birth, whereas adult rat 
brain expresses multiple FGF-2 isoforms (Powell et al., 1990; Weise et al., 1993). In 
the peripheral nervous system both FGF-1 and FGF-2 mRNA and protein have been 
detected in both embryo and adult rat DRG neurons (Grothe et al., 1991; Neuberger 
and DeVries 1993), and FGFs are also found . 
in the cytoplasm of Schwann cells in 
vitro by immunohistochemistry. In in situ hybridization studies it is shown that the 
levels of FGF-2 mRNA expression in peripheral nerves is quite constant whereas the 
levels of its corresponding receptor expression is variable during development 
(Davis, 1993; Neuberger and DeVries 1993). 
Two types of receptors that are relevant for FGF action have been identified: heparan 
sulfate proteoglycan (HSPGs) which serves as a low affinity receptor that can not 
transmit a biological response, and several different high-affinity receptors with 
intrinsic protein tyrosine kinase activity (Basilico, and Moscatelli, 1992) . So far four 
members of the high-affinity FGF receptor family have been isolated and sequenced, 
namely FGFR-I\Flg\Cek-1, FGFR-2\Bek\Cek-3, FGFR-3\Cek-2 and FGFRA FGF- 
Rs have three immunoglobulin-like loops, a hydrophobic transmembrane region, and 
a catalytic tyrosine kinase domain. It was found that the third immunoglobulin loop 
is the important domain for FGF binding (Miki et al., 1991). Several binding affinity 
studies have indicated that FGFR-l shows a similar high affinity binding for both 
FGF-2 and FGF-1, with about a 15-fold lower affinity for FGF-4 (Dionne et al., 
1990; Mansukhani et al., 1990). FGFR-2 appears to bind FGF-1, FGF-2 and FGF4 
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with similar high affinity, and FGFR-3 and FGFR-4 may have higher affinity binding 
to FGF-I than FGF-2. Many studies have demonstrated that heparin-like cell surface 
molecules are necessary for the induction of a biological activity when FGF binds to 
its high affinity receptor (Yayon et al., 1991; Ruosishti and Yamaguchi, 1991). 
Recently it was shown that heparin-like molecules are not required for ligand binding, 
however, heparin-like molecules induce FGF molecules to oligomerize which results 
in dimerization of FGF receptors and receptor activation (Spivak-Kroizman et al., 
1994). 
The expression of FGF receptors in the nervous system has been extensively studied. 
In the adult rat PNS, FGF-R mRNA is undetectable in contrast, E14-1117 DRG and 
trigeminal ganglia show distinct neuronal labeling in in situ hybridization 
experiments. In terms of FGF-R protein, most motomeuron and sensory neurons 
show weak labelling (Weise et al., 1993). In the developing chicken embryo, three 
receptor genes: cek-1 (FGFR-1), cek-2 (FGFR-3) and cek-3 (FGFR-2) have been 
studied. Although all three receptors are expressed in a number of the same tissues, 
the expression of each receptor within a given tissue is generally specific for different 
cell types, suggesting that the members of the FGF receptor family may represent 
cell-type-specific receptors rather than ligand-specific receptors (Patstone et al., 
1993). 
Biological effects of FGF in the nervous system have been shown both on neurons 
and glia. As mentioned before, FGF-1, FGF-2 and FGF-4 are survival factors for 
Schwann cell precursors in vitro if IGF is also provided (Jessen et al., 1994; 
Gavrilovic et al., 1995). FGFs are also well known mitogens for Schwann cells 
combined with forskolin and IGF (Davis and Stroobant 1990; Stewart et al., 1992; 
1995). In the CNS, FGF-2 has been shown to support survival and neurite outgrowth 
in several neuronal types (Basilico and Moscatelli, 1992; Barid, 1994). FGF-2 also 
promotes DNA synthesis in astrocytes and neural precursor cells (Murphy et al., 
1990), and can act with other growth factors and cytokines to stimulate NGF 
synthesis and secretion by astrocytes and fibroblasts (Yoshida et al., 1992; 1992). 
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Moreover, FGF-2 may also act as transdifferentiation factor to drive Schwann cell 
precursors into melanocytes in the avian system (Sherman et al., 1993). 
Transforming Growth Factor 0 (TGFfl) 
Transforming growth factors were first identified as sarcoma growth factors in the 
conditioned medium of transformed fibroblasts. Subsequently, two major factors were 
identified and named TGFcc and TGFP (Hsuan, 1989; Burgess, 1989). It is known 
that TGFcc and TGFP are two completely different growth factors. TGFP is 
widespread in most tissues and in all species, suggesting that this factor may be 
widely involved in tissue development and repair. TGFP protein and cDNA was first 
purified and cloned from human platelets (Assoian et al 1983; Derynck et al 1985). 
Since then, many family members have been reported. TGFO-like factors can be 
subdivided into four families: The TGFPs, the activins/inhibins, Mullerian inhibiting 
substance (MIS) and decapentaplegic/bone morphogenetic protein (dpp/MIBP), 
comprising more than 28 members in total (Massague, 1990; 1994). In the TGFP 
family, 5 members have been shown to have great sequence homology, ranging from 
64%-82% (Kondaiah et al 1990). The basic structure of TGFP includes an N- 
terminal, pro-region with three N-linked glycosylation sites and c-terminal bioactive 
domain with 9 cysteines. During secretion, the pro-region is cleaved and combines 
with the TGFP bioactive dimer to form a biologically latent complex. This latent 
complex can be activated in vivo by unknown mechanisms. In vitro it can be 
activated by exposure to extreme pH ( <4 or >9 ), sodium dodecyl sulfate or plasmin 
(Lyons et al 1988). 
There are three types of TGFP receptors identified so far, called TGFO receptor type 
1, type II and type III, which correspond to 53 kDa, 70-85 kDa and 200-400 kDa 
molecular weights. It is now clear that TGFP receptor type I and type II are involved 
in signalling, whereas the type III, which is a betaglycan, may function as a reservoir 
or clearance system for bioactive TGFP (Hsuan 1989; Massague 1990). Cloning of 
the gene for the type 11 receptor indicates that this receptor is a transmembrane 
serine\threonine kinase with a short extracellular region, a transmembrane domain, a 
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kinase domain and a c-terminal rich in serine and threonine. (Matthews et al 1991). 
Type I and type II receptors interact as the interdependent component of a 
heteromeric complex. The type II receptor is required for specific ligand binding and 
this binding recruits the type I receptor which results in the phosphorylation of serine 
residues on the type I receptor. This phosphorylation may activate the kinase domain 
of the type I receptor to transduce the signal to downstream components (Wrana et 
al., 1992; Yamashita et al 1994; Wrana et al 1994; Heldin, 1995). 
TGFPs have been widely detected in the PNS and also in dissociated neurons and 
Schwann cells (Flanders et al., 1991; Millan et al., 1991; Rogister et al., 1993; 
Scherer et al., 1993; Stewart et al., 1995). Neurons after lesion in vivo or dissociated 
in vitro have been shown to secrete a active TGFP while Schwann cells only release 
the latent form (Rogister et al 1993; Stewart et al 1995). But other evidence shows 
that neurons may also secrete latent TGFO (Einheber et al., 1995). Interestingly 
regeneration of axons; downregulates TGFO mRNA levels in peripheral nerve 
(Scherer et al., 1993). 
TGFPs have been shown to both inhibit or stimulate proliferation depending on the 
cell type to which they are applied. In avian neural crest cells, TGFOs promote cell 
differentiation and melanogenesis (Rogers et al., 1992). In Schwann cells, TGFOs 
stimulate DNA synthesis in serum containing medium (Eccleston et al., 1989; Ridley 
et al., 1989; Schubert, 1991; Rogister et al., 1993; Guenard et al 1995 ), but several 
papers show that TGFOs like FGFs or PDGF-BB, will not on their own promote 
Schwann cell proliferation in serum free medium (Stewart et al 1992; Morgan et al., 
1994; Mews and Meyer, 1993; Chandross et al 1995). It can, in contrast inhibit 
proliferation driven by neurons (Guenard et al., 1995; ). As discussed previously, 
TGFOs also downregulate Po, NGF receptor and GFAP in Schwann cells (Mews and 
Meyer 1993; Morgan et al., 1994; Stewart et al., 1995; Chandross et al., 1995), and 
upregulate LI and N-CAM (Einheber et al., 1995; Stewart et al 1995). 
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Insulin-like Growth Factorf! UF 
The term insulin-like growth factor was proposed due to the fact that the structure of 
these proteins is highly similar to proinsulin. There are two members in this family in 
addition to insulin, named IGF-I and IGF-II (Clemmons, 1989; Sara and Hall, 1990). 
IGF-I and IGF-II have been detected in most mesodermally derived tissues during 
early development which suggests that IGFs might be involved in embryogenesis 
(Beck et al 1987). In the nervous system IGF-I has been shown to be expressed at a 
high levels in fetal brain but its levels decreased significantly postnatally (Sandberg et 
al 1988). In the oligodendrocyte lineage, IGFs support the survival of both 0-2A 
progenitor cells and oligodendrocytes (Barres et al., 1992). In Schwann cells, IGF-I 
stimulates cell proliferation in the presence of cAMP analogoues and serum 
(Schumacher et al., 1993). Both IGF-I and IGF-II have been reported to induce DNA 
synthesis of Schwann cells in response to FGF-2 and PDGF in serum free medium 
(Stewart et al 1996). IGFs is also required in combination with FGFs for supporting 
Schwann cell precursor survival in vitro (Gavrilovic et al., 1995). IGF-I null 
mutations in mice result in dwarves which die shortly after birth (Liu et al., 1993). 
d wav-ý / 
In the early 1970s, IGF was thought to bind exclusively to the insulin receptor. 
Megyesi et al., (1975) first identified distinct plasma membrane receptors for insulin 
and IGF which finally led to the isolation and sequencing of two human IGF 
receptors: type I IGF receptor and type II IGF receptor (Rinderknecht et al., 1978; 
1978). Type I receptor is closely related to the insulin receptor. It is a 
heterotetrameric protein which comprises two a subunits (135 kDa) and two 0 
subunits (90 kDa). Type I receptor was cloned and sequenced in 1986 by Ullrich et al, 
revealing that the cc subunits have a growth factor binding domain and the P subunits 
contain a tyrosine kinase domain. In contrast to the type I receptor, the type II IGF 
receptor is monomeric and has no kinase activity (Morgan et al., 1987). Ligand 
binding studies show that the type I receptor has almost the same affinity for IGF-I 
and IGF-II but appears to have a very low binding affinity for insulin. In contrast, the 
type 11 receptor shows a high affinity for IGF-11 and 3-4 fold lower affinity for IGF-I, 
and no reaction with insulin (Neely et al., 1991; Schofield, 1992). IGF receptors and 
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the insulin receptor have been shown to be present in all rat and human brain regions 
including cerebral cortex, olfactory bulb, hippocampus, thalamus, cerebellum and 
pons (Brownstein and Roth 1981; Gammeltoft et al 1984; 1985; 1988). The amount 
of the type 11 receptor is significantly higher in fetal brain than adult brain 
(Gammeltoft et al., 1988). More recently, mice carrying null mutations of the genes 
encoding IGF type I or\and IGF-I or IGF-II have been analyzed. It has been shown 
that between El I to E12.5, IGF type I receptor is acted on by IGF-II in vivo to induce 
mitogenic signalling, while from E13.5 onward, IGF type I receptor interacts with 
both IGF-I and IGF-II (Baker et al., 1993; Liu et al., 1993). 
Platelet Derived Growth Factor (PDgFj 
PDGF is a hetero- or homodimer consisting of two A and B chains linked by 
disulphide bridges. So far, three members of this family have been found and named 
PDGF-AA, PDGF-BB and PDGF-AB (Heldin and Westermark, 1990). In the CNS, 
PDGF mRNA and protein have been detected in embryonic brain and optic nerve 
and throughout development until adulthood (Richardson et al., 1988; Pringle et al ., 
1989; Yeh et al ., 1991; Sasahara et al., 1991; Reddy and Pleasure, 1992). In culture, 
type-I astrocytes have been shown to produce PDGF A chain (Richardson et al., 
1988). In vitro, PDGF supports the survival of 0-2A progenitor cells and newly 
formed oligodendrocytes and stimulates the proliferation of 0-2A progenitor cells 
(Noble et al., 1988; Richardson et al., 1988; Barres et al., 1992). In vivo, PDGF 
decreases normal oligodendrocyte death by up to 90% in developing optic nerve 
(Barres et al., 1992). PDGF has also been shown to increase Fos and Jun expression 
in newly formed oligodendrocytes (Hart et al., 1992). In the PNS, PDGF has been 
detected at relatively high levels in neonatal rat DRG and sciatic nerve, and Schwann 
cells show a much stronger labeling than neurons. The levels in Schwann cells 
declined during the first postnatal weeks (Eccleston et al 1990; 1993). It is well 
known that PDGF in combination with cANT is a mitogen for Schwann cells (Davis 
and Stroobant, 1990; Eccleston et al, 1990; Stewart et al., 1992; Hardy et al ., 1992). 
In view of the interaction between PDGF and IGFs discussed above, it is of 
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interesting that PDGF increases the levels of IGF receptor mRNA in the c3T3 cell 
line (Rubini et al., 1994). 
The discovery of three PDGF isoforms has led to the identification of two different 
PDGF receptor types: PDGF cc-receptor and O-receptor (Hart et al., 1988; Heldin et 
al., 1988). It is clear now that the P-receptor binds PDGF-BB with high affinity and 
PDGF-AB with lower affinity, but does not bind PDGF-AA. Whereas the cc-receptor 
can bind both A and B chains (Heldin and Westermark, 1990). PDGF receptors are 
widely expressed both in the CNS and PNS. Reddy and Pleasure, (1992) reported that 
both PDGF cc and 0 receptor mRNA levels are markedly higher in rat brain at E15 
and postnatal day 6 than that in later life. It was also found that at E9 PDGF cc 
receptor mRNA was present in the most dorsal portion of the neural tube, associated 
with early neural crest cells (Schatteman et al., 1992), after E16 the signal is only 
expressed on glial cells, but not on neurons in the CNS (Pringle et al., 1992). Antisera 
specific for the PDGF cc- and 0-receptors revealed high levels of both receptors in the 
neonatal rat PNS, whereas, both receptors can only be detected in non-myelinated 
fibres in adult nerve (Eccleston et al., 1993). 
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Table 1.1 The molecular phenotype of Schwann cells 
Antigen 
Myelin-fom-dng 
Schwann cells 
Non-myelin-forming 
Schwann cells 
Short-tenn 
cultured cells Precursors 
CNPase + nd. + n. d. 
PO + 
WBP + 
MAG 
P170k + n. d. n. d. 
PLP + n. d. nd. 
P2 +. - n. d 
Oil + n. d. 
GFAP + + 
p75NGF-R + + + 
N-CAM + + + 
Ll =f: b + + + 
A5E3 + + + 
Ran-2 + + + 
C461 + md. n. d. 
sloo + + + 
Vimentin + + + + 
Laminin + + + + 
Nestin + + + + 
04,08,09 + + 
Gal-C + + 
Seminolipid + + + 
GAP-43 + + + 
a Present on some myelin-forming Schwann cells only 
b Present mainly at nodes of Ranvier 
n. d. Not determined. 
Adaped from Mirsky R and Jessen KR, (1990): Schwann cell development and regulation of 
myelination. Seminar in Neuroscience 2: 423-435 
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Tablel. 2 The different isoforms of NDF family 
Name Isofonn Source Protein Properties References 
NDF 01 rat neural tissue 4044 kDa Mainly in neural Wen-, et al. 
secreted protein tissue (1994) 
02a Ratl-EJ 40-44 kDa Mitogenic to Schwann Stewart et al. 
secreted protein cells (1996) 
95 kDa proNDF 
03 Ratl-EJ 30 kDa Not secreted Wen et al 
nonglycosylated protein (1994) 
04a Ratl-EJ 4044 kDa Phosphorylation of Neu Wen et al 
secreted protein in MDA-MB 453 cells (1994) 
95 kDa proNDF 
oc2a Ratl-EJ 40-44 kDa Rapind processing Wen et al 
secreted protein (1994) 
95 kDa proNDF 
a2b Ratl-EJ 40-44kDa Phosphorylation of New Wen et al 
secreted protein in MDA-MB 453 cells (1994) 
60-75 kDa proNDF 
(x2c Ratl-EJ 44 kDa Induces cell growth Wen et al 
secreted protein arrest in 565 breast (1994) 
60-75 kDa proNDF cancer cells 
Heregnilin 
4; 2 Ola MDA-MB-231 45 kDa Mitogcnic in SKBR-3 Holmes et al 
secreted protein breast cancer cell lines (1992) 
02a MDA-NIB-231 Phosphorylation of Neu Holmes et al 
in breast cancer cell lines (1992) 
03 MDA-N1B-231 - Not secreted Holmes et al 
(1992) 
oc2a MDA-NIB-231 45 kDa Mitogneic in SKBR-3 Holmes et al 
secreted protein and MCF-7 breast (1992) 
cancer cell lines 
GGFII 03-kringle Human brain 45 kDa Mitogenic to Schwann Marchionni 
spinal cord secreted protein cell et al., (1993) 
GGFHFBI 03 Human brain Not secreted protein Marchionni 
spinal cord et al., (1993) 
GGFBPP5 03 Bovine pituitary Not secreted protein Marchionni 
cDNA et al., (1993) 
ARIA Pla Chick brain 3342 kDa Stimulates the synthesis Falls et al., 
secreted protein of muscle acetylcholine 1993 
receptors 
Rat I -EJ: Ras-transformed Rat I cells. 
MDA-M[B-23 1: Human breast cancer cell line. 
Modified from Ben-Baruch N and Yarden Y, (1994): Neu differentiation factors: a family of 
alternatively spliced neuronal and mesenchymal factor. Pro. Soc. Exp. Biol. Med. 206: 221-227 
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CHAPTER 2 
MATERIALS AND GENERAL METHODS 
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Materials and Growth factors 
Transferrin, selenium, putrescine, triiodothyronine, thyroxine, dexamethasone, 
insulin, cytosine arabinoside, hyaluronidase, laminin, poly-L-lysine (Molecular 
weight 300,000), carbonic anhydrase, N6,2'-o-dibutyryladenosine 3': 5'-cAW 
(dbcAMP) and bovine serum albumin (BSA) were obtained from Sigma Chemical 
Company (Poole, UK). Forskolin was from Calbiochem-Behring Corporation (San 
Diego, CA). The protein assay kit was from Bio-Rad (Munich, Germany). Tissue 
culture petri dishes, and 24-well plates were from Falcon (Philip Harris Scientific, 
London, UK). Four-well plates were from Nunc Life Techno logies; (Scotland, UK). 
NGF was a gift from Dr. J. Winter and brought from Sigma Chemical company 
(Poole, UK). BDNF and NT-3 were a gift from Drs. G. Dechant and Y. Barde. FGF-l 
and FGF-2 was from R&D systems (Abingdon, UK). IGF-1, PDGF-AA, and PDGF- 
BB were from Pepro Tec Inc. Human recombinant TGFO-1 was from Boehringer 
Mannheim (Lewes, UK). Human recombinant EGF was a gift from Dr Fiona Watt. 
NDFP-I, NDFP-2, NDFP-3, NDF-EGFP-I, NDF-EGF, NDFoc-I NDF(x-2, NDFa-3 
and NDF-EGFa-2 were a gift from Amgen Inc (Thousand Oaks, CA. ). Calf serum 
(CS) was from Imperial Laboratories (Andover, UK). Fetal calf serum (FCS) was 
from Advanced Protein Products (Brierley, UK). DMEM, minimum essential 
medium, Ham's F12 medium, and trypsin were from GIBCO Laboratories (Paisley, 
UK). Collagenase was obtained from Worthington Biochemical Corporation 
(Freehold, NJ). Bromodeoxyuridine (BrdU) was from Boehringer Mannheim (Lewes, 
UK). Citifluor was obtained from City University (London, UK). XAR-2 and X- 
Omat film were from Kodak (Rochester, NY). 5-bromo-4-chloro-3-indolyl 
phosphate, nitroblue tetrazolium salt were from Boehringer Mannheim (Lewes, UK). 
All electrophoresis apparatus and reagents were from Bio Rad (Munich, Germany). 
Nitrocellulose paper was from Schleicher and Schuell (Dassel, Germany). 5(and-6) 
carboxyfluorescein diacetate, succinimidyl ester (CFSE) was obtained from 
Molecular Probes Inc (Eugene, OR). 
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Antibodies 
Rabbit antiserum to bovine S-100 protein from Dakopatts (Copenhagen, Denmark) 
was used at a dilution of 1: 10000. Monoclonal antibody 192 IgGl, which recognizes 
the low affinity p75 nerve growth factor receptor (p75NGF-R) was a gift from E. 
Johnson Jr. and used in the form of ascites fluid, at a dilution of 1: 100. Monoclonal 
antibody 217c IgG2a was a gift from Dr K. Fields, and used at a dilution of 1: 500. 
Monoclonal anti neurofilament antibody (RT97) was a gift from Dr. J Wood 
(Anderton et al., 1982). Monoclonal antibody against BrdU was a gift from M. Jones 
and Dr. K. Mason and used at a dilution of 1: 100. Two different rabbit polyclonal anti 
Po antibodies were used. One was a gift from Dr. B. D. Trapp and was used in diluted 
1: 500, and the other one was made in this laboratory essentially as described by 
Brockes et al., (1980) and used in dilution of 1: 8,000. Affinity purified rabbit 
antiserum 19154 to recombinant human NDF was used at a concentration of 0.1- 
10pg/ml for blocking and at a concentration of 5-10pg/ml for immunostaining, rabbit 
antiserum to recombinant rat NDF was used at a concentration of 1: 50, monoclonal 
antibody 5D6A against recmbinant NDF was used at a concentration of 5-10pg/ml, 
monoclonal antibody 114A specifically against recombinant NDFP isoforms was used 
at a concentration of 0.1-10pg/ml, monoclonal antibody lH7A4 against recombinant 
NDF(x isoforms was used at concentration of I-10gg/ml. All monoclonal and 
polyclonal anti NDF antibodies were from Amgen Inc (Thousand Oaks, CA). 
Polyclonal antibody K-15 to ErbB-2 receptor and polyclonal antibody C-18 to ErbB-4 
receptor were from Santa Cruz Biotechnology Inc (Santa Cruz, CA). Both of them 
were used at a concentration of Igg/ml. Fluorescein conjugated to goat anti-rabbit 
immunoglobulin from Cappel Labs. Inc (Durham, NC), absorbed with mouse 
immunoglobulin to remove cross-reacting antibodies, and tetramethyl rhodamine 
conjugated to goat antimouse immunoglobulin from Cappel Labs. Inc (Durham, NC), 
absorbed with rabbit immunoglobulin to remove cross-reacting antibodies, were both 
used at a dilution of 1: 100. Biotinylated sheep anti-rabbit and anti-mouse 
immunnoglobulins and streptavidin-fluorescein were from Amersham International 
(Bucks, UK). Polyclonal sheep anti-digoxygenin conjugated to alkaline phosphatase 
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was from Boehringer Mannheim (Lewes, UK). The ECL chemiluminescence kit and 
the species specific anti-rabbit Ig conjugated to horse radish peroxidase were from 
Amersham International (Bucks, LJK). The hybridoma cell lines ASCS4 secreting 
antibodies to the cell adhesion molecule Ll (Sweadner, 1983), was a gift from Dr. A. 
Furley, the hybridoma cell line OX7 secreting antibodies agaist to Thy 1.1 was 
obtained from European Collection of Animal Cell Cultures (Salisbury UK), the 
hybridoma cell line secreting antibodies to the 04 antigen was a gifts from Dr. I. 
Sommer (Sommer and Schachner, 1981). All these secreting antibodies were used in 
the form of cell culture supernatant. VectastainTm Elite ABC kit was from Vector 
Laboratories (Peterborough, UK). 
Defined medium 
Defined medium used in this study was a modification of the medium of Bottenstein 
and Sato (1979). A 1: 1 mixture of DMEM and Ham's F12 was supplemented with 
(final concentration in parentheses) transferrin (100 gg/ml), progesterone (60ng/ml), 
putrescine (16ýtg/nil), insulin (10-9 M), thyroxine (0.44g/ml), selenium (160 ng/ml), 
triiodothyronine (10.1 ng/ml), dexamethasone(38 ng/ml), glucose (7.9mg/ml), bovine 
serum albumin (0.3mg/ml), penicillin (1001U/ml), streptomycin (IOOIU/ml), and 
glutamine (2 mM). In some experiments insulin was used at high concentration (10-6 
M) or omitted from the medium; this is indicated in the text. 
Coating of coverslips and wells 
Glass coverslips (13mm diameter) were sterilized and then incubated with poly-L- 
lysine (PLL) (I mg/ml) at room temperature for 24 hr, washed with 12 changes of 
sterile distilled water over a period of 4 days, and allowed to dry. Laminin-coated 
coverslips were prepared by incubating PLL coated coverslips with 10-30 ýtl of 
laminin solution (20pg/ml in DMEM) for I hr before plating with cells. Plastic tissue 
culture wells were coated with PLL by incubating them with 20 pg/ml of PLL for 2 
hr at room temperation, draining and air drying. 
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Preparation of Schwann cell precursor cultures 
Cultures of Schwann cell precursors were prepared essentially as described previously 
(Jessen et al., 1990). Briefly, pregnant rats were killed by exposure to C02, and the 
embryos aged E14 or E13 were decapitated and kept in L-15 medium on ice. To date 
the embryos, the day of the vaginal plug was counted as EO (Christie 1965). The 
sciatic nerves and brachial plexus nerves were dissected out, dissociated, chopped and 
incubated in enzyme solution containing collagenase (2mg/ml), hyaluronidase 
(1.2mg/ml) and trypsin inhibitor (0.3mg/ml) for 1-1.5 h at 370C. The cells were then 
washed in 6-8ml defined medium. After centrifugation, the cells were resuspended in 
low insulin defined medium without serum, counted, and plated at a density of 2000 
cells per coverslip in a 10 ýil drop on laminin-coated coverslips. After 2.5 hr, the 
cultures were topped up with 3 80 ýtl of different experimental media. 
Preparation of freshly dissociated Schwann cells 
The sciatic nerves from E16 to new born rats, and also from adult sympthetic trunk 
nerves were dissected and digested in enzyme cocktail as described above for 1.5-2.5 
hr according to embryonic and postanatal ages. After washing and centrifugation (as 
above), 2000 cells were then plated on laminin coated coverslips in 10 [LI of defined 
medium. The cells were topped up to 400 pl of different culture media after 2.5-4 hr 
according to age. The adult freshly dissociated Schwann cells from sciatic nerves 
were obtained in the way described below. 
Preparation of Schwann cells for purification 
Sciatic nerves were dissected from postnatal rats aged newborn, 4 days and adult 
(above 4 weeks) and desheathed. The tissues were dissociated by a modified method 
of Brockes et al. (1979). Briefly, newborn and 4 day rat sciatic nerves were 
dissociated in 0.2% collagenase and 0.125% +in in calcium and magnesium-free 
DME at 370C and 5% C02 /95% air for 35 min. Adult sciatic nerves were 
dissociated in 0.2% collagenase and 0.25% trypsin for 1.5 hr, the same enzymes were 
then added for another 1-1.5 hr. After incubation a equal volume of MEM-BEPES 
containing 10% fetal calf serum or calf serum Was added and the tissue gently 
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disoociated. The cells were centrifuged at 500 xg for 10 minutes, resuspeneded in 
low insulin or high insulin defined medium. The dissociated Schwann cells were 
cultured in a flask (25cin) for further purification. In some cases, the cells were 
plated on coverslips immediately to test the effect of culture period and pre-exposure 
to serum. 
Schwann cell purificatio 
Schwann cells prepared by the above method were cultured in a 25CM 2 flask for 4 
days with Dulbecco's modified Eagles' medium (DMEM) containing 10% fetal calf 
serum supplemented with penicillin (100IU/nil), streptomycin (100[tg/ml), and 
glutamine (2mM). Cytosine arabinoside (10-5 M) was added after 24 hr for 72 hr to 
kill rapidly dividing fibroblasts. On the fourth day, the cells were detached from the 
flask with calcium- and magnesium- free M[F-M-HEPES containing 0.05% trypsin and 
0.2% EDTA for 2-3 minutes at 370 C for newborn and 4 day rat Schwann cells, and 
containing 0.075% trypsin and 0.2% EDTA for 4-5 minutes for adult Schwann cells. 
This procedure could further purify the Schwann cells since the Schwann cells 
detached from flask before the fibroblasts due the the cellular area difference between 
Schwann cells and fibroblasts. Detached cells were pelleted by centrifugation at 500 
XG for 10 minutes. The purified Schwann cells were then resuspended in defined 
medium with low or high insulin and plated on laminin coated coverslips at a density 
of 10,000 cells /coverslip in a 30 pl drop. 
Schwann cell precursor survival assa 
Schwann cell precursors were plated on coverslips and topped up with different 
experimental media after 2.5 hr as described above. Then the precursor cultures 
were fixed 
_ 
by using 2% paraformaldehyde at 3 hr, 20 hr, 44 hr and 68 hr 
respectively. After immuno-labelling with LI antibody (see below), the number of 
the cells counted at the 3 hr point was taken as the total number of Schwann cell 
precursors alive at the beginning of the assay. This is based on the observation that 
almost all cells plated on laminin coated coverslips would attach to coverslips during 
the first 2.5-3 hr. The total number of cells counted at 20 hr or 44 hr and 68 hr were 
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then divided by the total number of cells at 3 hr, to give the survival percentage at 
respective time points. 
DNA synthesis assay 
Two different DNA synthesis assays have been used in this thesis. For the 20 hr assay 
of freshly dissociated Schwann cell precursors and Schwann cells, DNA synthesis 
was monitored by exposing cells to BrdU (20ýM) for 1.5 hr pulse at 18.5 hr after 
plating. In some experiments, the cultured cells were exposed to BrdU three times at 
3.5 hr, 13.5 hr and 18.5 hr respectively for 1.5 hr pulses. For purified Schwann cells 
(pre-serum exposed), BrdU (IOgM) was introduced for the last 24 hr of a 48 hr 
assay. The cells from both types of assay were followed by double labelling with LI 
and BrdU antibodies for precursors and embyronic Schwann cells, or a p75NGF-R (or 
SIOO) and BrdU double label in most Schwann cell experiments (see below). Some 
experiments were triple labelled with LI, p75NGF-R and BrdU. The percentage of 
BrdU positive cells among the LI positive cells was taken as the proportion of 
Schwann cell precursors synthesizing DNA, and the percentage of BrdU positive cells 
among the p75NGF-R positive cells was taken as proportion of Schwann cells 
synthesizing DNA. BrdU labelling was carried out according to Gratzner, 1982. The 
cells, after labeling with Ll or p75NGF-R, were washed and fixed in methanol (- 
200C) for 10 minutes followed by 2M HCl for 20 minutes to denature DNA. After 
another washing, cells were incubated with 0.1 M sodium borate for 10 minutes to 
neutralize the acid, followed by incubation with BrdU antibodies in PBS containing 
0.1% Triton X-100 for 45 minutes. After washing the cells were incubated with 
rhodamine conjugated goat anti-mouse immunoglobulins (1: 100) for 30 minutes, 
washed and mounted in Citifluor anti-fade mounting medium. 
Preparation of neuronal cultures from dorsal root gangli 
DRG were dissected from newborn, E15 and E14 rats. 35-40 ganglia were obtained 
from each rat and incubated with 1.25mg/ml trypsin for 7-15 minutes at room 
temperature according to the age of rat from which the ganglia were derived. 
Following addition of 5-6 ml of DMEM or defined medium containing 10% fetal 
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calf serum, the dissociated cells in suspension were drawn through needles of 
decreasing diameter: 0.8 min, 0.6 mm, and 0.5 min (3-4 times through each needle). 
The resulting cell suspension was centrifuged at 500 xg for 10 minutes, and the 
enzyme solution was removed. The cells were either resuspended in low insulin 
defined medium containing 50ng/ml NGF for culture, or resuspended in DMEM plus 
10% fetal calf serum and NGF for further purification. 
Purification of DRG neurons by an immunopanning method 
Dissociated DRG neurons were resuspended in 6 ml of DMEM containing 10% fetal 
calf serum and 1-5ng/ml NGF as described above. The suspension was then 
transferred to a 90 mm plastic non-culture dish coated with anti Thy 1.1 antibodies, 
since Thy- I is known to be expressed on both neurons and fibroblasts, but not by glial 
cells (Fields et al., 1978). After 2-3 minutes at 370 C the dish was rinsed very quickly 
with DMEM or defined medium 4-5 times. The pure neurons attached to the bottom 
of dish were then streamed off with 10 ml of defined medium containing 5-50ng/ml 
NGF several times. After centrifugation, the pellet of pure neurons was resuspended 
in low insulin defined medium containing 50ng/ml NGF and 50ng/ml IGF-I. The 
neuron suspension was then plated and cultured on coverslips for 20 hr, and labeled 
with anti neurofilament antibodies (RT97) for neurons and SlOO antibodies for glia. 
All the neurons and non-neuronal cells were counted, and the purity of neurons 
generated from this immunopanning method was 95%±5.3. 
To prepare the anti Thy 1.1 antibody coated dish, the 90 mm 2 non-culture dish was 
incubated with 6-7 ml of Tris buffer solution (50 mM pH 9.5) containing 50-60ý1g/ml 
(40pl) of rabbit anti mouse immunoglobulin overnight at 40C, then the dish was 
washed 3 times with PBS and further incubated with a anti Thy 1.1 antibodies ( the 
antibodies were in the form of culture supernatant from the OX-7 cell line, and could 
be diluted in MIEM-HEPES according to the concentration of antibodies in 
supernatant ) for at least I hr at room temperature. The antibody coated dish was 
washed 3 times with PBS and used immediately.. 
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Neuron conditioned medium (NCM) 
To collect the NCM, 100,000-150,000 neurons purified from DRG of 3 rats were 
plated in 4-well poly-L-lysine coated plastic plates in 300-400ý11 of low insulin 
defined medium containing 50ng/ml of NGF and 50ng/ml of IGF-I. At 20 hr, the 
medium was replaced with 500-600ýtl of fresh medium, and cultured for another 48 
hr. The NCM was collected at 72 hr after plating. The NCM could either be used 
immediately or stored frozen (-700 Q in cryotubes coated with heat-treated bovine 
serum albumin. 
Schwann cell precursor and neuron co-cultures 
For co-culture the neurons were pre-labelled with the fluorecent dye, 5(and 6) 
carboxyfluorescein diacetate, succinimidyl ester (CFSE). The USE (30ýM) was 
introduced into the neuronal suspension for 30 minutes at 370 C just before the 
immunopanning procedure. After labelling with USE the neuronal suspension was 
purified by the immunopanning method described above. Therefore, the USE in 
suspension was washed out during this procedure. For the survival assay, 250 neurons 
in 60 pI of low insulin defined medium containing NGF (50ng/ml) were plated onto 
each laminin coated coverslip. The sparse neurons were cultured for 20 hr to allow 
neurite outgrowth, and during this period the medium could be topped up to IOOPI or 
changed once. 2000 Schwann cell precursors prepared as described earlier were added 
to the cultured neurons in 60 [tl of fresh low insulin defined medium containing NGF 
(50ng/ml). 340 ýtl of the same medium was added after 2.5-3 hr. The co-culture was 
ended at 3hr and 20hr. After Ll immuno-labelling the total numbers of precursors in 
contact with neurons or neurites was counted and the total number of precursors not 
in contact with neurons or neurites was also counted. The percentage of survival at 20 
hr represents the total number of cells at 20 hr divided by the total number of cells at 
3 hr. In this co-culture all the original neurons or non-neuronal cells could be easily 
distingushed from Schwann cell precursors since the USE is fluorescent and is 
present in neuronal cell bodies, neurites and original Schwann cells. For the 
proliferation and differentiation assay 2000 USE labeled and purified neurons were 
plated on each coverslip and 4000 Schwann cell precursors were added to the 
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neuronal culture on the second day. The neuron and Schwann cell precursor co- 
culture was kept for I day, 2 days, 4 days, 6 days, 8 days or 2 weeks for proliferation 
assays, and cultured for I day, 2 days, 4 days, I week or 2 weeks for maturation and 
differentiation assays. Half the medium was replaced each day. A 20 hr BrdU pulse 
was introduced to the co-culture at each time point for the proliferation assay, and 
S 100,04 and Po immunolabelling were used for maturation and differentiation assays 
(for details see immunocytochemistry procedures). 
Blocking experiments in NCM or the neuron-precursor co-culture system 
To block the survival activity of the NCM, the soluble ErbB4 proteins and DG-2 
antibodies were mixed with NCM for at least 2 hr at 370C before NCM was applied to 
the precursors. Then the mixture of NCM and proteins or antibodies was added at 3 hr 
to cultured Schwann cell precursors. To block the neuron and Schwann cell precursor 
co-cultures, the soluble ErbB4 proteins were introduced into culture 3 times. First the 
soluble ErbB4 proteins were added to the neuronal culture at 3-4 hr before the 
Schwann cell precursors were plated on neurons, secondly, the soluble ErbB4 
proteins were mixed with Schwann cell precursors to be plated on neurons, thirdly, 
the soluble ErbB4 proteins were introduced into the co-culture 5 hr after Schwann 
cell precursors were plated. Control experiments were carried out by incubating the 
soluble ErbB4 proteins or DG-2 antibodies with NDFO-2 and FGF-2 containing 
medium for at least 2 hr prior to addition to Schwann cell precursors in the 20 hr 
survival assay. 
ImmunocZochemisq_y 
To immunolabel cells for the p75NGF-R receptor and LI, cells were fixed in 2% 
paraformaldehyde for 5 minute, rinsed and then incubated with monoclonal antibody 
192 IgG to p75NGF-R or monoclonal antibody ASCS4 to LI for 30-60 minutes. 
After washing in minimum essential medium cells were then incubated with 
biotinylated anti-mouse IgG for 30 minutes followed by streptavidin-fluorescein for 
15 minutes. For p75NGF-R and LI double labelling monoclonal antibody 217c IgG2a 
and ASCS4 IgGI were used, and then Texas red anti-mouse IgG2a and biotinylated 
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anti-mouse IgGI were applied as the second layers. For staining these cells, 
antibodies (192 IgGl, 217c IgG2a, ASCS4 IgGl) were diluted in minimum essential 
medium containing 15 mM HEPES buffer plus 10% calf serum. 
For S-100 cells were fixed in 4% paraformaldehyde for 20 minutes, blocked in 3% 
gelatin PBS for I hr, then incubated with anti S-100 antibody (in PBS plus 10% calf 
serum, 0.02% sodium azide, 0.1 M lysine medium) I hr, followed by fluorescein 
labelling. For 04 labelling co-cultured cells were fixed in 4% paraformaldehyde for 
10 minutes, followed by a 1: 1 dilution of supernatant containing mouse 04 antibodies 
for I hr, followed by goat anti-mouse Ig fluorescein. For Po labelling, co-cultured 
cells were fixed in 2M HCI at room temperature for 15 minutes, followed by 10 
minutes in 0.1 M sodium borate. After washing in PB S, the cells were incubated for 
1-2 hr in antibody diluting solution (PBS containing 10% FCS, 0.1 M lysine and 
0.02% sodium azide). Cells were then incubated in Po antibody (1: 8000) in the same 
solution overnight. The cells were subsequently washed and incubated in donkey anti- 
rabbit Ig biotin for I hr, followed by streptavidin-fluorescein for 15 minutes. 
For ErbB2 and ErbB4, cells were fixed in 4% paraformaldehyde for at least 20 
minutes, incubated in 0.1% Triton MOO for 10 minutes followed by anti ErbB2 and 
ErbB4 antibodies for I hr, then followed by biotin-streptavidin as above. For 
immunohistochemistry controls, omission of the first antibody layer was used in 
every case as a standard control. For ErbB receptor staining, experiments were carried 
out in which ErbB2 was pre-absorbed with both ErbB2 and ErbB4 control peptides, 
and ErbB4 was Pre-absorbed with both ErbB4 and ErbB2 control peptides for at least 
2 hr before staining. This process further comfirmed the antibody specificity and 
excluded non-specific absorption. 
For NDF labelling, neurons or Schwann cell precursors were fixed in 2% 
paraformaldehyde for 5-7 minutes, followed by anti NDF antibodies (1915# 
polyclonal anti NDF antibody 1-10ýtg/nil, 5D6A monoclonal anti NDF antibody I- 
lOpg/ml, IH7A4 monoclonal anti NDFoc antibody I-IOpg/ml and 114A monoclonal 
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anti NDFP antibody 10-50gg/ml) in MEM-IHEPES containing 10% calf serum for I 
hr. The donkey anti rabbit Ig biotin or rabbit anti-mouse Ig biotin were applied for 30 
minutes, followed by streptavidin-fluorescein for 15 minutes. Control experiments for 
NDF labelling were carried out by absorbing 5D6A or 1915# antibodies with NDF 
for 2 hr prior to labelling. 
In situ hybridisation 
A digoxigenin-labelled cDNA probe was used to detect Po mRNA in Schwann cell 
precursor and neuron co-cultures, detecting hydridisation by alkaline phosphatase- 
liked immunohistochernistry. A cDNA (SN63c) encoding the entire Po coding 
sequence (1.8kb) subcloned into pGEM4, donated by Drs G. Lemke and 1. Griffiths 
was used (Lemke and Axel, 1985; Griffiths et al., 1989). Digoxigenin-labelled probes 
were transcribed using the Boehringer SP6/T7 transcription kit and manufacturer's 
instructions. Transcripts were hydrolysed to give an average probe length of 150 
bases and used at a concentration of 2.5 ng/ýtl. Schwann cell precursors and neurons 
on coverslips were fixed in 4% paraformaldehyde for 20 minutes and then dehydrated 
from 30% ethanol to 70% ethanol. The cells were rehydrated, and followed by 
digesting in proteinase-K (1.25gg/ml) for 3-3.5 minutes at room temperature. After 
washing in PBS the cells were refixed in 4% paraformaldehyde and treated with 0.1 
M triethanolamine acetate. After hybridisation with cDNA probe as mentioned above 
at 500 C for at least 18 hr, cells were washed in 4XSSC for 50 minutes at room 
temperature, followed by 5 minutes in RNase buffer then digested in RNase-A 
(20gg/ml) for 30 minutes at 370 C, and followed by washing in RNase buffer at 370 C 
for 30 minutes, 2XSSC at 45 0C for 30 minutes, O. IXSSC 30 minutes at 550 C and 
buffer I (Tris-HCI lOOmM, NaCl 150mM, pH 7.5) for 5 minutes. Cells were then 
blocked in 1% milk in buffer I for I hr at room temperature, and incubated in 
polyclonal sheep anti-digoxigenin conjugated to alkaline phosphatase in 1% milk in 
buffer I for I hr. After washing in buffer-I 30 minutes and buffer-3 (Tris-HCI 
lOOmM, NaCl lOOMM, MgC12 50mM, pH 9.5) 10 minutes, the hybridised cells were 
visualised by enzyme catalysed colour reaction using 5-bromo-4-chloro-3-indolyl 
phosphate and nitroblue tetrazolium salt. 
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Immunoblottinp, 
Neurons from newborn rat DRG were cultured in a 35 mm petri dish with defined 
medium containing 50 ng/ml NGF plus IGF-I (13nM) for 20 hr. The neurons were 
seeded at 3-4XIO 5 per dish. Schwann cells from newborn rat sicatic nerves were 
cultured in a 35 mm. 2 petri dish at a density of 5XI05 Cells per dish in defined 
medium containing FGF-2 (180pM) plus IGF-I (13nM) for 20 hr. 2XIO 5 Schwann 
cell precursors from E14 rat were cultured in defined medium containing FGF-2 
(180pM) plus IGF-I (13n" for 20 hr. Proteins were extracted from the cells 
described above or from brain tissue by using 50-100 gI of 2% SDS in 5 mM Tris- 
Cl, pH 6.8, containing 2 mM EGTA, 2 mM EDTA, and 2 mM PMSF per dish. 20gg 
of each sample was applied to a 8% polyacrylamide gel. The separated proteins were 
then transferred to nitrocellulose, a molecular weight markers, SDS 6H, were used to 
calibrate the gel. The nitrocellulose sheet was blocked with 5% milk in PBS and then 
exposed to NDF antibody 5136A (5 gg/ml) in 1% milk in PBS overnight at 40C. 
Rabbit anti-mouse Ig conjugated to biotin was applied for I hr followed by Vectastain 
Elite ABC kit for 30 minutes, made up according to manufacturers instructions. 
Bound antibody was detected using enhanced chemiluminescence (ECL) and X-ray 
film (X-Omat). 
Culture of hybridoma cell lines 
In order to obtain the anti Ll, Thy 1.1 and 04 antibodies, the ASCS4 cell lines, OX-7 
cell lines and 04 cell lines were cultured in 75 cm 2 flasks with 20-25 ml of hybridoma 
medium containing 10% fetal calf serum, 100mM glutamine, 100mM pyruvate, 
10,000 IU/ml penicillin and streptomycin and 0.1 M 2-mercaptoethanol in RPNH. The 
supernatant was collected every other day, and stored at -20'C until required. 
Quantification 
All quantitative results are based on a minimum of three separate experiments. Each 
determination within an experiment is based on counts from three coverslips in the 
majority of cases, but occasionally on counts from two coverslips. The error bar on 
graphs indicates SEM. 
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CHAPTER 3 
THE SCHWANN CELL PRECURSOR: 
SURVIVAL AND PROLIFERATION 
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Introduction 
The Schwann cell precursor, a distinct intermediate cell between neural crest cells 
and Schwann cells defined by previous work in our group, faces a life or death fate 
during development. In rat, Schwann cell precursors have been isolated from E14- 
E15 peripheral nerve (Jessen and Mirsky, 1992; Jessen et al., 1994). In vitro almost 
all Schwann cell precursors undergo apoptosis in 20 h in routine culture medium. The 
survival rate of these cells can be dramatically increased by the use of neuronal 
conditioned medium (Jessen et al., 1994), suggesting that neuronally derived 
molecules are crucial for the survival of these cells. In order to identify the molecules 
necessary for Schwann cell precursor survival many growth factors were screened in 
the short-term survival assay. It was found that FGFs combined with IGF could 
rescue 100% of the Schwann cell precursors from apoptosis in 20 h cultures (Jessen et 
al., 1994; Gavrilovic et al., 1995). However, for long-term survival, it was necessary 
to add serum in addition to FGF and IGF, suggesting that some unidentified 
molecules may act as a long-term survival factors for Schwann cell precursors. 
Schwann cell precursors in vivo normally undergo vigorous proliferation (Stewart et 
al., 1993). But so far no molecules have been identified as mitogens for Schwann cell 
precursors in vitro. FGF-2 plus forskolin, a typical mitogen for Schwann cells, fails to 
induce DNA synthesis in Schwann cell precursors (Garvrilovic et al., 1995). But in 
birds and rats, FGFs in the presence of serum and embryo extract stimulates neural 
crest cell proliferation (Bannerman and Pleasure, 1993; Murphy et al., 1994 ). 
Therefore, some unidentified molecules may exist in serum or embryo extract which 
synergize with FGF or act by themselves alone to trigger Schwann cell precursor 
proliferation. As mentioned previously, members of the novel growth factor family, 
NDF\ GGF\ HRG, have recently been found to be expressed at high levels in 
embryonic spinal cord and dorsal root ganglia (Off-Urtreger et al., 1993; Meyer and 
Birchmeier, 1994). These molecules have also been shown to have a potent mitogenic 
effect on Schwann. cells (Marchionni et al., 1993; Goodearl et al., 1993; Stewart et al., 
1995). Therefore it is of interest to know the role of these molecules in Schwann cell 
precursor development. 
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In early studies of Schwann cell proliferation, it was found that bovine pituitary 
extracts had ability to stimulate Schwann cell proliferation (Raff et al., 1978; Brockes 
et al., 1979), which led to the partial purification of a new growth factor named glial 
growth factor (GGF) (Lemke and Brockes, 1984). Recent purification and cDNA 
cloning of this molecule led to the discovery that GGF belongs to a novel growth 
factor family including NDF, HRG, GGF and ARIA (Ben-Baruch and Yarden, 1994). 
The biological activity of NDFs has been shown to promote both proliferation and 
differentiation depending upon the cell type (Peles et al., 1992; Falls et al., 1993; 
Goodearl et al., 1993). In the Schwann cell lineage, NDF has been shown to stimulate 
Schwann cell DNA synthesis both with and without cANW elevation (Goodearl et al., 
1993; Marchionni et al., 1993; Stewart et al., 1995). In the early stages of 
development, NDF is able to influence the lineage choice of neural crest cells in vitro. 
(Shah et al., 1994). This implies that NDF may act as a key molecule in the 
development of the Schwann cell lineage. 
NDF is known to activate its biological events by binding to specific receptors. The 
identified receptors for NDF are ErbB2, ErbB3 and ErbB4. It is clear that NDF can 
phosphorylate all three receptors when these receptors are co-expressed in cells, 
although the phosphorylation of the receptor is quite complicated when the receptor is 
expressed on its own (Tzahar et al., 1994 Sliwkowski et al., 1994; Carraway et al., 
1994; Carraway and Cantley, 1994). Both ErbB2 mRNA and protein have been 
shown to be highly expressed on Schwann cells at the early postnatal stage and their 
expression decreases significantly up to adulthood (Cohen et al., 1992; Jin et al., 
1993). More recently, ErbB2 and ErbB3 have also been detected in neural crest cells 
(Shah et al., 1994; Meyer and Birchmeier, 1995). But so far there is have been no 
reports showing the expression of ErbB4, the more recently discovered NDF ligand 
binding receptor, in cells of the Schwann cell lineage. 
The results in this chapter show that NDFP isoforms but not NDF(x isoforms act as 
survival factors for Schwann cell precursors in defined medium at the pM level. The 
survival activity of NDFO depends on its EGF-like domain. This survival activity of 
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NDFP can also be blocked by polyclonal anti-NDF antibody. In a long term survival 
assay, NDFO not only rescues Schwann cell precursors from programmed cell death 
for several days but also maintains the response of these cells to FGF. Furthermore, 
IGF is shown to significantly increase the survival activity of NDFcc. In contrast, 
neither IGF nor insulin is required for the effect of NDFP in promoting Schwann cell 
precursor survival. NDFP is so far the only known growth factor that acts as a 
mitogen for Schwann cell precursors when applied on its own. TGFP in combination 
with FGF and forskolin and IGF-1 can also stimulate Schwann cell precursor DNA 
synthesis. In addition the present study also shows that Schwann cell precursors 
express the NDF receptors ErbB2 and ErbB4. Together, these observations indicate 
that NDF may play a important role in Schwann cell precursor development. 
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Results 
NDFP acts as a survival factor for Schwann cell precursors in short term 
cultures 
In order to understand the effects of NDF in Schwann cell precursor survival assays, 
various doses of NDFO-2 and NDFcc-2 were used in defined serum free medium 
containing a low concentration of insulin (InM) for 20 h. In this entirely defined 
medium only insulin receptors but not IGF type I receptors will be activated due to 
very low insulin levels (Sara and Hall, 1990; Neely, 1991). The results showed that 
even at the pM level NDFP-2 markedly increased the survival rate of Schwann cell 
precursors (Figure 3.1). The dose-dependent survival curve indicated that maximal 
survival (100%) occured between 40-120pM. Without NDFP essentially all 
precursors were dead by 20 hr*(Figure 3.2). In contrast to NDFO-2, NDFcC-2 had 
little survival activity for precursors even at the nM level in this low insulin medium. 
To further test whether different domains of NDFs might affect survival, the NDFP-1 
or NDFO-3 which differ from NDFP-2 in the amino acid sequence in the 
juxtamembrane region (Wen et al., 1994), were tested in the same conditions as 
described above. The results indicated that both NDFP-I and NDFP-3 had a similar 
effect on survival to NDFO-2 (Figure 3.3A), while the corresponding cc isoforms were 
ineffective. Furthermore, the Schwann cell precursors were also challenged with 
NDF-EGFP-1 which lacks immunoglobulin domain and the spacer domain, and NDF- 
EGFO which only has the EGF-like domain. It was found that the polypeptide 
containing only the EGFP domain of 40 amino acids was sufficient to rescue all 
precursors from death (Figure 3.313). 
IGF-I promotes the survival activity of NDF 
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In previous studies from our group, IGF was thought to be an essential factor in 
mediating the FGF rescue of Schwann cell precursors. The survival activity of FGF 
appeared to depend on activation of IGF type I receptors (Gavrilovic et al., 1995). 
NDFP as shown above, was able to promote precursor survival in the low insulin and 
no IGF, indicating that IGF type I receptor activation is not necessary for NDFO 
mediated precursor survival. However, NDFoc in the same medium had very little 
survival promoting activity. Therefore, experiments were performed to test whether 
IGF was necessary for NDFcc to mediate survival and whether it would enhance 
NDFP survival activity in this assay. It was found that IGF-I (13nM) did not 
significantly shift the NDFP-2 survival curve. Surprisingly, when NDFP-2 was used 
in the absence of both insulin and IGF medium the survival of Schwann cell 
precursors could still reach 100% atpM concentrations of NDFO-2, but theED50 
(the concentration giving half maximal survival) was 5-6 fold h; ýher than that seen in 
low insulin medium (Figure 3.4A). In contrast to NDFO-2, IGF-1 markedly enhanced 
NDFa-2 mediated survival. The maximal survival rate of precursors in the presence 
of both IGF-I (13rlN4) and NDFoc-2 (4 nM) reached 70% (Figure 3.413). 
Since IGF-1 has been shown to greatly enhance the survival activity of NDFoc-2, the 
same experiment was also done using NDFcc-I and NDFoc-3. It was found that both 
NDRA and NDFcc-3 in the presence of IGF-1 (13nM) had a similar survival activity 
as NDFcc-2 (Figure 3.5A). Furthermore, NDF-EGFcc-2 which has an cc EGF-like 
domain and juxtamembrane region also showed some survival potential but less than 
that of the whole ot isoform in the presence of IGF-1 (13nM). Thus the limited 
survival potential of NDFoc may also partially depend on its cc-EGF-like domain 
(Figure 3.513). 
NDF induces DNA synthesis in Schwann cell precursors 
Before testing the mitogenic activity of NDFP on Schwann cell precursors it was 
noticed that the survival rate always overshot 100% when high concentrations of 
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NDFO had been applied in the medium (Figure 3.1). This suggests that NDFP may act 
as a mitogen for Schwann cell precursors as well as for Schwann cells. 
Two separate experiments performed in the presence of IGF-I (13nM) were devised 
to test this. First, in a 20 hr survival assay, BrdU was introduced into the medium 
three times, with 1.5 hr long pulses at each time point. The BrdU reaction was ended 
at 5 hr, 15 hr and 20 hr after plating. DNA synthesis was monitored in LI positive 
cells with BrdU nuclear labelling. It was found that in the presence of FGF-2 
(1 80pM) plus forskolin the proliferation of Schwann cell precursors fell rapidly from 
5h (13.67%) to 20 h (0.97%). In contrast, in the presence of NDFP-2 the division of 
precursors varied with different concentrations of NDFO-2. In high concentrations of 
NDFP-2 (400pM) DNA synthesis increased from 5h (13.88%) to 20 h (22.54%). But 
in low concentrations the division pattern is similar to that of FGF-2 plus forskolin 
(Figure 3.6A). Interestingly it was found that in the 5h assay DNA synthesis of 
precursors in all experimental groups was about 13% which excellently matched 
previous experiments in vivo (Stewart et al., 1993). 
In additional experiments, NDFO-2 was used in conditions in which Schwann cell 
precursors had fallen out of cell division. Schwann cell precursors were first cultured 
in FGF-2 medium for 20h, then changed to NDFP-2 medium for another 20 h. BrdU 
was introduced into the medium for only 1.5 hr at each time point and the incubation 
were terminated at 5 hr, 15 hr, 20 hr, 25 hr and 40 hr respectively. Under these 
conditions NDFP-2 still stimulated DNA synthesis of Schwann cell precursors to 
24.16% at the 40 hr point although at the 20 hr point the division rate of precursors 
was only 1% in FGF-2 medium (Figure 3.613). The DNA synthesis rate at the 40 hr 
(24.16%) in this experiment is similar to that in the 20 hr experiment (22.54%) when 
NDFP-2 was added directly after plating (Figure 3.7). 
In the experiments described above, the different NDFP isoforms were shown to have 
similar effects on the survival of Schwann cell precursors. The different isoforms 
were also used for mitogenic assays. Only the 20 hr assay was carried out in this 
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experiment and BrdU was added for the last 1.5 hr of a total 20 hr period. It was 
found that all NDFP isoforms have the same effect on DNA synthesis of precursors 
(Figure 3.8A). Moreover, NDF-EGFO-1 and NDF-EGFO, as described before for 
survival, also stimulated DNA synthesis of these cells and were as potent as NDFP-2 
(Figure 3.813). Since high concentrations (4nM) of NDFcc-2 could still support 70% 
of Schwann cell precursor survival. DNA synthesis of precursors at this concentration 
was also tested, but only 0.88% of cells were BrdU positive. All experiments 
described above were carried out in the presence of IGF-1 and it was shown that all 
NDFP isoforms are dose-dependent mitogens for Schwann cell precursors, while 
NDFa is not. Since NDFP is largely independent of IGF for support of precursor 
survival NDFP was also used in only low insulin defined medium for precursor 
division assays. It was found that the mitogenic dose-response curve in the absence of 
IGF was quite similar to that in the presence of IGF (Figure 3.9) although IGF 
seemed to slightly enhance the mitogenic activity of NDFP. 
TGFO stimulates Schwann cell precursor DNA synthesis in the presence of both 
FGF and IGF 
In the experiments above, NDFP acts as a dose-dependent mitogen for Schwann cell 
precursors. In order to identify other possible mitogenic molecules for Schwann cell 
precursors many growth factors were screened in the presence of FGF-2, since all 
growth factors applied in these experiments were previously found to be unable to 
support Schwann cell precursor survival (Jessen et al., 1994). FGF is the only 
molecule which is known to support survival without induction of DNA synthesis in 
Schwann cell precursors. Eight different growth factors including TGFO-1, TGFO-2, 
PDGF-BB, PDGF-AA, EGF, NGF, BDNF and NT-3, were added on top of medium 
containing FGF-2 (180pM), IGF-1 (6.5nNl) and forskolin (5PM) (referred to 
henceforth as FIF medium). BrdU was applied during the last 2-4 h of a total 20 h 
assay to measure DNA synthesis. The results showed that only TGFO stimulated 
Schwann cell precursor DNA synthesis under these culture conditions (Table 3.1). 
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Addition of TGFP (Ing/ml) to the FIF medium gave rise to 20% DNA synthesis of 
Schwann cell precursors in comparison to 1.8% in FIF medium alone (Figure 3.1 0A). 
Dose-response curves for the mitogenic activity of TGFP were generated in a 20 h 
BrdU assay on both E14 and E13 Schwann cell precursors. It was found that addition 
of 0.1 ng/ml of TGFP on top of the FIF medium caused DNA synthesis in more than 
90% of precursors (Figure 3.1013). Meanwhile, control experiments showed that 
without FGF in this growth factor cocktail all precursors underwent programmed cell 
death. This suggests that TGFP acts only as a mitogen in the presence of other 
factors and has no survival effect on precursors. 
Identirication of LI as a speciric. marker of Schwann cell precursors 
In previous studies p75NGF-R was used as specific marker for Schwann cell 
precursors (Jessen et al., 1994; Gavrilovic et al., 1995). At the beginning of the 
survival experiments described above, p75NGF-R staining was also used. It was 
found that a small population of the p75NGF-R positive cells showed distinctive 
characteristics which included a more bipolar morphology in comparison to the 
flattened morphology of Schwann cell precursors, and isolation as single cells in 
comparison to the group-forming tendency of p75NGF-R positive precursors. In 
FGF-2 medium a lot of these isolated bipolar cells were BrdU positive, whereas cells 
in the flattened grouped cells were not. After screening several antibodies, Ll was 
shown not to label these cells although it bound to cells of the other p75NGF-R 
positive cells in double label experiments (see below). Together, the evidence 
indicates that this small population of cells tend to lie isolated, have a bipolar 
phenotype, divide in FGF-2 medium and are LI negative (Figure 3.11). It is possible 
that these p75NGF-Rý, Ll' cells do not belong to the Schwann cell lineage. In order 
to monitor the effect of this small population of cells in the survival and proliferation 
assays, p75NGF-R, Ll and BrdU triple labelling was used in the medium containing 
either FGF-2 or NDFO-2. Three separate BrdU doses were applied in the 20 h assay 
(as above). It was found that all LI positive cells were p75NGF-R positive, whereas a 
few p75NGF-R positive cells were Ll negative, In FGF-2 medium BrdU positive, Ll 
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positive cells decreased rapidly, whereas BrdU positive, p75NGF-R positive cells 
still remained at 10% at 20 hr fture 3.12A). These data implied that FGF-2 might 
Only stimulate DNA synthesis in Ll-, p75NGF-Rý cells. In NIDFO-2 medium, only 
3% of p75NGF-R positive cells were found to be Ll negative, and the outcome of 
this division assay did not significantly depend on whether Ll or p75NGF-R were 
used (Figure 3.12B). Thus, the use of either Ll marker or p75NGF-R labelling 
would lead to similar results in the precursor survival assay. Nevertheless, all the 
proliferation assays described above and the long-term survival assay described later 
in this chapter were carried out using LI labelling, and in the short-term survival 
assay most experiments were confirmed by LI labelling although some of the early 
experiments began used the p75NGF-R marker. The evidence suggests that Ll is a 
more specific marker for Schwann cell precursors than p75NGF-R. 
NDF supports long term survival of Schwann cell precursors 
NDFP has been shown to support Schwann cell precursor survival in a 20 h assay 
(shown above), and FGF-2 was also reported as a survival factor in short term 
cultures in previous studies (Jessen et al., 1994; Gavrilovic et al., 1995). To further 
test whether these molecules can also support the long term survival of precursors, 
NDFP-2 and FGF-2 were applied in low insulin defined medium with IGF-1 (13nM). 
Meanwhile, in order to limit the effect of proliferation of precursors in this assay, a 
low concentration of NDFO-2 (32pM) only was used in all these experiments. The 
survival assay was carried Out at the 20 hr, 44 hr and 68 hr, and total surviving cells 
were counted using Ll labelling. It was found that in NDFP medium the total number 
of cells at the 68 hr point was higher than that at the 20 hr point (Figure 3.13B). 
Using BrdU to label precursors at the 20 hr and 44 hr it was found that about 3% of 
cells were synthesizing DNA, in the'l. 5 h BrdU assay. it implies that this small 
division may generate a small increase in the total number cells at 44 hr and 68 hr. In 
contrast to NDFO, in FGF-2 there was a dramatic decrease of precursor survival after 
20 hr, and at 68 hr less than 100 "o of cells survived (Figure 3.13A). This suggested that 
NDFP is a long-term survival f'actor, whereas FGF-2 is not. 
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To further understand why Schwann cell precursors died after 20 h in FGF-2 
medium, Schwann cell precursors were cultured in FGF-2 medium for 20 h, then 
cells were washed several times and changed to NDFO-2, NDFa-2 or fresh FGF-2 
medium respectively. The results showed that all precursors survived after being 
changed from FGF-2 to NDFO-2 (Figure 3.14A), whereas, massive cell death was 
found in the remaining FGF-2 medium after another 20 h as shown above (Figure 
3.13A). The survival rate in NDFcc-2 medium was similar to that previously show in 
the 20 h assay using NDFcc-2 (Figure 3.14B). These results indicated that NDFP 
could still rescue precursors even after they had been exposed to FGF-2 for 20 h. It 
seems that precursors gradually lose responsiveness to FGF-2 in FGF-2 medium. 
However, FGF-2 maintains the response of precursors to both NDFO and NDFcc. 
Since FGF-2 maintains the response of precursors to NDFP and NDFcc, but not FGF 
itself, it was of interest to know whether NDFO can also maintain responsiveness of 
precursors to FGF. The experiment designed for this purpose was carried out under 
the same conditions as above. The Schwann cell precursors were cultured in NDFO-2 
(32pM) for the first 20 hr or 44 hr respectively, then changed to FGF-2 (180pM) 
medium. It was found that after 20 hr in NDFP-2 the survival rate of precursors in 
response to FGF-2 over the next 24 hr was 83.61% (Figure 3.15A), which is similar 
to the precursors in FGF-2 in the 20 h assay (Figure 3.13A). Furthermore, after being 
in NDFO-2 for 44 h Schwann cell precursors can totally survive in FGF-2 medium 
(Figure 3.15B). Therefore, these experiment indicate that NDFP is able to maintain 
the survival response of precursors to FGF. 
The experiments above showed that NDFP-2 supports Schwann cell precursor 
survival for more than three days. It is known that E14 Schwann cell precursors 
develop into Schwann cells during three day period (E17 Schwann cells) in vivo 
(Jessen et at., 1994). Therefore it was of interest to know whether Schwann cell 
precursors under these culture conditions would also develop into Schwann cells. 
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Previous studies showed that Schwann cells differ from Schwann cell precursors by 
showing surviving well in routine medium and by expressing SlOO protein (Jessen 
and Mirsky, 1991; 1992). To test whether Schwann cell precursors undergo 
maturation in NDF containing medium, precursors were cultured in NDFP-2 for 20 h 
or 44 h respectively, then changed to low insulin defined medium without any 
specific survival factors, since only Schwann cells but not precursors can survive in 
this medium. The results showed that 52% of cells survived in this medium after the 
cells were exposed to NDFO-2 for 2 days although most precursors died in this 
medium after cells had been exposed to NDFP-2 for only 20 hr (Figure 3.16). 
Interestingly, the survival rate of 52% in this defined medium after 2 days in NDFP-2 
(which is equivalent to E 14 +2d= E16 in vivo) is similar to the survival rate of 
cells from E16 nerves in defined medium (Jessen et al., 1994). Meanwhile, a pilot 
study showed that Schwann cell Precursors cultured in NDFP-2 medium for more 
than 3 days expressed S-100. Parallel studies by A. Brennan give more detail and 
precise evidence to show that NDFP drives Schwann cell precursor maturation (Dong 
et al., 1995). 
The survival activity of NDF can be blocked by polyclonal anti NDF antibody. 
To further detennine the specificity of NDFO survival activity in Schwann cell 
precursors, two antibodies were used. 1915 ,a polyclonal antibody raised in rabbit, 
was originally thought to recognize NDFcc specifically. It is now known to recognize 
sequences present in NDFP as well (Personal communication from Dr. D. Wen 
Amgen Inc. ). 114A, a monoclonal antibody, was designed to specifically bind to the 
c-loop of 0 EGF-like domain and therefore recognizes only NDFO isoforms (Personal 
communication from Mr. D. Chang Amgen Inc. ). The experiments were carried out 
in medium containing low insulin plus IGF-1 (13nM). Different concentrations of 
antibodies were mixed with NDFO-2 (40pM) in the above medium and were kept for 
at least 2h before the mixture was applied to the precursors. It was shown that 1915 # 
antibody at lOpg/ml concentration significantly diminished the survival activity of 
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NDFP-2 (Figure 3.17A). On the other hand, 114A antibody even at high 
concentration (50pg/ml) only reduced NDFP-2 survival activity by 48% (Figure 
3.17B). Both antibodies were also tested in FGF-2 medium, where no block of 
survival was detected, indicating that the antibodies do not cause non-specific toxic 
effects. These experiments indicated that the survival activity of the molecules which 
have been used the above experiments were due to NDF molecules, since their 
activity could be blocked by its corresponding antibody. Furthermore, the observation 
that blocking of the c-looP of P EGF-like domain did not totally demolish survival 
activity of NDFP indicates that the biological function of NDFP may depend on the 
whole EGF-like domain rather than just on the c-loop which contains the key 
sequence difference between cc isoforms and P isoforms (Wen D et al., 1994). 
Schwann cell precursors express NDF binding receptors ErbB2 and ErbB4 
The results so far indicated that NDF not only supported Schwann cell precursor 
survival but also stimulated precursor DNA synthesis and probably promoted 
maturation of these cells. It is known that the ligand binding receptors for NDF are 
ErbB2, ErbB3 and ErbB4 (Carraway and Cantley, 1994). Therefore, it was important 
to know whether precursors also express these receptors to which NDF can bind to 
trigger survival and proliferation events. The experiment was carried out by applying 
anti ErbB2 and ErbB4 antibodies. Schwann cell precursors were cultured in both 
FGF-2 plus IGF and forskolin medium and NDFO-2 plus IGF-1 medium for 20 h. 
After fixation in 4% paraformaldehyde for 20 minutes Schwann cell precursors were 
stained with either anti ErbB2 (1pg/ml) or anti ErbB4 (Igg/ml) antibodies. It was 
found that almost all precursors showed membrane-associated immunolabelling in 
both antibodies, although the intensity of immunolabelling of ErbB2 was more 
variable (Figure 3.18). The corresponding control experiment showed that ErbB4 
control peptide abolished ErbB4 immunolabelling but not ErbB2 labelling, whereas 
ErbB2 control peptide diminished ErB2 immunolabelling but not ErbB4 labelling. 
This indicated that the staining applied here is a specific labelling for both ErbB2 and 
ErbB4, and therefore that Schwann cell precursors expressed both of these receptors. 
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Discussion 
The experiments presented here showed that proteins of the novel growth factor 
family, NDF\GGF\HRGIARIA, were able to support either short-term or long-term 
survival of Schwann cell precursors at pM concentrations without any other growth 
factors or serum. Neither IGF nor insulin is necessary for NDF to promote the 
survival of these cells. NDF not only rescues precursors from apoptosis but also 
stimulates the DNA synthesis of these cells at higher concentrations. In contrast, FGF 
acts as a short-term survival factor in combination with IGF, but it can neither support 
precursor long-term survival nor stimulate DNA synthesis in these cells. Whereas, 
TGFP has been found to promote Schwann cell precursor DNA synthesis in the 
presence of FGF-2, forskolin and IGF-1, it has no survival activity at all for 
precursors on its own. The ability of NDF to promote survival, proliferation and 
maturation of Schwann cell precursors suggests that NDF may activate multiple 
signalling pathways in these cells. 
NDF supports Schwann cell precursor survival 
For Schwann cell precursors NDF on its own seems sufficient for both short-term and 
long-term survival. This survival effect was in completely defined media and the cells 
used in these assays had never been exposed to serum or any other unidentified 
factors during either dissociating procedure or in culture. Meanwhile the rescue 
required neither IGF-l nor insulin, indicating that NDF is distinctly independent of 
any other factors to support Schwann cell precursor survival. 
It is known that a low concentration of insulin (lOnM) only activates the insulin 
receptor, while UnM IGF-I would activate both the insulin and IGF type-1 
receptors; high concentrations of insulin can mimic the effect of IGF-1 and activate 
both IGF type-1 receptors and insulin receptors (Sara and Hall, 1990; Neely et al., 
1991). FGF, unlike NDFO, depends on either IGF or high concentrations of insulin to 
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promote Schwann cell precursor survival, indicating that both IGF type-I and insulin 
receptor activation is necessary for FGF mediated precursor survival (Gavrilovic et 
al., 1995). Higher concentrations of NDFO-2 (4OOpM) support total precursor survival 
in the absence of both IGF and insulin. This implies that neither insulin receptor nor 
IGF type- I receptor activation is necessary for NDF mediated Schwann cell precursor 
survival. 
In addition to being independent of IGF, NDF promotes the long-term survival of 
these cells, while FGF only supports precursor survival for 20 hr. The rapid loss of 
survival of precursors during the 2nd and 3rd days in FGF-2 medium does not reflect 
a normal developmental change of these cells in vivo, since FGF-2 supports survival 
of cells directly dissociated from E15 or E16 nerves (Jessen et al., 1994). Meanwhile, 
it is also clear that Schwann cell precursors in FGF-2 medium for 20 hr are not 
irreversibly set on a death course, sinceýNDFP was shown to rescue all precursors 
which have been exposed to FGF-2 medium for 20 hr. Moreover, previous 
experiments show that FGF can support the long-term survival of precursors only 
when FGF is combined with some unidentified factors in serum (Jessen et al., 1994). 
Therefore, it is clear that Schwann cell precursors in vivo and in serum containing 
medium in vitro maintain full responsiveness to FGF, whereas precursors gradually 
lose the ability to respond to FGF in serum free medium containing FGF-2. It is 
probable that some unidentified molecules in vivo or serum may preserve the 
responsiveness of precursors to FGF. We have then taken a further step in this 
direction of identifying such molecules by showing that NDF maintains full FGF-2 
responsiveness in vitro. Although the molecular basis by which NDF regulates the 
response to FGF is not clear, one possibility is that NDF may regulate FGF receptor 
expression by precursors. The observation that responsiveness to NDF is maintained 
in vitro may reflect NDF regulation of its own receptors, since NDF\GGF has been 
shown to upregulate ErbB2 (neu) mRNA in Schwann cells (Cohen et al., 1992). 
Proliferation of Schwann cell precursors 
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Although it is clear that Schwann cell precursors in E14 or E15 nerves in vivo 
undergo proliferation (Stewart et al., 1993) the molecular basis for this is unknown. It 
has been shown previously that FGF plus IGF and forskolin, a routine mitogen for 
Schwann cells of all ages in culture, failed to stimulate Schwann cell precursor 
proliferation (Jessen et al., 1994; Gavrilovic et al., 1995). These results indicated that 
Schwann cells and Schwann cell precursors might have different responses to 
mitogens. The experiments presented here showed that NDFP and TGFP are mitogens 
for precursors in vitro, but the two growth factors showed significant differences in 
the conditions they require if they are to stimulate DNA synthesis. 
NDF, in the present study , showed a dose-dependent stimulation of Schwann cell 
precursor DNA synthesis in defined medium, and this effect is seen in the absence of 
forskolin or cAW analogues. It is well known that most growth factors rely on 
cAW elevation or cANT analogues to trigger Schwann cell proliferation in serum 
free defined medium, suggesting that elevation of intracellular cANT is necessary for 
Schwann cell division in most cases (Stewart et al., 1991). NDF, however, triggers 
DNA synthesis in Schwann cells also in the absence of cANT elevation (Stewart et 
al., 1996). It is not clear how these findings relate to the observation that NDF/GGF 
has been reported not to elevate intracellular cAMT in 3T3 cells (Yoshimura et al., 
1993). It is possible that NDF may activate the downstream components in cAW 
pathway which could also be triggered by elevating cAW. An alternative possibility 
is that NDF triggers a completely different pathway rather than the pathway triggered 
by cAMP. 
In the present experiments, NDF also stimulated precursor proliferation in low 
insulin defined medium, implying that IGF type-1 receptor activation is not 
necessary for NDF mediation of Schwann cell precursor proliferation. This is 
somewhat surprising since activation of IGF type-1 receptor was thought to be 
essential for other growth factors to generate proliferation and differentiation events 
of Schwann cells (Stewart et al., 1996). In the CNS, in order to stimulate purified 
oligodendrocyte precursor proliferation it is essential to activate the IGF type-1 
receptor, suggesting that the multiple signals are required for oligodendrocyte 
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proliferation (Barres et al., 1993; Barres and Raff, 1994). But NDFO expresses a very 
strong mitogenic potential which promotes Schwann cell precursor DNA synthesis in 
the absence both of elevation of intracellular cANT and activation of the IGF type-I 
receptor, indicating that, at least in vitro, multiple factors are not always necessary for 
the proliferation of cells in Schwann cell lineage. 
In contrast, TGFO acts only as a mitogen for precursors in the presence of FGF-2, 
IGF and forskolin. Without either FGF or IGF, precursors will not survive in TGFO 
alone. Therefore it is clear that TGFP acts only as a mitogen and has no survival 
activity, whereas FGF functions only as a survival factor and has no mitogenic 
activity for precursors. In these cases the survival pathway and the mitogenic pathway 
in Schwann cell precursors appears to be triggered separately by two different growth 
factors. However, NDF can activate both pathways to promote precursor survival and 
proliferation, and this activation seems independent of both IGF and forskolin. The 
most likely explanation for this observation is that NDF may activate a broad 
spectrum of cytoplasmic signalling pathways in Schwann cell precursors, including 
those activated by cAW, IGF, TGFO and FGF. 
The effect of different NDF isoforms 
The two main isoforms of NDF, NDFoc and NDFO, have a significantly different 
biological activity in terms of survival and mitogenic activity for Schwann cell 
precursors. NDFO gives rise to 100% precursor survival even in low or no insulin 
medium, whereas NDF(x at the same concentration (4OpM) only supports 12% 
precursor survival in the presence of both insulin and IGF. It is known that both 
NDFP and NDFcc can bind and phosphorylate ErbB3 and ErbB4, and when all three 
receptors, ErbB2, ErbB3 and ErbB4 are co-expressed in cells the phosphorylation of 
all three receptors has been observed (Tzahar et al., 1994; Sliwkowski et al., 1994; 
Scltoff et al., 1994). Meanwhile NDFP isoforms have been shown to have an 8-10 
fold higher binding affinity than that of NDFcc isoform in cultured mammary cells 
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(Wen et al., 1994). Therefore, it is possible that increasing concentrations of NDF(X 
may mimic the survival activity of NDFO. However, when 10 fold or even 100 fold 
higher concentrations of NDFcc (4nM) were tested for precursor survival in the 
presence of IGF, NDFcc only give rise to 70% precursor survival while NDFP at 
40PM already promoted 100% precursor survival. Therefore, it seems likely that 
NDFP may activate additional signalling pathways to those activated by NDFcc which 
leads NDFP to be a survival factor and also a mitogen for Schwann cell precursors. 
In line with this, NDFO-1 and 03-GGF-11 have been shown to be the predominant 
isoforms in nervous tissue, whereas NDFa isoforms are thought of as the 
mesenchymal and nonneuronal isoforms (Meyer and Birchmeier, 1994; Wen et al., 
1994). Thus, the expression of specific isoforms of NDF in a particular tissue may 
relate to its function in this tissue. As regards the question of which part of NDF 
domains acts as the functional domain in the survival and proliferation assays, the 
present study showed that differences in the juxtamembrane region which subdivides 
NDF into 1,2,3 and 4 sub-isoforms, do not generate differences in survival activity 
or mitogenic responses. It suggests that this region may not act as a functional 
domain. As suggested before, it may be involved in NDF secretion (Wen et al., 1994). 
The experiments here show that the 0 isoforin EGF-like domain alone effectively 
triggered both survival and proliferation, in agreement with previous observations that 
the EGF-like domain is the functional domain of NDF(Wen et al., 1994). 
Interestingly, monoclonal antibody 114A which specifically recognizes the c-loop of 
the P-EGF-like domain fails to block NDFP-2 activity completely, indicating that the 
whole EGF-like domain is necessary to trigger the biological activity of NDFP 
although the c-loop of the EGF-like domain is the key sequence which distinguishes 
NDFP from NDFcc isoforms. 
Co-expression of ErbB2 and ErbB4 in Schwann cell precursor 
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It is clear that NDF regulates cellular survival and proliferation by stimulating the 
intrinsic protein tyrosine kinase activities of their specific cell surface receptors, 
ErbB2, ErbB3 and ErbB4. When ErbB2 is co-expressed with either ErbB3 or ErbB4 
NDF can phosphorylate both receptors. When ErbB2 is expressed in the cells on its 
own, no phosphorylation of ErbB2 occurs (Carraway et al., 1994; Sliwkowski et al., 
1994; Tzahar et al., 1994). The present studies show that Schwann cell precursors 
express both ErbB2 and ErbB4 receptors. Since an anti rat ErbB3 antibody was not 
available when experiments were carrying out, this study was unable to determine 
whether ErbB3 is expressed by precursors, but one recent study showed that ErbB3 
mRNA was also detected on neural crest cells and Schwann cell precursors of mouse 
suggesting that this receptor may also be involved in early development of cells in the 
Schwann cell lineage (Meyer and Birchmeier, 1995). Based on an analysis of amino 
acid sequences of ErbB2, ErbB3 and ErbB4 receptors it has been suggested that 
ErbB2, ErbB3 and ErbB4 might recruit many SH2 domain-containing proteins to 
activate a wide range of signalling pathways (Carraway and Cantley, 1994). 
82 
Table 3.1: List of mitogens for Schwann cell precursors 
In the presence of FGF-2 
plus IGF and Forskolin 
Growth factor alone 
TGFO-1 0.01-10ng/ml + no survival 
TGFO-2 0.01-10ng/ml + no survival 
EGF lOng/ml - no survival 
PDGF-AA 4-10ng/ml - no survival 
PDGF-BB 5-10ng/ml - no survival 
NGF 50ng/ml - no survival 
BDNF 10ng/ml - no survival 
NT-3 10ng/ml - no survival 
FGF-1 1-10ng/ml n. d. 
FGF-2 1-10ng/ml 
FGF-4 20ng/ml n. d. 
NDFP 1-30ng/ml ++ 
NDFcc 1-100ng/ml n. d. 
n. d. Not determined. 
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Figure 3.1 NDFO-2 prevents death of Schwann cell precursors 
Schwann cell precursors obtained from E14 rat nerves were cultured in 
defined medium containing either NDFO-2 or NDFcc-2 for 20 hr. LI 
antibody was used to label precursors after 20 hr. The number of 
precursors counted on coverslips at 20 hr is expressed as a percentage of 
the number of precursors present 3 hr after plating. This is referred to as 
the percent survival. The results show that NDFP-2 acts as a dose- 
dependent survival factor for precursors, but not NDFcc-2. 
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Figure 3.2 NDFP supports precursor survival for 20 hr. 
Schwarm cell precursors dissociated from E14 sciatic nerves were 
cultured in defined medium or defined medium containing NDFP-2 for 20 
hr. At the 3 hr point, all precursors attached on coverslips (A). After 20 
hr, precursors in defined medium only die (B). Mide precursors In NDFP 
containing medium survive (C). The surviving preCUrsors are shoxvn by 
LI labeling (D). Magnification 60OX 
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Figure 3.3 NDFPs support Schwann cell precursor survival 
Schwann cell precursors were cultured in defined medium containing 
different isoforms of NDFP (A), or NDF-EGFO I domain and NDF-EGFO 
domain only (B) for 20 hr. 'Me precursors were labeled with LI 
antibodies. The results show that different NDFP isoforms have similar 
activity in supporting precursor survival and that the EGFP domain acts 
as the functional domain of NDFP forms. 
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Figure 3.4 Insulin4ike growth factor promotes NDF mediated 
Schwann cell precursor survival. 
sl I 
culluTed in defined medlum co'fttmnlng 
insulin, low insulin and low insulin plus IGF-l (UnM), and the NDYV2 
dose-response curves were constructed on top of these media (A). NDFCc- 
2 doses-response curves were based on defined medium containing low 
insulin or low insuVin plus JG'F_j (13nNi) for 20 11T. LI ari&odleswere 
used to label the surviving precursors. Ilic results show that NM 
supports precursor survival in Ilic abscncc of both insulin and IGF, and 
extra iflSUlin and IGF shift thc surNival curvc at low concentrations of 
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Figure 3.5 NDFcc isoforms share the same low survival activity for 
precursors 
Schwann cell precursors were cultured in defined medium containing 
IGF-I (13nM) plus different NDFa isoforms (A), or NDF-EGFCC-2 
domain (B). The result show that all NDFcc isoforms share the same low 
survival activity and EGFcc-2 domain alone has even less survival activity 
than that of NDFocs. 
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Figure 3.6 NDFP-2 acts as a dose-dependent mitogen for precursors 
(A) Schwann cell precursors were cultured in defined medium containing 
FGF-2 (180pM) plus forskolin (5pM) or NDFO-2 in different 
concentrations. BrdU was introduced into the culture at the 3.5 hr, 13.5 hr 
and 18.5 hr points with 1.5 hr pulse each (B) Schwann cell precursors 
were cultured in FGF-2 plus forskolin for 20 hr then the cultured medium 
was changed to NDFO-2 containing medium for a further 20 hr of culture. 
DNA synthesis was monitored at the 5 hr, 15 hr, 20 hr, 25 hr and 40 hr 
points with 1.5 hr BrdU pulse each. The results show that NDFO-2 
promotes DNA synthesis of precursors in dose-dependent manner. 
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Figure 3.7 NDFP stimulates DNA synthesis of Schwann cell 
precursors 
Schwann cell precursors were cultured in NDFý containing medium for 
20 hr (A). 1.5 lir BrdU pulse was Lised during 18.5-20 hr. The precursors 
were dOLible labeled with Ll (B) and BrdU (C). Magnification 80OX 
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Figure 3.8 NDFPs share a similar mitogenic potential 
Schwann cell precursors were cultured in defined medium containing 
different isoforms of NDFO (A), and NDF-EGFO-1 or NDF-EGFO 
domain (B) for 20 hr with 1.5 hr BrdU pulse. The results show all NDFp 
isoforms have the same mitogenic activity and EGFO domain alone was 
able to trigger the DNA synthesis in precursors. 
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Figure 3.9 NDFP retains mitogenic potential for precursors in low 
insulin medium 
Schwann cell precursors were cultured in defined medium containing low 
insulin- or low insulin plus IGF-I (13nM). NDFO-2 dose-response curves 
were constructed under these two conditions. BrdU was introduced into 
culture for the last 1.5 hr of total 20 hr assay. 'Me results show that NDFP 
also stimulates DNA synthesis of precursors in the absence of IGF. 
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Figure 3.10 TGFP acts as mitogen for precursors in the presence of 
FIF medium 
(A) Schwann cell precursors were cultured FIF medium (FGF-2 180pM 
plus IGF-I 13nM and forskolin 5pM) or FIF medium plus TGFPI 
(Ing/ml) for 20 hr, 1.5 pulse BrdU was used at the 18.5 hr point. (B) 
Schwann cell precursors were cultured in FIF medium plus various 
concentrations of TGFPI for a total of 44 hr, and a 20 hr BrdU pulse was 
used at the 24 hr point. The results showed that TGFP in the presence of 
FGF and forskolin stimulates DNA synthesis in Schwann cell precursors 
and acts in a dose-dependent manner. 
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Figure 3.11 Ll-/p75NGF-R-, cells dissociated from E14 nerves 
respond to FGF plus forskolin 
The cells dissociated from EW nerves ýýere cii1ttired in defined inediurn 
containing FGF-2 (180pM) plus forskohn (5pM) for 20 hr. 1.5 hr BrdU 
pulse was used. LI, p75NGF-R and BrdU triple-labelling was applied. 
(A) phase-contrast view of (B) and (C). (B) p75NGF-R and BrdU 
staining. (C) LI labelling. The results show that the isolated bipolar cells 
(arrows) are LI negative and p75NGF-R positive and BrdU positive, 
while group-forming cells are generally Ll positive. p75NGF-R positive 
and BrdU negative (A, B. C). Magnification 80OX 
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Figure 3.12 Ll+lp75NGF-W cells and Ll'lp75NGF-W cells respond 
differently to FGF-2 plus forskolin, but in the same manner to NDFP- 
2 
Schwann cell precursors were cultured in defined medium containing (A) 
FGF-2 (180pM) plus forskolin (5gM) and IGF-l (13nM), (B) NDFP-2 
(4OOpM) plus IGF-l (13nM) for 20 hr. LI, p75 NGF-R and BrdU triple- 
labelling was used for these precursors after 20 hr in culture. The results 
show that FGF-2 plus forskolin was mitogenic for p75NGF-RýýI- cells 
but not for Ll+/p75NGF-Rý cells. Whereas, NDFP plus IGF was 
mitogenic for both cell types. 
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Figure 3.13 The long-term survival factor for Schwann cell 
precursors 
Schwann cell precursors were cultured in defined medium containing (A) 
FGF-2 (180pM) plus IGF-I (13nM) or (B) NDFO-2 (32pM) plus IGF-I 
(13nM) for 20 hr, 44 hr and 68 hr. Ile culture medium was changed at 
the 20 hr and the 44 hr points. Ll antibodies were used to label the 
surviving precursors. The results show that NDFP supports precursor 
survival for more than 68 hr, while FGF-2 only supports precursor 
survival for 20 hr. 
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Figure 3.14 FGF-2 maintains responsiveness of precursors to NDF 
Schwann cell precursors were cultured in defined medium containing 
FGF-2 (180pM) plus IGF-I (13nM) for 20 hr, then cultured precursors' 
were washed several times with defined medium and changed to defined 
medium containing (A) NDFP-2 (4OOpM) plus IGF-I (13nM) or (B) 
NDFcc-2 (4OOpM) plus IGF-l (13nM) for a further 24 hr or 48 hr. The 
total LI positive cells at the 20 hr, 44 hr and 68 hr points were counted. 
The results show that NDFP supports survival of all precursors after these 
cells are cultured in FGF-2 for 20 hr, whereas, NDFcc only rescues about 
25% of precursors. 
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Figure 3.15 NDFP maintains precursor rcsponsivcness to FGF-'. ) 
Schwann cell precursors were cultured in defined medium containing 
NDFP-2 (32nM) plus IGF-I (13nM) for I day (A) or 2 days (B) then 
changed to FGF-2 (180pM) plus IGF-l (13nNI) containing medium. The 
surviving precursors were monitored at the 20 hr, 44 hr and 68 lir points 
as described before. The results show that NDFP fully maintains 
responsiveness of precursors to FGF-2. 
112 
140 
120 
100 
80 
60 
40 
20 
0 
140 
120 
_j 
100 
80 
60 
oe 40 
20 
0 
N 
20 44 68 
TIME (hours) 
20 44 68 
TIME (hours) 
Figure 3.16 NDFP drives Schawnn cell precursor maturation 
Schwann cell precursors were cultured in defined medium containing 
NDFP-2 (32nM) plus IGF-l (13nM) for I day (A) or 2 days (B). After 
washing the cultured cells were changed to dcrincd medium only. 'me 
surviving precursors were monitored at the 20 hr, 44 hr and 68 lir points 
by LI labelling. Ile results show that 50% of the LI positive cells 
survive in defined medium after culturing in NDFP-2 containing medium 
for 2 days. 
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Figure 3.17 Anti NDF antibodies block the survival activity of NDF 
(A) Various concentrations of polyclonal anti NDF antibodies 1915', and 
(B) various concentrations of monoclonal antibodies 114A were mixed 
with NIDFP-2 (4OpM) before introduction to the culture. Sch%%-ann cell 
precursors were plated in defined medium containing lGF- I (13 nNI) for 3 
hr, the cultured cells were then topped up with the antibodies containing 
medium for total 20 hr. The surviving precursors were labelled %%ith LI 
antibody. The results show that 19150 blocks 80% of the suni%-al acti,. ity 
of NDFP-2 (A), while 114A only diminishes the suni%-al acti%ity of 
NDFO-2 to 48% (B). 
116 
'120 
100 
80 
cr 60 
3 
C/) 40 
ol 
20 
0 
120 
100 
80 
60 
40 
0- 
20 
0 
0 0.1 1 10 
1915 ANTIBODY (pg/mi) 
0 0.05 0.5 5 50 
114A ANTIBODY (jig/ml) 
Figure 3.18 Schwann cell precursors express both ErbB2 and ErbB4 
E14 Schwann cell precursors were cultured in defined medium containing 
FGF plus IGF and forskolin containing medium for 20 hr. The precursors 
were then stained with anti ErbB2 (B) and anti ErbB4 (D) antibodies. 
Schwann cell precursors express both receptors (B. D). A and C are the 
corresponding phase-contrast view. Magnification 80OX. 
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CHAPTER 4 
INTERACTION OF SCHWANN CELL PRECURSORS AND 
NEURONS: NEURONAL CONTROL OF SURVIVAL, 
PROLIFERATION AND MATURATION 
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Introduction 
In the peripheral nervous system (PNS) Schwann cell precursors and Schwann cells 
are in close contact with axons and appear to rely on them for survival, proliferation 
and differentiation. The evidence for this close relationship comes from both in vivo 
and vitro studies. 
In vivo, a significant decrease of proliferation in Schwann cells was observed when 
neonatal rat sciatic nerves were transected which suggested that Schwann cell 
proliferation in vivo relies at least in part on neuronal mitogens (Komiyama and 
Suzuki, 1992). In adult rat, transection of peripheral nerve leads to Wallerian 
degeneration in which Schwann cells undergo de-differentiation and rapid 
proliferation (Brown and Asbury, 1981; Pelligrino et al., 1986; Clemence et al., 1989; 
De Vries and Baichwal 1991). When axons regrow into the distal stump, Po and other 
myelin proteins are induced and the myelin sheath is reformed, indicating that the 
signal for Schwann cell myelination comes from axons (Aguayo et al., 1977; Bray et 
al., 198 1; LeBlanc et al., 1987; Mitchell et al., 1990). Together, the evidence suggests 
that in vivo Schwann cells depend on signals from axons for proliferation and 
differentiation. 
In vitro, co-culture of Schwann cells and neurons has been widely used to study the 
molecular interaction between these two cell types. One of the most active research 
areas in this field focused on identifying Schwann cell mitogens derived from 
neurons. Wood and Bunge, (1976) first showed that Schwann cells which were in 
contact with neurons and their processes rapidly proliferated. Furthermore, a neurite 
membrane fraction and an axolemma from brain tissue were also reported to stimulate 
Schwann cell proliferation (Salzer and Bunge, 1980; 1980; Sobue et al., 1984). It was 
believed that the Schwann cell mitogen was located on the axonal surface (Salzer et 
al., 1980). It was later found that the neuronal mitogen was a heparin-binding protein 
which could elevate intracellular cAMP levels in the Schwann cells (Ratner et al., 
1984; 1985; 1988), and does not belong to the FGF growth factor family (Ratner et 
al., 1988). More recently a 50 kDa neuronal membrane associated mitogen was 
121 
isolated (Nordlund et al., 1992), but the molecular nature of the axonal mitogens had 
not been identified until Morrissey (1995) demonstrated that the rat neuronal surface 
molecule which stimulated both human and rat Schwann cell proliferation could be 
blocked by anti HRGOI(heregulino-1) antibody, and also showed that the mitogenic 
response of human Schwann cells to neurons was reduced by anti ErbB2 (p185 n0u) 
antibody in a co-culture system (Morrissey et al., 1995). This result indicated that 
IHRG\NDF\GGF or HRG\NDF\GGF-like molecules may act as a component of the 
neuronal mitogen for Schwann cells. 
In addition to the active study of neuronal mitogens, efforts have also been made to 
find the molecular basis of Schwann cell differentiation in the co-culture system. 
Bunge et al., (1986) reported that in co-culture it is necessary to have ascorbic acid 
and serum in the medium to induce myelin assembly in Schwann cells. But in terms 
of Po mRNA and protein induction in co-cultured Schwann cells only serum free 
defined medium is required (Brunden et al., 1990; Morrison et al., 1991). In addition 
to Po, PMP-22, another myelin molecule which has recently been shown to be 
expressed by Schwann cells, was also upregulated by contact with axons in vitro 
(Spreyer et al., 1991). Oct-6/SCIP (suppressed cAMP-inducible POU protein), a 
transcription factor probably related to myelin gene regulation was also induced when 
Schwann cells were co-cultured with neurons (Scherer et al., 1994). Furthermore, it 
was also found that direct contact between neurons and Schwann cells was not 
necessary for some upregulation of Po and SCIP genes by neurons (Bolin and 
Shooter, 1993). Considering all the evidence presented here it is clear that neuronal 
signals drive Schwann cell differentiation, but that the molecular identification of 
these signals is still generally unknown. 
To date, there have been few studies on the interaction of Schwann cell precursors 
and neurons. The only evidence comes from studying neuron conditioned medium 
(NCM). It was found that in not very pure NCM, Schwann cell precursors survived 
and developed into Schwann cells (Jessen et al., 1994). The molecular basis for this 
survival event was not known. In the present study highly purified (95%) neuron 
cultures generated using an immunopanning method are used. The experiments show 
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that NCM generated from these pure neuronal cultures can significantly rescue 
Schwann cell precursors from apoptotic death. Furthermore, direct contact between 
precursors and axons also supports precursor survival. Interestingly, the survival 
activity in the conditioned medium and generated by direct contact can be markedly 
diminished by applying soluble ErbB4 protein to the medium or the co-culture. The 
results presented here, together with previous observations of NDF survival activity, 
strongly support the idea that NDF is a component of the neuronally derived signal 
which supports precursor survival. This study also shows that neurons express NDF 
but that Schwann cell precursors* contain much lower levels or no NDF. In addition to 
survival, axons also stimulate Schwann cell precursor proliferation and promote the 
maturation and differentiation of these cells in co-culture. 
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Results 
Conditioned medium from purified neurons supports Schwann cell precursor 
survival 
Neuron conditioned medium (NCM) from E19 DRG neurons has been previously 
reported to support Schwann cell precursor survival. In that experiment the neurons 
were exposed to serum and mitotic poisons (cytosine arabinoside) several times to kill 
dividing non-neuronal cells and cultured neurons were kept for more than 10 days 
before the medium was collected. Meanwhile the purity of the neurons in the culture 
was not recorded (Jessen et al., 1994).. In order to get highly purified neurons, I 
devised an immunopanning technique (for detail see Methods). The purity of the 
neurons generated by this method is 95% ± 5.3 based on counting every single 
neuron and nonneuronal cell on the coverslips. The pure neurons were cultured in 
serum free defined medium and only I day of culture was necessary to allow neurite 
outgrowth (Figure 4.1). Therefore, the NCM collected from this culture contains 
neuron-derived factors which may closely mimic the factors secreted by neurons in 
vivo. The results showed that Schwann cell precursors cultured in this NCM for 20 hr 
survived and also showed flattened and group-forming morphology (Figure 4.2). The 
NCM acted as a dose-dependent survival factor, and pure NCM supported more than 
89% Schwann cell precursor survival. Dilution of the pure NCM resulted in a 
decreasing survival rate of precursors (Figure 4.3). The percentage survival rate in 
this experiment is similar to that of the previous report using less pure NCM (Jessen 
et al., 1994). This implies that neurons do secrete soluble factors into the culture 
medium that supports Schwann cell precursor survival. 
Direct contact with neurites also promotes Schwann cell precursor survival 
The experiment above showed that soluble factors in NCM supported 89% Schwann 
cell precursor survival. The NCM was collected from very dense neuronal cultures 
(100,000-150,000 neurons/300ul medium). In order to test whether neuronal surface 
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molecules also support precursor survival a co-culture experiment using neonatal 
DRG neurons and Schwann cell precursors was established with very sparse neuronal 
cultures (250 neurons/400gl medium). These cultures only contained few (5%) non- 
neuronal cells. It is believed that in these very sparse neuron cultures it is possible to 
exclude the effect of soluble survival factors on precursors since the NCM collected 
from these very sparse neuron cultures was unable to support Schwann cell precursor 
survival (less than 10% survival). Moreover, the fluorescent dye, 5(and-6) 
carboxyfluorescein diacetate succinimidyl ester (CFSE), was used to label all the cells 
in the culture before addition of the Schwann cell precursors. Therefore, the Schwann 
cell precursors added on the second day to the cultured neurons could be easily 
distinguished from the few Schwann cells originally present in the neuronal culture 
because after immunolabelling with Ll antibodies the added precursors are Ll 
positive and USE negative when viewed under the fluorescence microscope. The 
results generated from this co-culture system therefore, accurately represent the total 
survival of Schwann cell precursors on neurons. The caculation of survival rate of 
precursors in these co-cultures was based on the comparison of total mumber of 
precursors in or not in contact with neurons 20 hr after addition of precursors with 
that at 3 hr after addition of cells (for detail see Methods). It was found that all 
precursors not in contact with neuronal cell bodies or neurites had died by 20 hr, 
while almost all precursors in contact with neurons or neurite at 3 hr survived after 20 
hr (Figure 4.4). Schwann cell precursors aligned along the thin neurites had an 
elongated morphology. Strikingly, contact with a single neurite seemed enough to 
support Schwann cell precursor survival; a single neuron usually supported the 
survival of several Schwann cell precursors (Figure 4.5). 
NDF is expressed by neurons but not by Schwann cell precursors 
Both neuronal surface molecules and soluble molecules present in NCM showed the 
potential to support survival of Schwann cell precursors. On the other hand, as 
previously shown, NDFP can rescue all precursors from apoptosis in vitro (Chapter 
3). Therefore, I asked whether NDF was expressed in either neurons or Schwann cell 
precursors to determine if this molecule might play an role in the interaction of these 
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cells. The experiments described below used both immunocytochernistry and Western 
blotting to localize the expression of NDF. 
Schwann cell precursors from E14 rat were cultured in FGF-2 (180pM) plus IGF-I 
(13nM) medium for 20 hr. Meanwhile neurons dissociated from E14, E15 and new 
born DRG were cultured in NGF (50ng/ml) containing defined medium for 20 hr. 
After 2% paraformaldehyde fixation, both neurons and precursors were stained by 
both polyclonal anti NDF antibody 1915 # and monoclonal anti NDF antibody 5D6A. 
It was found that almost all neurons at all three developmental stages were labelled, 
whereas Schwann cell precursors were completely negative (Figure 4.6) (also see 
Figure 4.1). For Schwann cell precursors, double immuno-labelling with LI and 
1915 # was also used. To further confirm that the staining was specific by using these 
antibodies, both polyclonal and monoclonal antibodies were pre-absorbed with NDF 
before application to the cultures. The results showed that the neuronal NDF positive 
staining was markedly diminished, suggesting that NDF may only be expressed by 
neurons and not by Schwann cell precursors. In order to identify the isoforms of NDF 
expressed by neurons, two monoclonal antibodies (I 14A for NDFO, IH7A4 for 
NDFa) which specifically recognize NDFO and NDFoc c-loops (personnal 
communication with Dr D. Wen and Dr D. Chang Amgen Inc. ), were applied as 
above. The staining pattern is similar to that of 1915 4 and 5D6A, i. e. positive on 
neurons and completely negative on Schwann cell precursors (Figure 4.7), indicating 
that neurons express both NDFa and NDFO isoforms. 
In order to confirm the immunocytochemical observations, immunoblotting was used 
on recombinant NDFP and NDFoc proteins, and on proteins extracted from cultured 
pure neurons (from newborn DRG), Schwann cells (from newborn rat), Schwann cell - 
precursors (from E14 rat) and brain (from newborn rat). The monoclonal antibody 
5D6A which recognized all isoforms of NDF was used to label the proteins. It was 
found that the both recombinant NDFP and NDFcc showed a marked band at 
molecular weight 25kDa which matched the molecular weight of these recombinant 
proteins (NDFO-2 MW 24,701 , NDFcc-2 MW 24,566). The cultured DRG neurons 
expressed two marked bands at molecular weights around 45kDa and 66kDa, three 
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relatively weak bands were also observed between 97kDa to 116kDa. Schwann cell 
precursors did not express detectable NDF bands. Interestingly, in Schwann cells a 
weak NDF band appeared at molecular weight around 45 kDa, a slightly higher 
molecular weight than one of the bands seen in neurons (Figure 4.8). These molecular 
weights match the previous reports in COS-7 cells in which pro-NDF (both a and P 
isoforms) had a molecular weight at 60-75kDa and 95kDa, whereas, a secreted form 
of NDF had a molecular weight of 40-45kDa (Wen et al., 1994). Therefore, the data 
here indicated that neurons produced abundant pro-NDF isoforms and also secreted 
this protein. Schwann cell precursors did not produce any detectable NDF. Schwann 
cells may have low levels of secreted NDF forms. 
A Soluble ErbB4 extracellular domain blocks both NCM and neuron survival 
activity 
The experiment above showed that Schwann cell precursors survived both in NCM 
and on neuronal surfaces, and that only neurons but not Schwann cell precursors 
expressed NDF. It suggests that neurons contain Schwann cell precursor survival 
molecules which can either be expressed on the neuronal surface or be secreted into 
the medium. So far, NDF and FGF in the presence of IGF are the only known 
survival molecules for Schwann cell precursors (Chapter 3; Jessen et al., 1994; 
Gavrilovic et al., 1995). Meanwhile, these molecules have also been detected at high 
levels in spinal cord and DRG neurons in early development (Grothe et al., 1991; 
Bean et al., 1992; Orr-Urtreger et al., 1993; Meyer and Birchmeier, 1994). 
Furthermore, NDF but not FGF, has been shown like NCM to support the long-term 
survival of precursors (Chapter 3). Together, this suggests that NDF or FGF might 
act as a neuronal signal to regulate Schwann cell precursor survival. In order to 
identify the neuronal molecules involved in survival; a soluble ErbB4 protein, so far 
shown only to bind NDF molecules , was applied to see whether 
it could block the 
survival activity of NCM, and in the neuron-Schwann cell precursor co-culture 
system. Meanwhile an anti FGF-2 monoclonal antibody DG-2 known to block FGF-2 
activity in 3T3 cells (Reilly et al., 1989) was also used to see whether it would block 
the survival activity in the NCM. 
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In the NCM blocking assay, 2000 Schwann cell precursors were plated on coverslips 
in low insulin defined medium plus IGF (13nM). Meanwhile, pure NCM was mixed 
with soluble ErbB4 (1ýtg/ml and 3pg/ml) proteins. NDF02 (40pM) or FGF-2 
(180pM) plus forskolin (5ýtM) were also incubated with soluble ErbB4 protein 
(I ýtg/ml to 3 ýtg/ml) as both positive and negative controls. The results showed that in 
the 20 hr survival assay soluble ErbB4 protein at 3[tg/ml blocked 75% of the NCM 
survival activity (only 25% precursor survival), and lower doses of ErbB4 proteins 
had smaller effects (Figure 4.9A). The same dose of ErbB4 (3[tg/ml) blocked 86% of 
the NDFO-2 survival effect (Figure 4.913), and had no effect on FGF-2 medium 
(Figure 4.9Q. Therefore, it is clear that this soluble protein blocks the survival 
activity of NDFO-2, but has no effect on FGF-2 survival activity. The ErbB4 receptor 
has not been found to bind to any factors other than those of the NDF family 
(Culouscou et al., 1993; Plowman et al., 1993; Carraway and Cantley, 1994; Tzahar 
et al., 1994). Therefore, the blocking effect of this protein in NCM is likely to be 
specific to NDF or NDF-like molecules. Meanwhile the present. experiment also 
showed that ErbB4 protein itself has no toxic effect on Schwann cell precursors since 
all precursors survive in the medium containing a mixture of FGF-2 and ErbB4 
proteins. 
To test whether this protein also blocks the survival effect of neuronal surface 
molecules, the ErbB4 proteins were added three times in 24 hr to a neuron-precursor 
co-culture (for details see Methods). In these experiments, a new batch of ErbB4 
protein was used (Tested in the NDFO-2 survival assay it was found that the 9Ag/ml 
of the new batch of ErbB4 protein was equivalent to 3[tg/ml of the old batch of 
ErbB4 protein previously applied to the NCM; this may be due to the purity of this 
protein in different batches). It was found that ErbB4 at 9ýtg/ml blocked 60% of the 
neuronal survival effect (Figure 4.10), and this concentration of ErbB4 protein 
showed no toxic effect on either Schwann cell precursors in FGF-2 medium (about 
90% survival) or neurons in NGF medium (97% survival). Therefore, the major 
survival molecules on the neuronal surface are likely to be NDF-like molecules. 
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It was noticed that the soluble ErbB4 protein did not block 100% of the survival 
activity of either NCM or the neuronal surface, indicating that some other molecules 
in neurons may also be involved in Schwann cell precursor survival. FGF, another 
molecule expressed on neurons (Grothe et al., 1991; Bean et al., 1992) was also 
previously reported to support Schwann cell precursor survival in short term culture 
(Jessen et al., 1994; Garvrilovic et al., 1995). In order to know whether this molecule 
also contributed to the survival effect in neurons, the NCM was incubated with DG-2, 
a monoclonal anti FGF-2 antibody, for at least 2 hours before adding to Schwann cell 
precursors. Both positive and negative control experiments were carried out in FGF-2 
plus forskolin and NDF02 medium. It was found that DG-2 antibody (40ug/ml) 
blocked only 25% of survival activity of NCM (Figure 4.1 IA), whereas, the same 
concentration of this antibody blocked a 88% of FGF-2 survival activity (Figure 
4.1113), and had no effect at all on NDF02 (100% survival). This suggested that FGF 
molecules in NCM may also make a minor contribution to Schwann cell precursor 
survival. 
In co-culture, neurons stimulate Schwann cell precursors DNA synthesis 
Previous experiments showed that NCM was unable to stimulate Schwann cell 
precursor DNA synthesis (Jessen et al., 1994). In contrast, Schwann cells in direct 
contact with neurons in a neuron-Schwann cell co-culture system appear proliferate 
massively (Salzer, 1980). To test whether Schwann cell precursors can also 
proliferate in response to neuronal surface molecules 4000 Schwann cell precursors 
were co-cultured with 2000 purified DRG neurons in defined medium containing 
NGF only, for 24 h, 2 days, 4 days, 6 days, 8 days and 2 weeks respectively. BrdU 
was added to the medium during the last 2h on each experimental day. It was found 
that the DNA synthesis of Schwann cell precursors on the first day remained at 13%, 
which is the same figure previously shown in vivo (Stewart et al 1993). At 4 days, 
(which is equivalent to E14+4=EI8, it is assumed that the E14 Schwann cell 
precursors cultured with neurons for 4 days might mimic the development of these 
cells in vivo for 4 days), the number of BrdU positive cells increased to 18% of the 
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total Schwann cells. This matches the increased Schwann cell proliferation seen at 
this stage in vivo. Interestingly, after 2 weeks in co-culture, Schwann cell 
proliferation decreased to 6% (Figure 4.12). Therefore, Schwann cell precursors co- 
cultured with neurons share a similar proliferation pattern to that of Schwann cell 
precursors or Schwann cells in vivo. The results also suggest that neuronal surface 
molecules, unlike NCM, can stimulate Schwann cell precursor DNA synthesis in 
culture (Figure 4.13). 
In co-culture, neurons drive Schwann cell precursor maturation and 
differentiation as judged by expression of SIOO, 04, and Po mRNA and protein. 
In the proliferation assay described above, it was noticed that Schwann cell precursors 
co-cultured with neurons underwent a significant morphological change at later stages 
in vitro. It was found that flattened precursors gradually became bi-polar or tripolar 
cells, a typical Schwann cell morphology, in 4-7 days co-culture (Figure 4.14), 
suggesting that Schwann cell precursors in contact with neurons may undergo 
maturation. To investigate the possible axon-induced maturation and differentiation 
of Schwann cell precursors I tested whether molecules typical of Schwann cells, but 
not present on Schwann cell precursors appeared in the co-culture system. Molecules 
tested in this assay included S100,04, Po mRNA and protein. The co-culture 
procedure was identical to that used in the proliferation assay. 4000 precursors were 
co-cultured with 2000 purified neurons for 24 hours, 2 days, 4 days and I week 
respectively and anti S100 antibody, anti 04 antibody and anti Po antibody were 
applied to stain the Schwann cell precursors/Schwann cells at each point (Figure 4.14, 
4.15) 4.16). It was found that on the first day no S100,04 or Po positive cells were 
detected. By day 2,20% of cells in co-culture expressed SIN (Figure 4.17A), only 
5% of cells expressed 04 (Figure 4.17B), and surprisingly about 55% of cells 
expressed low levels of Po protein (Figure 4.17C). On day 4, almost all cells express 
S100 protein (83%) and 55% of cells were 04 positive, interestingly the percentage of 
Po positive cells in contact neurons decreased to 47%, but the Po levels in individual 
cell were upregulated. By the 7th day, most cells were 04 positive (93%) and the 
number of Po positive cells went down further to 39%, and most Po positive cells 
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showed a several fold increase of Po protein levels (Figure 4.14). It is unknown why 
some cells with low levels of Po expression will eventually become Po negative when 
these cells are in continued in contact with neurons, while other Po positive cells 
showed a significant increase of Po levels in 7 days co-culture. One possibility is that 
different neurons may produce either positive or negative signals to drive Schwann 
cells to develop into either myelin-forming Schwann cells or non-myelin-forming 
Schwann cells. Moreover, by using these three different antibodies the neuronal cell 
bodies and neurites were all unlabelled, indicating that the staining is specific. 
To test whether the Po mRNA expression parallels Po protein expression in this 
system, in situ hybridisation using a digoxygenin labelled riboprobe was employed to 
detect Po mRNA (Figure 4.18). The Schwann cell precursor-neuron co-culture was 
set up as above. The results showed that during the first 24 hr no Po mRNA was 
detected, by day 4,40% of cells in co-culture were Po mRNA positive and the 
number of positive cells decreased to 35% during the 2nd week (Figure 4.19). The 
control experiment, treated with digoxygenin-labelled probe in the sense orientation, 
was completely negative. These observations indicated that the expression pattern of 
both Po mRNA and protein is similar when these cells were co-cultured with neurons. 
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Discussion 
Understanding the molecular dialogue between neurons and glia which triggers 
survival, proliferation and differentiation events in these cells, is an important step 
towards understanding the development of the PNS. Therefore, identifying one of 
these signals at the molecular level is a significant step. This study has presented 
strong evidence that NDF ,a neuronal molecule, can act as a neuro-glia signal to 
control Schwann cell precursor survival. Meanwhile, NDF has also been reported to 
act as a neuronal mitogen to stimulate Schwann cell proliferation (Morrissey et al., 
1995). Together, it seems likely that NDF can function as a key neuronal molecule to 
trigger several biological events in the cells of the Schwann cell lineage. 
In addition to identifying NDF as the neuronal survival factor, evidence was also 
presented that FGF is involved in neuronally mediated Schwann cell precursor 
survival, both soluble proteins in NCM and neuronal surface molecules supported 
Schwann cell precursor survival. Furthermore, Schwann cell precursor proliferation 
relies on direct contact with axons, and the interaction of Schwann cell precursors 
and neurons in culture leads to maturation and differentiation of Schwann cell 
precursors. 
Both soluble and surface molecules derived from neurons can act as survival 
factors for Schwann cell precursors 
It has always been interesting to know whether direct neuro-glia membrane signalling 
is necessary for Schwann cell precursor or Schwann cell survival, proliferation and 
differentiation. At least for Schwann cell proliferation it is known that secreted 
molecules from neurons were insufficient to activate proliferation of these cells. Only 
direct contact with axons caused DNA synthesis in Schwann cells (Salzer et al 1980). 
But for Schwann cell differentiation towards a myelin phenotype both soluble and 
neuronal surface molecules are active although the molecules involved in these events 
are still elusive (LeBeau et al 1988; 1990; Lemke and Chao, 1988; Bolin and 
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Shooter, 1993). The present experiments demonstrated that both pure NCM and direct 
contact with axons can rescue almost all Schwann cell precursors from cell death. 
Therefore, it seems likely that Schwann cell precursor survival and Schwann cell 
differentiation depend on either soluble neuronal proteins or neuronal surface 
molecules. Proliferation of cells in the Schwann cell lineage may, in contrast, strictly 
rely on direct contact with axons. 
Although both survival factors in NCM and on the neuronal surface support Schwann 
cell precursor survival the survival activity generated from these two conditions 
appears to be quantitatively different although strict comparisons are difficult. In the 
very sparse cultures of neurons, it was found that a single neuron can support survival 
of several precursors. In contrast the NCM in this study was generated from 100,000- 
150,000 neurons which seems just enough to support precursor survival since 
dilution of the NCM resulted in significant decrease of survival in these cells. It is 
unclear what causes these different survival potentials, the simplest explanation for 
this is that neuronal surface may have a higher levels of survival molecules than that 
NCM. The other alternative possibility is that the survival molecules expressed in 
NCM or on neuronal surface are different. 
Identification NDF as the key neuronal molecule for precursor survival 
Although it seems likely that the neuronally derived molecules for Schwann cell 
precursor survival are both soluble and cell surface molecules the molecular nature of 
the survival factor was previously unidentified. The studies described in Chapter 3 
demonstrated that NDF has the same biological potential as NCM to support Schwann 
cell precursor short-term and long-term survival, and to Promote maturation of these 
cells (Dong et al., 1995). The present experiments showed that a soluble ErbB4 
extracellular domain, a highly specific receptor, which, as far as is known, binds only 
to NDFMG\GGF molecules, significantly blocked both neuron conditioned medium 
and neuron surface mediated Schwann cell precursor survival. Meanwhile, 
immunocytochemistry showed that only neurons and not Schwann cell precursors 
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express NDF. The Western blot analysis of proteins from both neurons and Schwann 
cell precursors in this study also indicated that only neurons produced pro-NDF and 
secreted forms of NDF. Together, the evidence here implies that NDF acts as a 
neuron-glia signal to promote Schwann cell precursor survival, and that the survival 
molecules both in NCM and on the neuronal surface are likely to be NDF or NDF- 
like molecules. More recently, it is found that in NDF (also called neuregulin) 
knockout mouse embryos, Schwann cell precursors in the trunk appear severely 
reduced in number (Meyer and Birchmeier, 1995). These observations further 
indicated that NDF or NDF-like molecules may play a important role in the 
modulation of precursor survival and its fate decisions. 
Interestingly, the present data also showed that Schwann cells but not Schwann cell 
precursors express low amounts of NDF in a Western blot assay. It gives rise to the 
possibility that the survival of Schwann cells in routine medium may depend on the 
endogenous NDF which is expressed in these cells, whereas Schwann cell precursors 
which do not. express NDF undergo programmed cell death in culture. It is unclear, 
however, whether the NDF expressed in Schwann cells is produced by the Schwann 
cells themselves, since no high molecular weight bands, probably indicative of pro- 
NDF, were detected in Schwann cells by Western blot. Therefore, the secreted form 
of NDF which is detected in Schwann cells may still be derived from neurons. 
The blocking of NDF survival activity both in NCM and co-culture results in only 60- 
75% cell death. Some of precursors can still survive, suggesting that other molecules 
may also be involved in regulation of precursor survival. In the oligdendrocyte 
lineage, multiple signals are necessary for the long-term survival (Barres and Raff, 
1994). This probably reflects the general advantages of combinatorial control in the 
animal kingdom. Experiments presented here further showed that FGF-2 blocking 
antibody diminished Schwann cell precursor survival by 25% in NCM suggesting that 
FGF-like molecules in neurons may also contribute to Schwann cell precursor 
survival. Therefore it is possible that multiple signals exist in the PNS to support 
Schwann cell precursor survival although the multiple factors are not necessary to 
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support precursor survival in vitro. However, NDF is likely to play a major role in the 
neuro-glia signalling which mediates Schwann cell precursor survival. 
The proliferation of Schwann cell precursors depends on direct contact with 
neurons in A ro 
The data present here show that Schwann cell precursors in contact with neurons or 
neurites in co-culture are stimulated to synthesize DNA, and that over a period of 
time, the DNA synthesis pattern by precursors in this co-culture system is similar to 
that of Schwann cell precursors in vivo (Strewart et al., 1993), suggesting that the 
development of Schwann cell precursors in vivo can be mimicked in vitro in this co- 
culture system, at least in terms of the proliferation. Although this study gives no 
direct evidence to identify the neuronal mitogen for Schwann cell Precursors, three 
relevant pieces of evidence suggest that NDF may also act as an axonal mitogen for 
Schwann cell precursors. Firstly, NDF has been shown to stimulate DNA synthesis in 
isolated Schwann cell precursors in culture (Chapter 3). Secondly, NDF\HRG\GGF 
has recently been identified as a component of the axonal mitogen of human and rat 
Schwann cells (Morrissey et al., 1995). Thirdly, both neurons and axons were shown 
to express high levels of NDF protein. Considering NDF as a neuronally-derived 
mitogenic signal it raises the further question as to why NCM does not activate 
Schwann cell precursor proliferation. It is possible that the concentration of 
HRG\NDF\GGF in NCM is too low to activate proliferation events, since previous 
experiments have shown that only high concentrations of NDF act as a mitogen for 
Schwann cell precursors (Chapter 3). 
The lack of mitogenic activity in NCM, because of the low concentration of NDF, 
may also affect Schwann cell proliferation since blocking direct contact between 
neurons and Schwann cells by a permeable collagen diaphragm prevented division in 
these cells (Salzer et al., 1980). It is unclear why direct contact with neurons 
promotes DNA synthesis in these cells. Two possibilities exist to explain the fact that 
the neuronal surface membrane has mitogenic activity for both Schwann cell 
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precursors and Schwann cells whereas NCM does not. First, the neuronal surface may 
recruit a high local concentration of NDF which stimulates proliferation in these 
cells. The evidence for this hypothesis is based on the fact that NDF is synthesized as 
a transmembrane protein, and the pro-NDF isoforms could be expressed in 
association with the membrane, and could also be cleaved from the membrane 
(Marchionni et at., 1993; Wen et al., 1994), in which case the soluble protein could 
also bind to cell surface heparin and other membrane-associated proteoglycans. 
Therefore, theoretically, the NDF concentration at neuronal membrane could be 
higher than that in NCM. Moreover, the Western blotting in this study suggested that 
neurons expressed abundant pro-NDF isoforms and the 45kDa secreted isoform. 
Furthermore, the survival experiments discussed above also indicated that the 
concentration of the survival molecule, NDF, at the neuronal surface might be higher 
than that in NCM. Together, it is possible that the NDF concentration at the neuronal 
surface is higher than that in NCM, which leads to proliferation of Schwann cells and 
Schwann cell precursors on neurons. The other possibility is that the mitogenic 
activity of neuronal surfaces for these cells may depend on a combination of several 
factors which includes NDF and some other factors which may not be cleaved and 
secreted into medium. 
Schwann cell precursors in contact with axons generate Schwann cells 
Schwann cell precursors in vivo eventually develop into Schwann cells. This cell 
conversion involves a change in several cellular proprieties, including expression of 
the Schwann cell marker SlOO, survival ability in routine medium and a 
morphological change (Jessen and Mirsky, 1991; 1992; Jessen et al., 1994). The 
experiments described here showed that Schwann cell precursors in contact with 
neuronal cell bodies or neurites were induced to express SlOO, 04 and Po. The 
percentage of SlOO positive cells at day 4 in co-culture (82%) is similar to that of 
SlOO positive cells in vivo at E18 (96%) (Jessen et al., 1994). Meanwhile, the 04 
expression of these cells in 1-7 days co-culture period is also well matched to that 
seen in vivo. These results indicate that Schwann cell precursors in contact with 
neurons generate Schwann cells. The morphological change of precursors in co- 
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culture also suggests that conversion has occured. Combined with previous 
observations that NCM can also drive precursors to develop into Schwann cells 
(Jessen et al., 1994), the data presented here provide substantial support for the idea 
that neuronal derived signals drive Schwann cell precursor maturation. 
It is clear that Schwann cells in co-culture with neurons can be induced to express 
relatively high levels of myelin protein Po (Brunden et al., 1990; 1992; Morrison et 
al., 1991). Therefore, it is of interest to know whether Schwann cell precursors, after 
conversion to Schwann cells, could also be induced to differentiate further. This study 
also indicated that at day 2, almost 55% of cells in co-culture express low levels of Po 
protein, and later about 40% of cells were induced to express high levels of Po. It is 
unclear what is the function of this low levels of Po protein at early stage, at least, it 
is known that in chicken, Schwann cell precursors also express Po protein 
(Bhattacharyya et al., 1991; 1994). Neverthless, Schwann cell precursors after 
conversion to Schwann cells could also be induced to express high levels of Po, 
indicating that neuronal signals not only drive Schwann cell precursor maturation but 
also promote its differentiation. Alternatively, Schwann cell precursors may only 
require neuronal survival signals, and subsequently, Schwann cell precursors may 
control their maturation and differentiation autonomously. To date, there is no direct 
evidence in this regard. 
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Figure 4.1 Purified DRG neurons and their expression of the NDF 
Newborn rat DRGs were dissociated and immunopanned in Thyl. 1 
coated dishes, and 95% pure DRG neurons were obtained and plated at a 
density of 100,000-150,000 neurons/300gl with 50ng/ml NGF (A). The 
neuron conditioned medium was collected from these pure neuron 
cultures on the 2nd and on the 3rd day. In another experiment, the same 
purified neurons were plated on coverslips and stained with anti NDF 
antibody 5D6A. Neurons from newborn DRG express NDF (B). 
Magnification 60OX 
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Figure 4.2 Pure neuron conditioned medium rescues precursors from 
apoptotic cell death 
Schwann cell precursors ftom E14 nerves were plated on coverslips in 10 
gI defined medium containing IGF-I (13nM) for 3hr (A), then the 
precursors were topped up either defined medium with IGF (B) or neuron 
conditioned medium (C, D) for total 20 hr. LI antibodies were used to 
label the surviving precursors (D) after a total 20 hr assay. Magnification 
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Figure 4.3 Neuron conditioned medium supports Schwann cell 
precursor survival 
Various concentrations of neuron conditioned medium were used on 
Schwann cell precursors for a 20 hr assay. The surviving precursors were 
labelled with LI antibody and counted. The results show that neuron 
conditioned medium acts as a dose-dependent survival factor for 
precursors. 
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Figure 4.4 Direct contact with the neuronal surface supports 
Schwann cell precursor survival 
Purified DRG neurons were obtained from neonatal animals by an 
immunopanning method. 250 neurons pre-labeled with USE were 
cultured in 100 gl of defined medium with 50ng/ml NGF for 18-20 hr. 
2000 Schwann cell precursors were then plated on cultured neurons on 
the second day for a further 24 hr of culture. The precursors were labelled 
with anti LI antibodies. The total number of precursors in contact with or 
without neruones or neurites as counted at the 3 hr and 24 hr point after 
plating. The survival percentage refers to the total surviving precursors at 
the 24 hr point in comparison with that at the 3 hr point. The results show 
that precursors in contact with neurons or neurites survive. 
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Figure 4.5 Surviving precursors in contact with neurites 
E14 Schwann cell precursors were co-cultured with purified neurons in 
defined medium containing NGF 50ng/ml for 20 hr. The precursors in 
contact with neurites survive and a single neuron supports survival of 
several precursors. (A) phase-contrast of a single neuron with several 
precursors in 20 hr culture. (B) neuron is labelled with CFSE. (C) LI 
labels on both precursors and neurons. Magnification 80OX 
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Figure 4.6 Neurons, but not Schwann cell precursors, express NDF 
Anti NDF monoclonal antibody 5D6A was used to stain both E14 
neurons (A, B) and E14 Schwarm cell precursors (C. D). The results show 
that both neuronal cell bodies and neUrites are NDF positive (B), while 
precursors are NDF negative (D). Magnification 70OX 
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Figure 4.7 Neurons express both NDFP and NDFo( isoforms. 
Neurons from E15 rat DRG were stained with anti NDFý monoclonal 
ant1body 114A and antl NDFu monoclonal antibody lH7A4. The result's 
sho\ý that both neuronal cell bodies and neurites are NDFp (B) and 
NDFu, (D) positive. A and C are the corresponding phase-contrast views. 
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Fioure 4.8 NDF expression in different cell types and tissues by Western 
blot 
Lane Iý 100ng recombinant NDFP-2 protem 
LaIIC2ý 20pu, protem extracted fi-om purified and cultured 
newborn rat DRG neurons. 
I-ane')ý 20pg protein extracted from cultured newborn rat Schwalm cells. 
Lanc4- 20[ig, protein extracted fi-oni cultured E14 rat Sch\vann cell precursors. 
Lanc5ý 20pg protem extracted from ne\\born rat brain tissue. 
Lanc6.100ng reconbinant NDI'u-2 protem. 
Scliv, ann cell precursors and ScImann cells \\ere cultured ill dCtlllCd I)IC(IILIIII 
containing FGF-22 (180p\l) plus IGF-I ( l)nM) for 20 Ill- and ncurons \\ci, c 
culturcd in detined medium containing NGF (50qg/1111) t'()I- 20 hr After 
\\ashing ill 1113S. proteins \\Cl, e extracted from the culture dish. The extracted 
proteins \\ere then loaded oil all Soo acrylamide gel and monoclonal antibody 
5D6A \\as Lised to detect the \DF protelil. 
Figure 4.9 Soluble ErbB4 protein blocks NCM and NDF survival 
activity 
Soluble ErbB4 protein blocks the survival activity in pure neuron 
conditioned medium (A) and NDFP-2 containing medium (B). It has no 
effect on FGF-2 containing medium (C). The experiment was based on 
the 20 hr precursor survival assay as described before. 
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Figure 4.10 Soluble ErbB4 protein blocks neuronal surface survival 
activity 
Soluble ErbB4 protein was also used in neuron-Schwann cell precursor 
co-cultures to block the survival activity generated by neuronal surface 
molecules. Almost 60% of survival activity is blocked by 9pg/ml of 
ErbB4 in a 20 hr assay. 
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Figure 4.11 The survival activity of FGF-2 in neuron conditioned 
medium 
An FGF-2 monoclonal antibody DG-2 blocks only 25% of survival 
activity in neuron conditioned medium (A), while the same antibody 
blocks almost 90% survival activity in FGF-2 containing medium (B). 
The survival assay was carried out on E14 Schwann cell precursors in a 
20 hr assay as shown before. 
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Figure 4.12 DNA synthesis of Schwann cell precursors in e neuron- 
Schwann cell precursor co-cultures 
E14 Schwann cell precursors were co-cultured with pure DRG neurons 
for 1-14 days. The DNA synthesis of precursors was monitored by 
introducing a 1.5 hr BrdU pulse on each culturing day. The results show 
that DNA synthesis of the precursors in co-culture is similar to the DNA 
synthesis seen in developing nerve (Figure 1.2). 
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Figure 4.13 Neurons stimulate Sch-ovann cell precursor DNA synthesis 
Schwann cell precursors were co-cultured with pure DRG neurons for 4 
days, precursors in contact with neurons and neurites were stimulated to 
synthesize DNA. (A) BrdU positive-nuclei in precursors labelled with Ll 
antibody. (B) neuronal cell body and neurites were labelled by CFSE. (C) 
phase-contrast view. Magnification 70OX 
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Figure 4.14 Neurons regulate Po expression in Schwann cell 
precursors 
Schwann cell precursors were co-cultm-ed with purified neurons for 2-7 
days. Po antibody was used to label the Po positive cells. The results 
show that at day 2, precursors are induced to express low levels of Po (B). 
At the day 4, the Po levels In individual cell are elevated (D), and at day 7 
cells tend to be imich rnore bi-polar and the Po levels in cells are even 
higher (F). A, C, E are the corresponding phase-contrast views. 
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Figure 4.15 Neurons induce SlOO expression in Schwann cell 
precursors 
Schwann cell precursors were co-cultured with purified neurons. Anti S- 
100 antibody was used on the 2nd and 4th day of co-culture. The results 
show that only a few cells are S-100 positive at day 2 (A, B), and almost 
all cells are S- 100 positive at day 4 (C, D). Magnification 60OX 
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Figure 4.16 Neurons induce 04 expression in Schwann cell precursors 
Schwarin cell precursors were co-cultured with purified neurons. 04 
antibody was used on the 2nd and 4th day of co-culture. The results show 
that at day 2, less than 10% of the cells are 04 positive (A, B), and most 
cells are 04 positive at day 4 (C, D). Magnification 60OX 
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Figure 4.17 SIOO, 04 and Po expression of the cells in neuron- 
Schwann cell precursor co-cultures 
Schwann cell precursors were co-cultured with purified neurons for 1-7 
days. S- 100 or 04 or Po antibodies were used to label the cells at day 1, 
day 2, day 4 and day 7. The results show that at day 1. no S- 100.04 and 
Po positive cells are seen, S-100 positive cells are increased frorn 20% at 
day 2 to more than 80% at day 4 (A). and 04 positive cells are increased 
from less than 10% at day 2 to 90% at day 7 (B). The Po positive cells 
are decreased from day 2 to day 7 (C), but the Po levels in individual cells 
are increased (Figure 4.14) 
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Figure 4.18 Neurons induce Schwann cell precursors to express Po 
mRNA. 
Schwann cell precursors co-cultured with purified neurons were induced 
to express Po rnRNA. In situ hybridisation was carried out by using 
digoxigeiiiii-labelled probes. The results show that at day 1, no Po mRNA 
was seen (B), and at day 7 cells were heavily labeled (D). A and C are tile 
corresponding phase-contrast views. Magnification 60OX 
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Figure 4.19 Po mRNA expression of the cells in neuron-Schwann cell 
precursor co-cultures 
Schwann cell precursors were co-cultured with purified neurons for 1-14 
days. Dogoxigenin-labeled Po probes were used to detect the Po mRNA 
in cells. The results show that the percentage of Po mRNA positive cells 
is increased at day 4 and slightly decreased at day 14. 
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CHAPTER 5 
MITOGENIC RESPONSES IN 
CELLS OF THE SCHWANN CELL LINEAGE 
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Introduction 
The regulation of Schwann cell proliferation is an important part of peripheral nerve 
development and Wallerian degeneration. In the early stages of rat development, 
Schwann cell precursors, which are generated from neural crest undergo significant 
DNA synthesis in vivo (Stewart et at., 1993). The cells continue to proliferate during 
Schwann cell precursor maturation and throughout early Schwann cell development 
with a peak at E19-E20. After birth, DNA synthesis of the Schwann cells declines 
rapidly, coinciding with the appearance of myelin. In adult rats, Schwann cells are 
generally quiescent in normal peripheral nerve (Friede and Samorajski, 1968; 
Komiyama and Suzuki, 1991; Stewart et al., 1993). 
If an adult nerve is transected, however, the Schwann cells in the distal stump of the 
nerve proliferate vigorously 3 days after the injury (Abercrombie and Johnson, 1946; 
Clemence et al., 1989; Komiyama and Suzuki, 1992). The proliferation rate remains 
elevated up to 8 days after transection, and both myelin-forming and non-myelin- 
forming Schwann cells contribute to this massive proliferation (Clemence et al, 1989; 
Komiyama and Suzuki, 1992). In contrast, transecting the sciatic nerve in a neonatal 
animal results in a reduction of Schwann cell DNA synthesis (Komiyama and 
Suzuki, 1992). It has been suggested that myelin debris is an important source of the 
mitogen which induces adult Schwann cell division in degenerating nerves, since 
myelin-enriched membrane fractions and myelin basic protein are able to stimulate 
DNA synthesis in neonatal Schwann cells in culture (Yoshino et al., 1978; Baichwal 
and DeVries, 1989). Furthermore, invading macrophages have been shown to digest 
myelin membrane fragments resulting in the production of a Schwann cell mitogen 
(Baichwal et al., 1989). This concentration on the contribution of extrinsic factors to 
the mitogenic response during Wallerian degeneration has not been matched by 
consideration of the role that alteration in the Schwann cells themselves might play. 
This issue will be addressed in the present chapter. 
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The technique of Schwann cell culture has been established for nearly a century. The 
recent purification of Schwann cells most commonly involves culturing cells in serum 
containing medium for several days or weeks and exposure to anti-mitotic agents 
(Wood and Bunge, 1975, Brockes et al., 1978). These cultured Schwann cells have 
been widely used to study the proliferation and differentiation of these cells and also 
their molecular interaction with neurons (Ratner, 1986; Mirsky and Jessen, 1990). It 
is clear that Schwann cells generated by this purification method are still 
myelinogenic in response to axons and the degree to which they respond by DNA 
synthesis to various recombinant growth factors has been carefully documented 
(Wood and Bunge, 1975; Wood, 1976; Brockes et al., 1978, Stewart et al., 1991). An 
issue that generally has not been addressed in these studies, however, is whether the 
mitogenic response of Schwann cells might be altered by the purification procedure 
itself. Similarly, insufficient attention has been paid to the possibility that mitogenic 
responses of Schwann cells might depend on their developmental stage. For these 
reasons it is unclear how faithfully the data from most current mitogen studies reflect 
the responses of Schwann cells in developing or denervated nerves in vivo. 
It is clear that Schwann cells in short term cultures are quiescent in serum free 
medium. Even in serum containing medium these cells normally divide very slowly, 
although this will depend to some extent on type of serum that is used (Raff et al., 
1978; Brockes et al., 1980; Porter et al., 1987; Scorpini et al., 1988). When the cells 
are exposed to some growth factors proliferation can be triggered. Thus, FGF, 
PDGF-BB, TGFO and GGF are mitogens for Schwann cells in serum-containing 
medium and the mitogenic response to these factors is enhanced by forskolin or 
cholera toxin both of which elevate intracellular cANT levels (Ridley et al., 1989; 
Eccleston et al., 1989; Weinmaster and Lemke, 1990; Davis, 1990). In serum free 
defined medium only GGF and hepatocyte growth factor (HGF) show mitogenic 
potential when used alone, while the mitogenic activity of FGF and PDGF-BB 
depends on combination with forskolin or cAJv1P analogues (Stewart et al., 1991; 
Hardy et al., 1992; Krasnoselsky et al., 1994). Although TGFP can replace cAN1P in 
stimulating Schwann cell DNA synthesis when combined with FGF-2, the mitogenic 
potential generated by this combination is limited (Schubert, 1992). A recent study 
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indicates that TGFP suppresses the DNA synthesis of Schwann cells triggered by 
axons (Guenard et al., 1995). More recently IGF has also been shown to be essential 
for the mitogenic activity of growth factors apart from NDF in Schwann cells 
(Stewart et al., 1996). It should be noted that most mitogenic assays are based on the 
use of 2-5 day old rat Schwann cells. It is therefore not known whether, or how, the 
mitogenic potential of growth factors depends on the developmental age of the cells. 
Clarification of this issue may help to further understand the molecular interaction 
between Schwann cells and axons in terms of proliferation throughout peripheral 
nerve development. 
The work described in this chapter shows that Schwann cell precursors and Schwann 
cells have different mitogenic responses to NDF, FGF, PDGF, TGFP and forskolin at 
different developmental stages. NDF acts as a mitogen throughout both Schwann cell 
precursor and Schwann cell development. FGF is not a mitogen for the rat Schwann 
cell precursor but strongly induces DNA synthesis in Schwann cells in the presence of 
forskolin. Interestingly, PDGF shows no mitogenic potential for both Schwann cell 
precursors and Schwann cells. TGFP can both positively and negatively control DNA 
synthesis in the Schwann cell precursors and Schwann cells indicating that this factor 
may act as regulator in nerve development. In addition, this study also demonstrates 
that two different mitogenic assays, in which cells are either freshly dissociated from 
nerves or purified in serum for 5 days, may reflect two different proliferation events 
during peripheral nerve development and Wallerian degeneration. Furthermore, adult 
Schwann cells cultured for 5 days in serum showed a strong mitogenic response to 
these growth factors, suggesting that intrinsic alteration in the response of adult 
Schwann cells to mitogens may also greatly contribute to significant proliferation of 
these cells during Wallerian degeneration. 
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Results 
A transient mitogenic response to FGF-2 plus forskolin appears as precursors 
convert to Schwann cells. 
FGF-2 in the presence of forskolin was shown not to stimulate Schwann cell 
precursor DNA synthesis (Chapter 3), whereas this combination promotes 
proliferation of Schwann cells from neonatal rats (Davis, 1992; Stewart et al., 1992). 
In order to know when the cells in Schwann cell lineage start to respond to this 
combination of mitogens, cells dissociated from E14, E15, E16, E17, E18, newborn 
and adult nerves were plated onto coverslips immediately after dissociation and 
cultured in defined medium containing FGF-2 (180pM), forskolin (5ýM) and IGF-1 
(13nM) for 20 hr. BrdU (20ýM) was added three times during the 20 hr culture for 
1.5 hr each time, and cell cultures were terminated at 5 hr, 15 hr and 20 hr 
respectively (as shown in Chapter 3 ). Cells were then double immuno-labelled with 
Li and BrdU (Figure 5.1). The results showed that at the 5 hr point the DNA 
synthesis of E17 and E18 Schwann cells is considerably higher than that of E14 and 
E15 precursors and newborn cells. This result is in close agreement with the relative 
rates of DNA synthesis of these cells measured in vivo (Stewart et al., 1993). During 
the 20 hr period, DNA synthesis in E14 and E15 precursors decreased significantly, 
and at the 20 hr point was 0.97% and 4.66%, respectively. The same result was 
obtained when the FGF-2 concentration was increased from 180pM to 600 pM which 
is known to give maximal DNA synthesis in neonatal Schwann cells. In contrast, 
DNA synthesis was maintained over a 20 hr period in E17 cells and elevated in E18 
cells. As expected, this combination stimulated DNA synthesis in newborn Schwann 
cells. Interestingly, freshly dissociated and plated adult Schwann cells from both 
sciatic nerve and sympathetic trunk showed no response to this combination of 
mitogens in this assay (Figure 5.2). 
The observations so far indicated that the mitogenic activity of FGF-2 plus forskolin 
appeared between E15-EI7, which has been defined as the period of Schwann cell 
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precursor to Schwann cell conversion (Jessen et al., 1994). Therefore it is most likely 
that FGF-2 in the presence of forskolin is a mitogen for Schwann cells but not for 
Schwann cell precursors. The mitogenic potential of this combination rapidly 
increased in E18 cells, and markedly decreased in newborn cells, and was lost in 
adult Schwann cells. On other hand, the mitogenic response of these cells at the 5 hr 
point increases from 10-15% at E14 and E15 to over 20% at E17 and E18 but falls 
below 10% in newborn cells and reaches zero in adult cells. 
NDF retains its mitogenic activity throughout Schwann cell development 
Previously, NDF has been shown to stimulate DNA synthesis of Schwann cell 
precursors. To understand its mitogenic potential during development, cells from 
E 14, E 15, E 16, E 17, E 18, newborn and adult nerves were cultured in defined medium 
containing NDFO-2 (120pM) and IGF-l (13nM) for 20 hr. The control experiment 
was set up in defined medium containing IGF-1(13nM) only. In the case of NDFO-2, 
BrdU was introduced into the cultures at the 18.5 hr point for 1.5 hr while in the case 
of IGF alone, BrdU was introduced in two 1.5 hr pulses at 3.5 hr and 18.5 hr (Figure 
5.3). It was found that NDF consistently promoted DNA synthesis of cells from all 
embryonic stages but failed to stimulate DNA synthesis in adult Schwann cells from 
both sciatic nerve and sympathetic trunk (Figure 5.4A). Interestingly the mitogenic 
response curve at different developmental stages in this study exactly matched the 
curve obtained from experiments in vivo in which similar BrdU pulses were used 
both for Schwann cell precursors and Schwann cells (Stewart et al., 1993). In 
contrast, FGF-2 appears to be non-mitogenic for precursors and to become a mitogen 
during later developmental stages (Figure 5.4B); see also (Figure 5.1). In the control 
experiment, the rate of DNA synthesis declined rapidly during 20 hr in defined 
medium (Figure 5.4C). 
PDGF-BB in the presence of forskolin failed to stimulate DNA synthesis'in 
freshly dissociated Schwann cells 
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PDGF-BB in the presence of forskolin is a well known mitogen for Schwann cells 
which have been cultured in serum for several days (Eccleston et al., 1989; Stewart et 
al., 1991). In the present study, Schwann cell precursors and Schwann cells from E14, 
E18, newborn and adult nerves were exposed to PDGF-BB (5-50ng/ml) plus forskolin 
(5VM) immediately after dissociation from the nerve, and the 1.5 hr BrdU pulse was 
applied between 18.5 and 20 hr to the culture. For E14 Schwann cell precursors, 
PDGF-BB plus forskolin was applied on top of FGF-2 (3ng/ml) plus IGF since 
PDGF-BB plus forskolin was unable to support precursor survival (Figure 5.5). The 
results showed that the combination of PDGF-BB plus forskolin was unable to 
stimulate DNA synthesis either in Schwann cell precursors or Schwann cells at any 
developmental stage. Thus, PDGF-BB in the presence of forskolin appears to have no 
mitogenic effect on these cells in this type of assay. 
Following serum exposure for 5 days the mitogenic activity of FGF-2 plus 
forskolin is more potent in adult Schwann cells than in neonatal cells 
The experiments above examined the mitogenic activity of FGF, NDF and PDGF in 
cells which were plated on coverslips immediately after dissociation without any 
exposure to serum and without a significant time delay between removal from nerves 
and the mitogenic assay. In order to compare these results with the mitogenic 
response in Schwann cells from different postnatal ages under the conditions most 
frequently used in mitogenic assays, a series of experiments were carried out on cells 
that were first purified in medium containing 10% serum plus cytosine arabinoside 
for 4 days (see Methods). The purification procedure applied here is a modification of 
the previous method used by Brockes (1978), and is routinely used to obtain purified 
Schwann cells for proliferation and differentiation assays. This method is based on 
two considerations. Firstly, the presence of myelin from 4 day to adult rat Schwann 
cells could affect the mitogenic assay because myelin debris in culture has been 
shown to stimulate Schwann cell proliferation (Baichwal and DeVris, 1989; DeVris 
and Baichwal, 1991). Secondly, the number of fibroblasts in nerves increases 
dramatically after birth which could result in significant fibroblast contamination in 
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Schwann cell cultures (Scarpini et al., 1988). After purification, the purity of 
Schwann cells in cultures from newborn, 4 days and adult rats was assayed by using 
p75NGF-R as a Schwann cell marker, and found to be 99.87%±0.09,99.16%±0.13 
and 92.68%±0.94 respectively, The percentage of Po positive cells was reduced from 
17.42%±I. l (24 hr) to 2.04%±0.27 (5 days) after purification of adult Schwann cells, 
and was less than 1% in purified newborn and 4 day Schwann cells. 
To compare the mitogenic potential of FGF-2 in the presence of forskolin in cells 
from different postnatal ages, purified Schwann cells from newborn, 4 day and adult 
sciatic nerves were exposed to FGF-2 plus forskolin for a total of 44 hr. BrdU was 
added after 24 hr for a 20 hr pulse. p75 NGF-R and BrdU double labelling was used 
to determine Schwann cell DNA synthesis. FGF-2 dose-response curves were 
constructed in a constant amount of forskolin (2pM). The experiments revealed that 
the mitogenic response was strikingly age-dependent (Figure 5.6A). The DNA 
synthesis in Schwann cells from 4 day old animals and adult animals was up to four 
and six fold greater, respectively, than that of cells from I day old animals. The peak 
concentration of FGF-2 was between 60-6OOpM. The forskolin dose-response curves 
were also established in constant FGF-2 (4OOpM). A similar age-dependent mitogenic 
response pattern was obtained (Figure 5.6B). These results indicate that in serum- 
purified cells the mitogenic potential of the combination of FGF-2 plus forskolin 
increases with the postnatal age of the cells (Figure 5.7). 
To test whether myelin debris was likely to contribute to these unexpected 
differences, Schwann cells from the largely unmyelinated sympathetic trunk of adult 
rats were exposed to various concentrations of FGF-2 in constant forskolin. The 
dose- response curve obtained with these cells was similar to that of cells from the 
myelinated sciatic nerve of adult rats (Figure 5.8). Moreover, Po immunolabelling 
showed that after a total of 5 days in culture essentially no Po positive cells were seen 
in these cells from adult sympathetic truck and 4 day old sciatic nerves, and the 
percentage of Po positive cells from adult sciatic nerves in purified cultures was 
2.04%±0.27 as mentioned above. These observations strongly suggest that the age- 
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dependent changes in mitogenic responsiveness are due to an intrinsic mechanism 
rather than the effect of any exogenous myelin-related substances. 
Either FGF-2 or forskolin alone stimulates DNA synthesis in adult Schwann 
cells, but not in neonatal cells 
The experiment described in the previous section indicated that the combination of 
FGF-2 and forskolin had a particularly strong mitogenic effect on adult Schwann 
cells. Therefore, it was of interest to test whether adult cells might respond to FGF-2 
or forskolin alone although FGF-2 normally requires a cANW elevating agent for 
stimulation of DNA synthesis. The Schwann cells were exposed to FGF-2 (0-600pM) 
or forskolin (0-10ýtM) alone for 44 hr. The BrdU was applied and the cells were 
labelled as described above (Figure 5.9). Surprisingly, either FGF-2 or forskolin 
alone stimulated DNA synthesis in these cells in a dose-dependent manner, resulting 
in a maximum of over 10% DNA synthesis in these cells in either forskolin (10ýtm) 
or FGF-2 (600pM). No BrdU labelling (0.2%) was detected in p75 NGF-R positive 
Schwann cells from adult sciatic nerves in defined medium without FGF-2 or 
forskolin. Furthermore, high concentrations of forskolin (IOgM) or FGF-2 (600pM) 
also stimulated DNA synthesis in adult Schwann cells from sympathetic trunk (data 
not shown). In contrast to these observations, no significant DNA synthesis was 
observed in Schwann cells from 4 day or newborn animals when these cells were 
exposed to forskolin or FGF-2 alone (Figure 5.9), which confirmed a previous report 
that neither forskolin nor FGF-2 alone stimulated DNA synthesis in neonatal 
Schwann cells in defined medium (Stewart et al., 1992). 
PDGF-BB combined with forskolin also shows a distinctly age-dependent 
mitogenic activity in Schwann cells pre-exposed to serum. 
The combination of PDGF-BB and forskolin is known to be a mitogen for neonatal 
Schwann cells which have been cultured in serum for more than 5 days (Eccleston et 
al., 1990; Davis., 1990; Stewart et al., 1992). In freshly dissociated Schwann cells, 
however, this combination failed to stimulate DNA synthesis in precursors or in 
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Schwann cells from E18, newborn and adult nerves as shown above. To test whether 
serum exposure could also affect the mitogenic responses of this combination, dose- 
response curves were constructed for PDGF-BB in the presence of a constant 
forskolin levels (2pM) and for forskolin in the presence of constant PDGF- 
BB(5ng/ml) in Schwann cells purified in serum for 5 days (Figure 5.10). The results 
showed that Schwann cells do respond to this combination after exposure to serum. 
Strikingly, the responses of adult and 4 day Schwann cells were up to 10 and 5 fold 
higher, respectively, than that of newborn cells. In general, the mitogenic activity of 
PDGF-BB in the presence of forskolin was smaller than that of FGF-2 in the 
presence of forskolin. 
Mitogenic activity of TGFP in the Schwann cell lineage 
Previously, TGFO has been shown to act as a mitogen for Schwann cell precursors in 
the FIF medium (FGF-2 180pM plus IGF-I l3nM and forskolin 5W) (Chapter 3). 
To understand the mitogenic response to TGFO during development, cells from E14, 
E18 and newborn sciatic nerves were plated on coverslips immediately after 
dissociation as previously described for the culture of embryonic cells. The cells were 
exposed to both FIF medium and FIF medium plus TGFO1 (Ing/ml)-for 20 hr with a 
1.5 hr BrdU pulse at 18.5 hr. In the case of precursors, it was found that when TGFO 
was added to FIF medium TGFO acted as mitogen even though FGF-2 plus IGF and 
forskolin did not stimulate DNA synthesis in these cells as shown previously (Figure 
5.11). However, TGFP slightly suppressed the mitogenic activity of FGF-2 plus'IGF 
and forskolin in Schwann cells from E18 and newborn rats (Figure 5.12A). These 
experiments suggested that TGFO may act as both positive and negative regulator to 
control cell proliferation depending on the proliferative situation of these cells. To 
further test this idea, TGFO was used on top of NDFO-2 (400pM) plus IGF-I (13nM) 
in the Schwann cell precursor DNA synthesis assay. In one experiment, TGFO1 
(Ing/ml) significantly suppressed DNA synthesis triggered by NDFO plus IGF 
(Figure 5.13,5.14). 
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To explore the mitogenic potential of TGFO in Schwann cells from postnatal stages, 
Schwann cells from I day, 4 day and adult rat nerves were purified for 5 days in 
serum containing medium as described above. The cells were then exposed to FGF-2 
(600pM) plus forskolin (2ýM) or this combination plus TGFOI (Ing/ml) for 44 hr in 
total. BrdU was introduced into the culture for the last 20 hr (Figure 5.12B). The 
results showed that in these culture conditions, the addition of TGFOI caused a 2.5 
fold increase in DNA synthesis in newborn Schwann cells, in contrast to previous 
findings in which Schwann cells were freshly dissociated from nerves. Slight 
suppression of DNA synthesis triggered by FGF-2 plus forskolin was seen in adult 
cells, while the effect of TGFP on top of FGF-2 plus forskolin in 4 day Schwann 
cells was insignificant. 
Pre-exposure to serum affects the mitogenic response of Schwann cells to growth 
factors 
One of the more striking observations described in the previous sections concerns the 
mitogenic responses of adult Schwann cells. They did not respond to any previously 
known mitogens in the assay performed on freshly dissociated cells, while they 
showed a vigorous mitogenic response to the same mitogens after being cultured in 
serum for 5 days, although the BrdU assay applied in these two experiments was 
different. It is possible that the growth factors present in serum may alter Schwann 
cell properties. To test this possibility directly, Schwann cells freshly dissociated from 
adult and newborn rats were cultured in FGF-2 (180pM) plus forskolin (5gM) for 2 
days, while in another experiment, Schwann cells from adult and newborn were 
cultured in serum for 5 days then exposed to FGF-2 (180pM) plus forskolin (5gm) 
for a further 2 days. The cells from both experiments were dosed with BrdU for the 
last 20 hr of the 2 or 7 day assays (Figure 5.15). Using this comparable BrdU assay, 
the results showed that in cells from newborn rats the DNA synthesis in response to 
FGF-2 plus forskolin fell from 51.26%±0.55 to 21.22%±2.88 after treatment with 
serum. Interestingly, in Schwann cells from adult rat, the DNA synthesis response 
increased from 6.19%±1.99 to 73.13%±3.68 after the same treatment in serum 
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-Lo (Figure 5.15). Therefore, it is clear that pre-exposure )ý erum can radically alter the 
mitogenic response of Schwann cells. 
The length of the culture period determines the mitogenic response 
During the purification procedure Schwann cells were not only exposed to serum but 
also cultured for 5 days. It was of interest to know whether the length of the culture 
period alone would also affect the mitogenic response even in the absence of serum. 
Cells dissociated from newborn and adult rat nerves were firstly cultured in serum 
free defined medium for 0,1,2,3ý 4 and 5 days respectively. FGF-2 (180pM) plus 
forskolin (5gM) was applied to each group. The BrdU incorporation was monitored 
in the last 20 hr of a total 2 day incubation period of FGF plus forskolin as previously 
described (Figure 5.16). The results showed that the mitogenic response to this 
combination diminished rapidly with time in newborn cells. In contrast, the mitogenic 
response increased gradually in adult cells. It is instructive to compare these results 
with those obtained when newborn and adult cells were exposed to serum for 5 days 
prior to a2 day exposure to FGF plus forskolin (see Figure 5.15). The comparison 
shows that the 5 day period has similar qualitative effects irrespective of whether 
serum is present or not i. e. the mitogenic responsiveness of newborn cells decreases 
and that of adult cells increases. The magnitude of these changes, however, is much 
greater in the presence of serum. 
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Discussion 
It is important to define the molecular regulation of Schwann cell proliferation during 
development and Wallerian degeneration. The present study clearly shows that the 
mitogenic potential of FGF, NDF, PDGF and TGFP differs in Schwann cell 
precursors and Schwann cells at different developmental stages, indicating that the 
role that a given growth factor plays in Schwann cell proliferation may vary during 
development. The differences in mitogenic responses between cells assayed soon 
after plating and cells assayed following 5 day exposure to defined medium or serum 
suggest that the culture period and culture conditions might alter the intrinsic 
biological properties of Schwann cells. The two different mitogenic assays used in 
this study (on freshly plated cells or on serum-exposed cells) provide two different 
ways of understanding the proliferative behaviour of Schwann cells during normal 
development and Wallerian degeneration. 
The alteration of biological activity of Schwann cells in culture 
Purification of Schwann cells in culture was established in the middle of the 1970s. 
There are two main Schwann cell purification methods which have been used in 
recent studies. In one method DRG explants were cultured for about a month, then 
Schwann cells were harvested by excision of the center of the explant (Wood and 
Bunge., 1976). The other method involved Schwann cells being directly dissociated 
from nerves and cultured in serum for 4-5 days (Brockes et al., 1979). Both of these 
methods involve culturing Schwann cells for a period and exposing them to serum. It 
has been unknown whether these culture conditions affect the biological activity of 
Schwann cells although it is clear that Schwann cells generated by these methods 
seem to respond to mitogens and can also be induced to myelinate (Raff. M., 1978; 
Salzer et al., 1980; Mirsky et al., 1980; Sobue and Pleasure., 1984; Ratner et al., 
1985; 1986; Eccleston et al., 1989; Stewart et al., 1990; Morgan et al., 1991). 
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The experiments presented here were based on two different methods. Firstly, 
Schwann cell precursors or Schwann cells were immediately exposed to mitogens 
after dissociation from nerves without any purification. Most experiments of this type 
were carried out on cells from embryonic stages, at which no myelin and few 
fibroblasts are present in peripheral nerves (Scarpini et al., 1988; Mirsky and Jessen, 
1990; Jessen and Mirsky, 1991). The purity of the cells in such cultures is 95%±1.3 
at E14 and 93%±1.4 at E18. To monitor the DNA synthesis during a 20 hr assay. 
BrdU (1.5 hr pulse) was added three times into the culture or in some experiments 
during the last 1.5 hr period, between 18.5 to 20 hr only. This assay showed clearly 
that DNA synthesis of these cells was elevated or remained at the same levels if a 
mitogen was applied. In contrast, the rate of DNA synthesis rapidly declined when 
non-mitogens were used. The percentage of DNA synthesis of these cells based on 
this type of assay was about 13% in E14 precursors, 35% in E 18 Schwann cells , 
10% in newborn cells and 0.2% in adult cells in response to NDF or FGF plus 
forskolin at the 20 hr point. The magnitude of the mitogenic response at different 
developmental stages correlated well with the amount of DNA synthesis seen in vivo 
when a similar BrdU pulse (2.4 hr) was applied to living animals (Stewart et al., 
1993). It is likely that this type of assay has the following characteristics. Firstly the 
cells synthesize DNA during the first 1.5 hr BrdU pulse primarily in response to the 
mitogens they were exposed to in vivo prior to dissociation; secondly, the cells 
synthesize DNA during the second and particularly the third pulse primarily in 
response to mitogenic input in the culture dish; and thirdly, this mitogenic response to 
applied growth factor is similar to the response that the cells would show in vivo, 
while the response of the cells that have been exposed to serum for 4-5 days (see 
below) are likely to be affected by some factors in serum and by time in vitro. 
Therefore, growth factors were tested in this assay in the hope of understanding the 
mitogenic potential of these factors in normal peripheral nerve development. 
Secondly, Schwann cells were dissociated and cultured in serum medium for 5 days, 
giving rise to pure cultured Schwann cells. Schwann cells from adults generated by 
this method showed a great increase in responsiveness to mitogens such as NDF, 
FGF, PDGF-BB and forskolin (from 6% to 73%), whereas a significant reduction in 
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responsiveness to the same mitogens was seen in Schwann cells from newborn 
animals (from 51% to 25%). This response to mitogens poorly reflects the 
proliferation tendency of these Schwann cells in normal nerves, since it is well known 
that adult Schwann cells are quiesc ent in normal nerves. On the other hand, the 
change in mitogenic response during culture matches the alteration of these cells in 
terms of mitogenic response during Wallerian degeneration both of newborn and 
adult nerves. Previous experiments indicated that transecting neonatal sciatic nerves 
resulted in a decrease in DNA synthesis in these Schwann cells (Komiyama and 
Suzuki, 1992). In contrast, transecting adult sciatic nerves led to massive proliferation 
of adult Schwann cells (Clemence et al., 1989; Komiyama and Suzuki, 1992). It was 
suggested that myelin debris and macrophage participation might be the cause of this. 
Nevertheless, the observations in the present study indicate that Schwann cells 
cultured in serum or defined medium for several days change their mitogenic 
response, closely mimicking the response of Schwann cells during Wallerian 
degeneration. Although it is still unclear what causes this alteration in terms of 
molecular regulation in these cells, one possible explanation is that lack of axonal 
signals in these cultures may result in changes in the expression of growth factor 
receptors. 
The present study not only shows that Schwann cells in culture change their 
mitogenic response but also indicates that the length of the culture period determines 
this alteration since Schwann cells cultured in serum or defined medium changed their 
responsiveness in a similar direction, although the presence of serum in the culture 
medium significantly affected the extent of these changes. In conclusion, it is most 
likely that a study of Schwann cells which have been cultured for several days in the 
absence of neuronal signals is more conducive to understanding the biological 
activity of Schwann cells during Wallerian degeneration, whereas a study of Schwann 
cells which are tested immediately after dissociation from nerves leads to an 
understanding of the biological activity of Schwann cells in normal nerves. 
Mitogenic responses in the Schwann cell lineage 
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Many growth factors have been found to stimulate DNA synthesis in Schwann cells in 
vitro (Davies, 1991; Stewart et al., 1992). It is noteworthy that most mitogenic assays 
have been carried out on neonatal Schwann cells which were cultured in serum 
containing medium for several days before the start of the assay. As discussed above, 
it is unclear how these results can be directly related to factors in the nerve that might 
promote Schwann cell proliferation throughout development. 
Mitogenic responses to growth factors during developmen 
The present experiment in which Schwann cells were immediately exposed to growth 
factors after fresh dissociation from the nerve showed that NDF, FGF, PDGF and 
TGFO act differently on Schwann cells in terms of mitogenic activity at different 
developmental stages. FGF in the presence of forskolin is non-mitogenic for Schwann 
cell precursors, and then gradually becomes a mitogen for Schwann cells. The 
mitogenic potential of this combination reaches a peak at E 18, dropping significantly 
by the newborn stage. In this assay, adult Schwann cells do not respond to this 
combination. In contrast, TGFO on top of FGF and forskolin stimulates DNA 
synthesis in Schwann cell precursors, and then its mitogenic potential is gradually lost 
when it is added on top of FGF and forskolin. As FGF plus forskolin becomes 
increasingly mitogenic for Schwann cells TGFP rather than stimulating DNA 
synthesis, slightly inhibits mitogenic activity triggered by FGF plus forskolin. In adult 
cells, TGFO did not stimulate DNA synthesis in any of the growth factor 
combinations tested. NDF seems to be a consistent mitogen throughout early 
Schwann cell development, its activity being gradually reduced in postnatal cells. In 
adult cells, NDF had no mitogenic potential. PDGF-BB in the presence of forskolin, a 
typical mitogen for longer term cultured Schwann cells (Eccleston et al., 1992; 
Stewart et al., 1992), was unable to stimulate DNA synthesis in this assay, suggesting 
that this combination may not contribute to proliferation of Schwann cells in normal 
nerves. It was a consistent finding that the mitogenic potential of all of these growth 
factors was lost in adult Schwann cells although they showed varying mitogenic 
effects on cells from more immature animals. Some evidence indicates that Schwann 
cells in the adult nerve express low levels of PDGF receptor, FGF receptor and ErbB2 
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mRNA or protein (Eccleston et al., 1992; Reddy and Pleasure, 1992; Cohen et al., 
1992; Jin et al., 1993; Davis, 1993). Therefore, one possibility is that down-regulation 
of corresponding receptors in the adult may lead to the loss of response in these cells 
to growth factors. 
Mitogenic responses to growth factor during Wallerian degeneration 
When experiments were done in a different way by using Schwann cells mainly from 
postnatal stages cultured in serum for 5 days, different results were obtained. Under 
these conditions, the mitogenic potential of FGF plus forskolin, was much greater in 
adult Schwann cells than in younger cells. Moreover, it was found that FGF was 
sufficient on its own to stimulate DNA synthesis in adult Schwann cells. PDGF-BB 
plus forskolin, as expected, was mitogenic for these Schwann cells and showed an 
age-dependent mitogenic response. It seems likely that the mitogenic response of 
adult Schwann cells to all growth factors is upregulated under these culture 
conditions. It is possible that this can be related to the vigorous division of these cells 
seen during Wallerian degeneration. 
Effects of TGFD on cells in Schwann cell lineage 
TGFP, as mentioned above, slightly suppressed DNA synthesis triggered by FGF 
plus forskolin in freshly dissociated newborn Schwann cells. In contrast, it promoted 
the mitogenic potential of FGF plus forskolin in the same newborn Schwann cells 
following cultured in serum containing medium for 5 days. One of the differences 
between freshly dissociated cells and serum-exposed cells is that the mitogenic 
response to FGF plus forskolin was reduced (from 51% in freshly dissociated cells to 
25% in serum-exposed cells). In addition, TGFP suppressed the high DNA synthesis 
generated by FGF plus forskolin in serum-exposed adult Schwann cells. Taken 
together, it seems most likely that the positive or negative effect of TGFP on 
Schwann cells depended on proliferation status of cells. When the cells are quiescent 
or the proliferative response of these cells to FGF plus forskolin is declining, TGFP 
synergizes with FGF plus forskolin to stimulate DNA synthesis in these cells. When 
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Schwann cells were dividing at a maximum rate TGFO lowers the proliferation rate. 
TGFO also inhibited DNA synthesis in Schwann cells driven by neurons (Chandross 
et al., 1995). The positive and negative regulation by TGFO was also observed in 
Schwann cell precursors. TGFP promoted precursor DNA synthesis in the presence of 
the non-mitogenic combination of FGF-2 plus forskolin, but inhibited DNA synthesis 
in the mitogenic agent NDFO. Thus, TGFP is able to act as both a positive and 
negative regulator of proliferation of the cells in the Schwann cell lineage. A study on 
3T3 cells indicated that TGFO might downregulate PDGF receptors in these cells 
resulting in a decreased mitogenic response to PDGF-AA (Gronwald et al., 1989). 
Therefore, it is also possible that the positive and negative regulation by TGFP in 
Schwann cells may also relate to the receptor regulation in these cells by TGFO. 
The potential for mitogenic response in adult Schwann cells 
Culturing adult Schwann cells has always been thought to be difficult due to 
fibroblast contamination and the effects of myelin debris (Yoshino et al., 1987; 
Scarpini et al., 1988; Baichwal and DeVries, 1989; Morrissey et al., 1991). The adult 
Schwann cells generated in this study were 93% pure, confirmed by both p75 NGF-R 
and S-100 staining. Although this purity is slightly less than that of previous reports 
in which purified adult Schwann cells were obtained by processing in culture for 
more than I month ( Morrissey et al., 199 1) it greatly simplified the culture method 
for adult Schwann cells. Adult Schwann cells cultured for 5 days in serum containing 
medium, showed a strong response to known mitogens. It is clear that this response 
does not relate to the effects of myelin debris since the Po positive adult Schwann 
cells were less than 2% after 6 days in culture, or fibroblast contamination (only 7% 
in these cultures). Meanwhile non-myelinating Schwann cells from the adult 
sympathetic trunk showed a similar mitogenic response pattern to those derived from 
the sciatic nerve. These observations suggest that intrinsic changes which occur in 
these Schwann cells in response a denevation may lead to the massive DNA synthesis 
in response to growth factors and that the effect of exogenous myelin debris is 
secondary to the response. These intrinsic changes in Schwann cell biological activity 
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may contribute to the strong proliferation of adult Schwann cells seen during 
Wallerian degeneration. 
Although the present study does not examine the changes in growth factor receptors 
that may occur when these cells are cultured, related studies show that adult Schwann 
cells in normal nerves express very low levels of ErbB2 mRNA and protein. After 
sciatic'nerve transection Schwann cells in the distal stump expressed high levels of 
this protein and mRNA (Cohen et al., 1992). Therefore, it is possible that 
corresponding growth factor receptors such as PDGF receptor, FGF receptor and 
ErbB2 which are expressed in very low levels in adult Schwann cells in vivo 
(Eccleston et al., 1992; Reddy and Pleasure, 1992; Cohen et al., 1992; Jin et al., 
1993), could be upregulated in cultures and during Wallerian degeneration. This 
receptor regulation may act as an intrinsic control on Schwann cell proliferation 
during development and Wallerian degeneration. 
Recently, two separate groups have reported on the mitogenic responses of adult 
mouse Schwann cells. It was found that Schwann cells from adult mouse did not 
respond to any growth factor combinations except GGF in high concentrations when 
these cells were cultured in mixed serum and serum free medium for 4 days on a 
collagen-coated substrate (Zhang et al., 1995). It was also found that Schwann cells 
from adult mouse did respond to FGF alone, forskolin alone and their combination 
when these cells were cultured in serum medium for 3 more weeks (Watabe et al., 
1994). These different mitogenic responses of adult Schwann cells may be due to the 
culture period and serum exposure since the present study has indicated that the 
culture period determines the mitogenic response of adult Schwann cells and serum 
exposure significantly enhances the mitogenic potential of these cells. Moreover, this 
time-dependent mitogenic responsiveness can also be seen in transected adult nerve, 
since 3 post-transectional days are necessary for the proliferation of the adult 
Schwann cells in the distal stump to reach a maximum level (Komyama and Suzuki, 
1992). It would therefore, be of interest to know whether the culture period and 
serum exposure are related to receptor regulation which leads to the proliferation of 
Schwann cells. 
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Figure 5.1. Developmental regulation of the mitogenic potential of 
FGF-2 plus forskolin in cells of the Schwann cell lineage 
Cells dissociated from E14, E15ý E171P E18, newborn and adult rat sciatic 
nerves were immediately cultured in FIF medium [FGF-2 (180pM) plus 
forskolin (5pM) and IGF-I (13nM)] for 20 hr. A 1.5 hr BrdU pulse was 
used at the 3.5 hr, 13.5 hr and 18.5 hr points. BrdU and LI antibodies (or 
SlOO, p75NGF-R for postnatal stage) were used to measure the DNA 
synthesis in identified cells. The results show that the mitogenic response 
to FGF-2 plus forskolin is absent in E14 and E15 precursors and adult 
Schwann cells, and present in El 79 El 8 and NB Schwann cells. 
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Figure 5.2 FGF-2 in combination with forskolin stimulates DNA 
synthesis in E18 and NB Schwann cells, but not in E14 precursors or 
adult Schwann cells. 
Cells were exposed to FGF-2 plus forskolin and IGF- I immediately after 
dissociation from nerves for 20 hr. A 1.5 hr BrdU pulse was Lised at the 
18.5 hr point. E14 Schwann cell precursors (A) and EI8 Schwarin cells 
(C) were labelled with Ll. NB Schwann cells (E) were labelled with 
p75NGF-R. Adult Schwarm cells (G) were labelled with SlOO. B, D, F, H 
show the BrdU labelling in corresponding to A, C. E. G. Magnification 
60OX 
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Figure 5.3 NDFP stimulates DNA synthesis in E14 Schwann cell 
precursors and E18, NB Schwann cells, but not in adult Schwann 
cells. 
Cells were exposed to NDFP plus IGF- I immediately after dissociation 
from nerves for 20 hr. A 1.5 lir BrdU Pulse was used at the 18.5 lir point. 
E14 Schwann cell precursors (A) and E18 Sch\, vann cells (C) were 
labelled with Ll. NB Schwann cells (E) were labelled with p75NGF-R. 
Adult Schwann cells (G) were labelled with SlOO. B, D, F, H were tile 
BrdU labelling in corresponding to A, C, E, G. Magnification 60OX 
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Figure 5.4 Developmental regulation of the mitogenic potential of 
NDFP-2 in cells of the Schwann cell lineage 
Cells dissociated from EK E159 E169 E17ý E18, newborn and adult rat 
sciatic nerves were immediately cultured in defined medium containing 
(A) NDFP (4OOpM) plus IGF-I (13nM), (B) FGF-2 (180pM) plus 
forskolin (5gM) and IGF-I (13nM) taken from Figure 5.1 at 20 hr point, 
(C) IGF (13nM) control at 20 hr. A 1.5 hr BrdU pulse was used at the 
18.5 hr point or the 3.5 hr point for IGF only. The results show that 
NDFP, but not FGF-2 plus forskolin, stimulates DNA synthesis in E14 
and E15 precursors. Both NDFP and FGF-2 plus forskolin are mitogenic 
for embryonic and newborn Schwann cells, but have no mitogenic 
activity for adult Schwann cells. In IGF alone, DNA synthesis in these 
cells decreased dramatically from the 5 hr point to the 20 hr point at all 
ages from E16 to adult. 
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Figure 5.5 The mitogenic potential of PDGF-BB plus forskolin in 
cells of the Schwann cell lineage 
Cells dissociated from EK E18, newbom and adult rat sciatic nerves 
were immediately cultured in defined medium containing PDGF-BB 
(50ng/ml) plus forskolin (5gM) and IGF-I (13nM) for 20 hr. In E14 
precursor cultures, FGF-2 (180pM) was included since precursors die in 
PDGF-BB alone. A 1.5 hr BrdU pulse was used at the 18.5 hr point. The 
results show that DNA synthesis of these cells in PDGF-BB plus 
forskolin medium is similar to that seen in IGF alone medium (Figure 
5.4C). 
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Figure 5.6 Mitogenic potential of FGF-2 plus forskolin in Schwann 
cells pre-cultured in serum-containing medium for 5 days. 
Schwann cells from newborn, postnatal day 4 (N) and adult sciatic 
nerves were cultured in serum-containing medium for 5 days, then the 
purified Schwann cells were exposed to (A) various concentrations of 
FGF-2 in constant of forskolin 2gM, (B) various concentrations of 
forskolin in constant FGF-2 (4OOpM) for a total of 44 hr. BrdU was used 
for the last 20 hrs of the assay. The results show that DNA synthesis 
stimulated by FGF-2 plus forskolin is higher in adult Schwann cells than 
that seen in P4 and NB Schwann cells. 
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Figure 5.7 Mitogenic activity of FGF plus forskolin in adult Schwann 
cells was higher than that in younger cells. 
Schwarin cells from adult (A, B), postriatal day 4 (C, D) and newborn (E, F) 
rat sciatic nerves were pre-CUltured in serum-containing medium for 5 
days, and then the purified cells were exposed to FGF-2 plus forskolin for 
44 hr. A 20 lir Bi-dU pulse was used for the last 20 lir assay. Cells were 
double-labelled with p75NGF-R (A, C, E) and Bi-dU (B, D, F). 
Magnification 50OX 
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Figure 5.8 Mitogenic potential of FGF-2 plus forskolin was similar in 
Schwann cells from both adult sciatic nerves and sympathetic trunk 
nerves 
Schwann cells from both adult sciatic nerves and sympathtic trunk nerves 
were cultured in serum-containing medium for 5 days. The purified 
Schwann cells were then exposed to various concentrations of FGF-2 in 
constant of forskolin, 2 gM for 44 hr. BrdU was used for the last 20 hr. 
The results show that Schwann cells from both adult sciatic nerves and 
sympathetic trunk nerves have a similar response to the combination of 
FGF-2 plus forskolin. 
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Figure 5.9 Mitogenic potential of FGF-2 or forskolin alone in 
Schwann cells pre-cultured in serum-containing medium for 5 days. 
Schwann cells from newborn (NB), postnatal day 4 (N) and adult sciatic 
nerves were cultured in serum-containing medium for 5 days, then the 
purified Schwann cells were exposed to various concentrations of FGF-2 
(A) or forskolin (B) for 44 hr. BrdU was used for the last 20 hr of the 
assay. The results show that FGF-2 or forskolin alone acts as a dose- 
dependent mitogen for adult Schwann cells, but not for NB and P4 
Schwann cells. 
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Figure 5.10 Mitogenic potential of PDGF-BB plus forskolin in 
Schwann cells pre-cultured in serum-containing medium for 5 days. 
Schwann cells from newborn, postnatal day 4 (N) and adult sciatic 
nerves were cultured in serum-containing medium for 5 days, then the 
purified Schwann cells were exposed to (A) various concentrations of 
PDGF-BB in constant forskolin (2gM), (B) various concentrations of 
forskolin in constant PDGF-BB (50ng/ml) for 44 hr. BrdU was used in 
the last 20 hr of the assay. The results show that PGDF-BB plus forskolin 
are hardly mitogenic for newbom Schwann cells and show age-dependent 
mitogenic activity for P4 and adult Schwann cells. 
212 
60 
ui 
50 
40 
0 
IL 
30 
M 20 
--o 0' 
10 
0-i 
0 
PDGF-BB (ng/ml) 
60 
50 
LU 
40 
cn 0 
30 
20 
10 
0 
0 0.1 10 100 
13 Adult 
.... P4 
NB 
z OA 
FORSKOLIN (gM) 
0.1 10 100 
Figure 5.11 TGFP stimulates DNA synthesis of precursors in the 
presence of the non mitogenic combination of FGF-2 plus forskolin. 
Schwann cell precursors dissociated frorn E14 rat nerves were 
immediately cultured in FIF medium (FGF-2 plus IGIF and Forskolin) 
(A, B) or FIF mediLlIn plus TGFP-l (C, D) for 20 lir. A 1.5 hr BrdU pulse 
was used at the 18.5 hr point. Tile precursors were double-labelled with 
1,1 antibodies (A, C) and BrdU antibodies (13, D). Magnification 70OX 
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Figure 5.12 Mitogenic regulation of TGFP in cells of the Schwann cell 
lineage 
(A) Cells dissociated from E14, E18, newborn and adult sciatic nerves 
were immediately cultured in defined medium containing FGF-2 (180pM) 
plus forskolin (5ptM) or FGF-2 (180pM) plus forskolin (5gM) and TGFO I 
(Ing/ml) for 20 hr. BrdU was used in the last 1.5 hr of the assay. (B) 
Schwann cells from newborn, 4 day and adult sciatic nerves were pre- 
cultured in serum-containing medium for 5 days, and then exposed to 
FGF-2 (180pM) plus forskolin (5ýM) or FGF-2 (180pM) plus forskolin 
(5ýM) and TGFPI (Ing/ml) for 44 hr, BrdU was used for the last 20 hr of 
the assay. The results show that TGFP produces both a positive and 
negative effect on DNA synthesis in these cells 
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Figtire 5.13 TGF[i inhibits DNA synthesis of Schwann cell precursors 
indticed by NDFJý. 
1,11-1 Schwalill CCII precill-sol's fivshly dissociated from nerve were culturcd 
III defined inc(lium cillier containing NDF[i-2 (AB) or TGFý plus NDFP- 
2 ((', D) FOr 20 hr. A 1.5 hr BrdU pulse was used at the 18.5 lir point. The 
precursors wcre double-labelled with Ll antibody (A, C) and BI-dU 
aiMbody (11, D). Magnification 70X 
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Figm-e 5.14 TGFJý suppresses DNA synthesis in precursors stimulated 
by ND Fjý 
Schwaim cell precursors dissociatcd from E14 sciatic nerve were 
111111lediatek, cultill-ed III defilied medium containing NDFý-2 (400pM) or 
NDFJý-2 (4001)M) plus TGF111 (Ing/ml) for 20 hr. A 1.5 lir BrdU pulse 
was used at 1he 18.5 hi- 1)01111. The I)I-CCLII-SOI-S were double labelled with 
1,1 mid BrdU millbodles. The result shows that TGFP on top of NDF[1 
suppi-csses DNA synthesis Ili Schwalm cell precursors. 
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J, 'jgtj, -e .;. p; 'I'lle effect of serum exposure on 
the mitogenic response 
of Schwann cells to FGF-2 plus forskolin 
scimann cells dissociated from newborn or adult sciatic nerves were 
Cillicl- cXpOSC(I to FGF-_2 (1801)M) PILIS forskolin (5pM) immediately for 
44 lir oi- cultured in seruni-containing medium foi- 5 days then exposed to 
F( &*-2 (18()I)M) plus I'Orskolin (5n1M) for 44 hr. BrdU was used for tile 
last 20 lir ol'the assay in both conditions. The results show that tile DNA 
synthesis is decreased in newborn Schwann cells and significantly 
increased in adult Schwann cells after serum exposure. 
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Figure 5.16 The effect of culture period on the mitogenic response of 
Schwann cells to FGF-2 plus forskolin 
Schwann cells dissociated from (A) newborn or (B) adult sciatic nerves 
were cultured in serum-free defined medium for 0-8 days. The cultured 
Schwann cells were then changed to FGF-2 (180pM) plus forskolin 
(5gM) containing medium at day 0,1,2,3,4,5,6,8. Schwann cells were 
cultured in FGF-2 plus forskolin containing medium for 44 hr and BrdU 
was introduced to the culture for the last 20 hr of the assay. The results 
show that the mitogenic response of Schwann cells to FGF-2 plus 
forskolin is reduced dramatically in newborn animals (A) and gradually 
increases in adult animals (B). 
224 
A6 
w 
50 
40 
0 
30 
Ct 20 m 
-0 0- 10 
B 40 
35 
w 
> 30 
0 
20 
15 
10 
-0 0- 
5 
0 
0123456 
DAYS IN CULTURE 
ADULT I 
NB 
78 
0- 
0 234567 
DAYS IN CULTURE 
10 
CHAPTER 6 
GENERAL DISCUSSION 
226 
This study has systematically investigated the survival, proliferation, maturation and 
differentiation of cells in the Schwann cell lineage and focused on the molecular 
interactions between neurons and Schwann cell precursors\Schwann cells. The thesis 
aimed: firstly, to identify the neuron-derived survival factors for Schwann cell 
precursors; secondly, to investigate the interactions between Schwann cell precursors 
and neurons that led to survival, proliferation, maturation and differentiation of 
Schwann cell precursors; thirdly, to explore the mitogenic potential of NDF, FGF, 
TGFO and PDGF-BB throughout Schwann cell precursor and Schwann cell 
development including an analysis of the mitogenic response to these growth factors 
in cultured adult Schwann cells. This study also introduced a method of obtaining 
purified DRG neurons, and demonstrated that DNA synthesis assays performed at 
different stages of Schwann cell culture gave very different results. These results may 
relate to different proliferation events that occur during normal development and 
Wallerian degeneration. 
The identification of the neuron-derived survival signal is a important step in 
understanding the development of the PNS. The study present here strongly supports 
the idea addressed previously (Jessen et al., 1994) that the interaction of neurons and 
Schwann cell precursors supports Schwann cell precursor survival. The survival 
signals were found to be the molecules located in both neuron conditioned medium 
and on or associated with neuronal surface. This thesis also provides strong evidence 
(see below) that this signal is 0 forms pf the NDF family. 
Selecting NDF as a candidate for neuronal survival signal was based on the fact that 
this newly purified and sequenced growth factor belongs to a novel growth factor 
family, [NDF, heregulin(HRG), glia growth factor(GGF) and ARIA]. Some members 
of this family (pure and impure GGF) have been shown to play a important role in 
Schwann cell proliferation, and have a more potent mitogenic activity in comparison 
to other Schwann cell mitogens (Stewart et al., 1992; 1995). Meanwhile, this growth 
factor has also been shown to be highly expressed in the embryonic peripheral 
nervous system ( Orr-Urtreger et al., 1993; Meyer and Birchmeier, 1994). InImuno. 
labelling and Western blotting observations in this study revealed that NDF was 
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strongly expressed on neurons but was not detectable in Schwann cell precursors. 
Interestingly, Schwann cells from the neonatal rat also appeared to express a weak 
NDF signal. Together, it seems likely that this molecule may act as a survival 
molecule for Schwann cell precursors. In this regard, NDF was tested in survival 
assays of these cells. As expected, NDF showed a marked potential to support 
Schwann cell precursor survival both in short-term and long-term culture, closely 
mimicking the survival signal from NCM (Jessen et al., 1994). Based on these 
observations, blocking experiments were designed by using soluble ErbB4 protein, 
since similar blocking experiments have been widely used to explore the function of 
identified molecules in other systems (Kalebic et al., 1994; Barren et al., 1993). The 
results in this study showed that soluble ErbB4 protein significantly reduced die 
survival activity both in NCM and on the neuronal surface. Taken together, all tile 
observations presented here strongly support the idea that NDF acts as the key 
neuronal survival factor for Schwann cell precursors. 
Previous reports from our group indicated that FGF could also support precursor 
survival in the presence of IGF (Jessen et al., 1994; Gavrilovic et al., 1995). Thc 
present study further explored the role of this molecule in the interaction of neurons 
and Schwann cell precursors. The results revealed that FGF-2 may also be involved in 
neuronally mediated precursor survival, but the survival contribution of this molecule 
in the neuronal survival signals for Schwann cell precursors appears to be minor. In 
the CNS, oligdendrocytes and their progenitors rely on multiple survival signals 
which are derived from neurons (Barres et al, 1992; 1994 ). The Schwann cell 
precursor may also rely on multiple neuronal signals for survival such as NDF, FGF 
and other unidentified factors, but it is most likely that NDF plays the key role in 
Schwann cell precursor survival during peripheral nerve development. 
In vivo, Schwann cell precursors not only survive but also show vigorous 
proliferation (Stewart et al., 1993). Interestingly, NCM which supports Schwann cell 
precursor survival, was unable to stimulate DNA synthesis in these cells (Jessen et al., 
1994). Does the proliferative signal for precursors derive from neurons? The 
experiment using very pure and immunolabelled neurons, showed that direct contact 
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with neurons or axons promotes DNA synthesis in the Schwann cell Precursor. The 
difference between NCM and direct contact with neurons in terms of mitogenic 
potential may relate to the differing concentration of mitogens in these two different 
conditions. With regard to identifying the neuronal mitogenic signal for precursors, 
this study revealed that NDF alone and TGFO in the presence of FGF plus forskolin 
stimulated DNA synthesis in Schwann cell precursors. In view of the recent 
identification of NDF as a neuronal associated mitogen for Schwann cells ( 
Morrissery et al., 1995), it is also possible that NDF acts as an axon-associated 
mitogenic signal for Schwann cell precursors. Although this study also showed that 
TGFO can stimulate DNA synthesis in Schwann cell precursors in the presence of 
other factors, some other observations in this study indicated that TGFO can either 
promote or suppress DNA synthesis in both Schwann cell precursors and Schwann 
cells, indicating that this molecule may act in a more complicated way to control the 
proliferation of these cells. Recent studies on TGFO receptors suggest that different 
combinations of TGFO receptors might be involved in triggering different functional 
pathways ( Waran et al 1992; Massague et al 1994). Therefore, exploring TGFP 
receptor expression and functional analysis of the receptor combination in the 
Schwann cell lineage will be one of the approaches for future study. 
Schwann cell precursors proliferate and develop into Schwann cells in vivo. The 
conversion of the Schwann cell precursor to Schwann cell has been defined as 
appearing between EIS-E17 in the rat by showing an alteration of antigcnic 
phenotype, survival ability and mitogenic response potential (Jessen et al., 1994). 
This study revealed that direct contact with neurons led to maturation of Schwann cell 
precursors, as does NCM (Jessen et al., 1994). Therefore, it is clear that neuronal 
molecules play an important role during this conversion. NDF has been shown to 
support this conversion on schedule (Dong et al., 1995). It seems likely that NDF is 
the neuronal molecule that promotes the conversion of Schwann cell precursors to 
Schwann cells. Alternatively, it is also possible that NDF may only block the 
apoptosis of precursors without providing a positive signal for lineage progression. 
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During Schwann cell generation, Schwann cell precursors\Schwann cells also 
undergo vigorous proliferation. The molecular basis for this proliferation appears to 
change markedly as the cells mature. My studies show that FGF plus forskolin 
gradually becomes a mitogen as Schwann cell precursors convert to Schwann cells in 
vivo. In contrast, the mitogenic potential of TGFP is reduced and in older rat 
Schwann cells, TGFP slightly suppressed mitogenic activity triggered by FGF plus 
forskolin at later stages. NDF is a mitogen for Schwann cell precursors, and 
continually acts as a strong mitogen in Schwann cells. Interestingly, PDGF-BB plus 
forskolin, a well known Schwann cell mitogen in short term culture systems, may not 
act as mitogen for the Schwann cell during normal peripheral nerve development 
since this study shows that this combination does not stimulate DNA synthesis of 
freshly dissociated Schwann cells at any developmental stage. It is unclear why Ole 
proliferation rate of Schwann cells in vivo is markedly increased as Schwann cell 
precursors convert to Schwann cells (Stewart et al., 1993). One possibility is that with 
the increasing mitogenic potential of FGF-2, NDF and other unknown mitogens, the 
combination of these factors may drive Schwann cells towards massive proliferation, 
reaching a peak at EI 9-E20. 
With the onset of myelination, Schwann cells recede from proliferation and undergo 
differentiation. Experiments in this study showed that Schwann cell precursors in 
contact with neurons can be induced to express relatively high levels of the myelin. 
related protein Po. Together with previous reports, in which elevated Po levels were 
also found in neonatal Schwann cells when these cells were co-cultured with neurons 
(Morrison et al., 1991; Brunden et al., 1990; 1992), this shows that neuronal 
molecules can promote Schwann cell differentiation. In addition, it is also known that 
there are soluble myelinogenic molecules in medium from cultured neurons since 
blocking direct contact between neurons and Schwann cells in a co-culture also 
results in induction of both Po and SCIP gene expression in Schwann cells (Bolin and 
Shooter, 1993). Although the evidence is clear that neuronal signals regulate the 
differentiation of Schwann cells the molecular nature of the neuronal differentiation 
signals are still generally unknown. 
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As mentioned above, parallel to Schwann cell differentiation is the rapid recession 
from proliferation of these cells. It is unknown what causes this recession. The 
experiments presented in this study, indicated that after birth, Schwann cells which 
were dissociated from the nerve and immediately exposed to potential mitogens, 
showed a significant decline in response to these mitogens compared with cells from 
embryonic animals. In the adult, freshly dissociated Schwann cells do not respond to 
any growth factors or their combinations when tested immediately after removal from 
the animal. One possibility for this mitogenic shift may relate to their corresponding 
receptor regulation since it has been shown that ErbB2 (neu), FGF receptor and 
PDGF receptors were downregulated in peripheral nerves in adult animals (Eccleston 
et al., 1992; Reddy and Pleasure, 1992; Cohen et al., 1992; Jin et al., 1993; Davis, 
1993). Alternatively, it is also possible that the Schwann cell may respond to different 
mitogens after birth, but the parallel experiments in this study also demonstrated that 
after culturing in serum medium for 5 days adult cells show a significant mitogenic 
response to the same mitogens as cells from younger animals, making the requirement 
for different mitogens during postnatal development less likely. 
Schwann cells in the adult animal are quiescent, but when adult nerve is transectcd 
Schwann cells in the nerve undergo de-differentiation and proliferation (Abercrombie 
and Johnson, 1946; Clemence et al., 1989; Komiyama and Suzuki, 1992). This 
proliferation event may relate to myelin debris, macrophage invasion and also axonal 
surface exposure (Yoshino et al., 1978; Baichwal and DeVries, 1989; Clemence et al., 
1989). My experiments reveal that an alteration in the biological activity of adult 
Schwann cells may also contribute significantly to this proliferation since this thesis 
shows that adult Schwann cells become gradually more potent in response to 
mitogens if they are deprived of axonal contact in vitro. The molecular basis for this 
alteration is unclear. One of the most likely explanations for this is that the 
upregulation of corresponding growth factor receptors in these cells after peripheral 
nerve transection may lead to restoration of proliferation. With regard to Schwann 
cell mitogens during Wallerian degeneration, NDF, and FGF or PDGF-BB in the 
presence of forskolin are potent mitogens for Schwann cells, especially for adult 
Schwann cells. TGFP in contrast, acts negatively on DNA synthesis triggered by FGF 
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plus forskolin, suggesting its function may involve suppression of proliferation which 
is in agreement with a previous report that TGFO slightly inhibited Schwann cell 
proliferation triggered by neurons (Guenard et al., 1995). 
I have also introduced a immunopanning method, in which more than 95% pure DRG 
neurons were obtained. Immunopanning methods have previously been used to purify 
oligodendrocytes, Schwann cells and retinal ganglion cells (Barres et al., 1992; 
Lindsey et al., 1994; Cheng et al., 1995). The two great advantages of this method are 
firstly, that the neurons are highly pure, secondly, the purification procedure takes 
only 2-3 hrs, and only one day of culture is required to obtain extensive neurite 
outgrowth. As we know from this study that Schwann cells cultured in serum for 
several days appear to significantly alter their biological activity, it is also possible 
that neurons in culture for several days or weeks may also change their molecular 
expression or molecular secretions. A study of FGF expression in cultured DRG 
neurons indicated that the FGF-2 and FGF- I expression on neurons changed during 2 
to 30 days in culture (Neuberger and DeVries, 1993). In this regard, neurons 
obtained by the present immunopanning method, may more closely mimic the natural 
neurons in vivo in terms of molecular expression, in comparison to most other 
methods in which neurons were cultured and exposed to serum for several days 
(Salzer et al., 1980), This should allow us to further explore the key molecules in the 
interaction between neurons and Schwann cells. 
The second technical innovation introduced in this study is the comparison of two 
different mitogenic assays. The routine mitogenic assay for Schwann cells has always 
involved culturing Schwann cells in serum for several days. My experiments showed 
that Schwann cells purified using this procedure alter their biological activity and that 
this change shows similarities with the change that takes place during Wallerian 
degeneration in terms of mitogenic responsiveness. In contrast, to understand the 
mitogenic response of Schwann cells in normal nerve freshly dissociated Schwann 
cells are required. 
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Future studies 
The molecular interactions between Schwann cells and neurons which lead to the 
differentiation of Schwann cells are still unclear. Some recent studies have indicated 
that TGFO may play a important role in inhibiting proliferation of Schwann cells 
driven by neurons in a co-culture system (Guenard et al., 1995), upregulating LI and 
N-CAM and downregulating the expression of myelin-related proteins including Gal- 
C, Po, MAG and MBP (Mews and Meyer, 1993; Chandross et al., 1995; Guenard et 
al., 1995; Einheber et al., 1995; Stewart et al., 1995). Thus TGFO may act as a 
neuronal signal to drive Schwann cells into the non-myelin-forming Schwann cell 
pathway. As previously described, neurons from the SCG did not induce non-myelin- 
forming Schwann cells to express Po while neurons from the DRG did (Brunden et 
al., 1992). Therefore, it is possible that some unidentified molecules which are 
expressed by SCG, drive Schwann cells into the non-myelin-forming path. TGFP 
may act as one of these molecules. Using the immunopanning method introduced in 
this thesis it should be possible to co-culture Schwann cells with purified neurons 
from different sources (SCG, DRG) or different ages (E14, newborn). TGFP 
neutralizing antibody will be used to block the different neuronal signals from 
different sources (SCG, DRG) in these co-cultures, to determine whether TGFP acts 
as a neuronal non-myelin signal. 
The studies presented in this thesis also indicated that alteration of the biological 
activity of adult Schwann cells may contribute to the proliferation of these cells in 
both long term culture and during Wallerian degeneration. The molecular basis for 
this alteration may relate to receptor regulation in these cells. Future studies on 
receptor expression during development and also receptor regulation in different 
culture conditions might help us to understand variations in proliferation in Schwann 
cells during development and Wallerian degeneration. Based on the present study, 
-, NDF and FGF but not PDGF-BB are likely to be mitogens for Schwann cells during 
development. Therefore, one area of future studies will focus on the regulation of 
FGF-R and ErbB receptors during development by using immunocytochemistry, 
Western blotting and RNAse protection assays. 
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One other line of future research will focus on the developmental alteration of 
Schwann cell precursors in those mice with specific gene knock outs. Recent studies 
showed myelin disruption of Schwann cells in Krox-20 and Oct6/SCIP knock out 
mice (Herdegen et al., 1994; Bermingham et al., 1995). It is of interest to further 
study the role of these genes in Schwann cell development and myelination in vitro 
and co-culture system. 
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